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This thesis provides a description of the development of electrospun hydrogel fiber 
strings, fiber sheets, and fiber tubes by characterizing their property changes with 
variations in spinning properties such as collector rotation speed, solution concentrations, 
and crosslinking conditions, for biologically derived materials such as alginate, fibrin, 
collagen, and hyaluronic acid. The basic, as spun, fibers were applied to several clinical 
applications including guidance of axons and Schwann cell outgrowth in peripheral nerve 
repair using fibrin and collagen fibers, where guidance by the collagen fiber sheets 
improved neurite outgrowth by 2.5 mm over 14 days compared to anisotropic collagen 
gels; alignment and maturation of cardiomyocytes, adipose-tissue derived stem cells 
(ASCs), and microvessel network formation in cardiac patches composed of fibrin; skeletal 
muscle implants formed through use of porous fibrin generated by removing co-spun 
alginate via sodium citrate treatment; and fibrin fiber-based vascular grafts to demonstrate 
the versatility and utility of the material for enhancing ECM deposition from vascular cell 
types and perfusibility. These hydrogel fibers were then modified to serve as growth factor 
delivery vehicles to enhance cellular interaction and provide the topographical guidance to 
promote neurite outgrowth for improving peripheral nerve regeneration through local 
release of GDNF. A robust protective nerve guide outer conduit, to serve as a carrier for 
hydrogel fibers, was developed in collaboration with a corporate partner, the Secant Group 
(Telford, PA, USA) using poly(glycolic acid) (PGA) braided tubes that were coated with a 
biodegradable elastomer, poly(glycerol sebacate) (PGS). The fibrin-loaded PGA/PGS 
conduits were implanted in a rat sciatic nerve defect model to assess their effect on nerve 
regeneration, the local inflammatory microenvironment, and improvement in coated tube 
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mechanical properties to ease surgical handling of the guide. PGS-coated conduits 
improved the M2/M1 macrophage ratio and improved action potential amplitudes 
compared to the uncoated nerve guide group. In addition, PGS-coated conduits containing 
electrospun fibrin hydrogel fibers and collagen fibers with uniform and gradient 
presentation of loaded neurotrophic factor were evaluated in a rat sciatic defect model to 
determine the potential feasibility of hydrogel fibers for peripheral nerve repair. Nerve 
guide groups containing collagen fiber sheets showed high permissivity of cells through 
the aligned hydrogel structure. These studies demonstrate the broad potential and unique 
properties of the hydrogel fibers for regenerative engineering applications. 
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Research and development of innovative engineered products requires the 
interaction with, and contribution of ideas from, many people. This Ph.D., in particular, 
was primarily focused on the generation of new electrospun materials technologies and 
engineering products for use in many tissue engineering applications including: peripheral 
nerve guides, cardiac patches, vascular grafts, therapeutic delivery systems, ocular patches, 
liver regeneration scaffolds, and the development of a plethora of tools and methods to 
quickly prototype solutions to other potential needs and problems as they arise. Out of the 
many people who helped along the way, the first and foremost person I would like to thank 
is Dr. Hai-Quan Mao for allowing me to join his lab effectively as a walk-on whose only 
relevant background was Mrs. Geesman’s 9th grade biology from before the human genome 
was fully sequenced and some experience with biological coatings while working in the 
orthopaedics industry prior to starting a master’s at JHU. Dr. Mao gave me a fair 
opportunity to develop my skills as I caught up with the field of tissue engineering, 
developed my soft materials science knowledge, and learned many new lab techniques. I 
would particularly like to thank Dr. Mao for giving me way too much freedom in 
determining my own workflow and projects during my Ph.D. studies. Both Dr. Mao and I 
were awful at saying no to projects and collaborations, which made my six years at Hopkins 
incredibly stressful, but I wouldn’t have learned nearly as much during my time here if this 
weren’t the case. 
There are several people I’d like to thank from before my time at Johns Hopkins 
while I was working DePuy Orthopaedics (now DePuy Synthes). Jim Smous helped 
coordinate a position for me at DePuy in R&D that allowed me to escape the nightmare 
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year I had stuck in limbo trying to find employment after graduating from Purdue 
University directly into the Great Recession of 2008. I want to thank Craig Ernsberger for 
his patience as my engineering skills transitioned from the theoretical style of problem 
solving that plagues undergraduate thinking to a more practical based thought process that 
proved to be invaluable during my Ph.D. studies. Dr. Weidong Tong took me under his 
wing while at DePuy and was a great mentor during my time there and taught me, along 
with Craig, that sometimes when you need to determine the adhesion of something, to just 
throw it on the ground. Lastly from DePuy I’d like to thank Dr. Jason Langhorn for his 
constant willingness to help me solve practical problems that arose in my labwork there 
and for being the only other one there that would get excited when it was World Cup time. 
I’d like to thank the fellow Mao lab members that served in the trenches with me 
during my time in the lab. Dr. Russ Martin has been a great person to go to for advice and 
was always willing to share his experiences of his Ph.D. process at Hopkins, which was 
very helpful for my own preparation for big milestones such as the thesis proposal and 
dissertation. Dr. Kellin Krick and Dr. Jose Roman were always great sounding boards for 
more outlandish ideas and were great resources for getting BME perspectives on potential 
solutions. Dr. Markus Tammia helped jumpstart my skill acquisition early on in my Ph.D. 
research with anything related to cells or immunostaining and was an incredible source of 
knowledge on anything related to Schwann cells and peripheral nerves. Dr. Herdeline Ann 
Ardoña was consistently one of my favorite people to talk engineering shop with during 
my Ph.D. and I look forward to seeing the great things she does as a PI in a few years. I’ll 
always look back fondly on the horribly doomed “electrospinning boat” method that we 
attempted to electrospin some of her self-assembling peptides at one point.  
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The undergraduates I had the pleasure of mentoring were all great troopers with 
their willingness to put up with any electrospinning tasks they were delegated. I want to 
give special thanks to Brook Jeang who was the first undergraduate student I mentored. 
Brook was incredibly helpful during the early to middle stages of the project where there 
was still a lot of flux in the spinning processes for many of the materials that were 
standardized by the end of this Ph.D. She helped to push forward potential modification 
methods of the fibrin fibers with her research into heparinization of the material and the 
subsequent release of growth factors during her senior design and master’s work. It was 
fantastic seeing her develop from a highly dependent undergraduate student researcher to 
one able to independently determine what important experiments needed to be run to test 
her own independent hypotheses. Lucy Li helped to advance some of the later fibrin fiber 
bundle spinning work during her time in the lab. Zachary Olah helped with the fibrin and 
collagen fiber sheet development. Haoze Duan was a great help with his production of 
alginate sheets for liver regeneration projects. 
The postdocs in the lab were always a great help and I want to thank Dr. Shuming 
Zhang for the training he provided me in the electrospun hydrogel platform he initially 
developed and the trust he placed in me to carry the technique forward as his successor. 
Dr. Huanhuan Liu was instrumental in the characterization of macrophage response results 
in Chapter 4 with the PGS coated materials and Dr. Jisuk Choi was of great assistance 
during the pilot PGS experiments with Schwann cell adhesion on the coating. Dr. Xiaowei 
Li was an indispensable source of knowledge on soft hydrogel materials and neural stem 
cell biology and provided much of the early cell training I received early in my Ph.D. Of 
all the postdocs, I want to give greatest thanks to Dr. Xuesong Jiang who had the 
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unfortunate pleasure to sit directly behind me in lab and surely came to dread the sound of 
my chair spinning around followed by “Hey Xuesong…” with whatever random idea I had 
at the moment. 
A key cornerstone of this Ph.D. are the collaborations that occurred and I want to 
thank all of those who placed their trust in the materials developed in this thesis for their 
own research. Dr. Sebastian Barreto-Ortiz was one of the earliest adopters of the 
electrospun hydrogel materials with his use of electrospun fibrin fiber bundles for vascular 
applications and characterizing the deposition and orientation of ECM from vascular 
support cells. Dr. Pinar Huri and Jordie Gilbert-Honick utilized alginate-fibrin composite 
fiber bundles to tune mechanical properties and porosity for skeletal tissue engineering 
projects. Justin Morrissette-McAlmon has been the source of one of my favorite 
collaborations with our development of implantable cardiac patches that mimic the 
properties of heart myocardium using aligned fibrin fiber sheets. This collaboration is 
particularly special as it was initiated by the two of us bumping into each other one 
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gels and was started without instigation by either of our respective PIs. Morgan Elliot has 
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Chapter 1   Hydrogels and Topographical Alignment 
Cues in Tissue Engineering 
 
1.1 Tissue engineering 
 
Modern tissue engineering is an excellent example of a rapidly evolving field that 
has developed as a result of the intersection of two previously unrelated fields of study, 
biomaterials science and cellular engineering, for solving tissue related medical problems 
with many advances in the field being made as a result of collaboration between surgeons 
and engineers.  In essence, modern tissue engineering is focused on restoring or improving 
function though a combination of: 1) scaffold design, 2) cellular interactions between 
scaffolding and native tissue, and 3) the application of biological factors to enhance cellular 
response.  Application of these three key design factors present the tissue engineer with the 
flexibility required to improve patient recovery from injury and disease to a plethora of 
tissues in the body, all having unique properties and function. 
Very early instances of tissue engineering were generally related to applications 
involving the grafting of skin with modern grafting applications being established by 
Webster’s studies in graft preservation during the twilight days of World War II [1]. Prior 
to World War II, implantation of biomaterials was primarily focused on biocompatibility. 
It wasn’t until following the war that a shift occurred leading to improved focus on 
performance materials following implantation. Noteworthy with this is the development of 
early metal-on-polymer hip implants by Sir John Charnley who first developed hip 
implants where the wear properties were first taken into account as a design parameter 
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during the engineering of the device. Whereas previously hip implants had been metal-on-
metal, Charnley developed metal on ultra-high molecular weight poly(ethylene) 
(UHMWPE) implants to reduce wear, reducing inflammation and extending the lifetime of 
the implant before revision surgery was needed [2]. Improvements in cell culture and 
expansions techniques were made throughout the 1940s through 1960s that truly opened 
the door for the tissue engineering field to begin to coalesce. Shortly thereafter, rapid 
advancements were made in the cryopreservation techniques for cells, leading to early off-
the-shelf skin allograft products by Genzyme in the late 1970s and 1980s [3-6].  
It was around this time that the term “tissue engineering” began to be used to 
describe the developing field at the intersection of material science engineering and cell 
based therapies to create combinatory products for replacing or promote the healing of 
damaged tissue [7]. The 1990s saw approval of several tissue engineered products by the 
FDA including coral-derived bone grafts (Pro-Osteon, Interpore), non-biological artificial 
skin (Integra), and living skin treatments for leg and foot ulcers (Apligraf, Organogenesis 
Inc). In the orthopedic industry, focus began to shift towards improving bioactivity of 
implants through the addition of calcium phosphate coatings to enhance osseointegration 
of regenerating bone with the implant [8]. This marked a turning point of engineering 
implants from minimizing unwanted negative biological responses to designing materials 
that actively interact with the body in an engineered manner. Early excitement for the field 
peaked in the late 1990’s with the widespread media circulation of the “Vacanti Mouse” 
where tissue engineered cartilage was grown using chondrocytes on the back of a mouse 
utilizing a PLGA scaffold in the shape of a human ear [9]. 
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Despite the emerging commercial market in the late 1980s and 1990s for tissue 
engineered products, the field remained high risk for investors and suffered a downturn in 
the early 2000s after the tech bubble collapse [10]. It has taken the past decade for the field 
to recover from the loss of investment and we are currently in a second tissue engineering 
boom. The largest driving force behind the current second boom of tissue engineering has 
been the development improved knowledge of stem cells and their use [11]. Recent leaps 
in tissue engineering caused by improvement in characterization and production techniques 
have yielded engineered tissue with increased complexity compared to skin grafting [12], 
cartilage [13], and bone regeneration [14], tissue which are predominantly avascular. 
Amongst these are artificial bladders containing cells cultured in vitro that are later 
implanted [15] and trachea constructs composed of decellularized extracellular matrix that 
complimented with stem cell derived cells [16]. Engineered tissues with even higher 
complexity will soon be realized as further advancements are made in materials processing 
techniques such as 3D printing, electrospinning, decellularized matrices, self-assembled 
nanofibers, microfluidics, and others technologies. Further maturity of these technologies 
along with our continually improving understanding of the manipulation, plasticity, and 
materials interaction of cells offer great hope that the early excitement and promises of 







1.2 Hydrogels and the native extracellular matrix 
 
Hydrogels are crosslinked networks of hydrophilic natural or synthetic polymers 
that are composed of mostly water by weight. Due to their 3D crosslinked structure, 
hydrogels behave much like solids despite being mostly solution. They make an excellent 
implantable tissue engineering material due to their mimicry of the structural and 
mechanical properties of the native extracellular matrix [17]. Hydration of hydrogels are a 
result of high negative or positive charge along the polymer chains causing an attraction of 
water due to water’s dipole structure. Because of this, both naturally derived and synthetic 
materials can be used for hydrogel formation through a variety of crosslinking methods 
such as ionic [18], changes in pH [19], addition of photocrosslinkable molecules [20], or 
even combinations of orthogonal crosslinking methods to create interpenetrating networks 
of different hydrogel materials [21, 22]. Gelation for many materials can be induced 
through either a physical process such as repeated freeze-thaw cycles [23] or through 
chemically induced crosslinks [24]. Hydrogel materials are particularly important for 
recreating the native 3D microenvironment that is home to cells and their use enables cells 
to avoid unusual integrin binding patterns that are forced to exist in 2D cell culture systems 
[25].  
Synthetic materials typically used for gel formation include poly-L-lactide (PLA), 
polyurethane, polyethylene glycol, and others [26-28]. Usage of hydrogels are highly 
dependent on the material and its specific properties, such as the high oxygen permeability 
of poly(2-hydroxethyl methacrylate) (Poly(HEMA)) for creation of contact lenses [29], or 
the temperature dependent swelling and contraction of poly(N-isopropylacrylamide) which 
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will shrink and exclude water when heated above its lower critical solution temperature, 
making the material excellent for easily releasing engineered cell sheets [30]. The good 
biocompatibility of poly(ethylene oxides) (PEO) make them excellent materials for 
modifying the surfaces of other implantable materials to induce ‘stealth’ like properties 
that bypass immune system response due to this high hydrophilicity minimizing protein 
adsorption [31] although they have low biodegradability without copolymerization with 
hydrolysable materials [32]. PEO is frequently used for drug delivery applications though 
block copolymer formation with other materials such as poly(propylene oxide) to create 
thermally reversible gels [33] and can enhance drug uptake [34]. 
Synthetic hydrogel materials are particularly applicable where high batch-to-batch 
consistency is required as the precursor materials will be more homogeneous than naturally 
derived materials that may have variation in properties due to differences in materials 
sourcing or age. Additionally, synthetic materials allow the generation of highly tuned 
modification chemistries to control mechanical, release, and degradation properties. Such 
an example is the modification of PEO chain ends with photocrosslinkable acrylate groups 
for gelation upon exposure to UV light and photoinitiatior or addition of polymers in a 
block copolymer that are more susceptible to hydrolytic degradation [35]. Peptide 
engineering has gained significant traction in the past decade, enabling researchers to 
generate specific amino acid sequences to control hydrogel properties. These polypeptides 
can be directly gelled with themselves to form structures such as self-assembling aligned 
gels [36] or electrically active peptide-π-peptide triblock self-assembled peptides that have 
excellent energy transport properties in aqueous environments [37] that have great potential 
as tissue engineering constructs for action potential propagating tissues such as cardiac 
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tissue or nerve. Other synthetic hydrogels have been developed for delivery of BMP-2 
during remodeling of bone defects [38], or particular structures like ECM-like poly(lactic 
acid) (PLL) foams [39] and poly(glycolic acid) (PGA) fibers to reinforce coating collagen 
sponges [40]. Synthetic hydrogels have excellent biocompatibility and can be designed to 
have extensive structural lifetimes while retaining high strength after implantation or have 
more rapid degradation as needed based on copolymerization techniques, enabling highly 
application-specific hydrogel engineering and furthermore can be combined with natural 
biomaterials to make hybrid structures. 
Naturally derived hydrogel materials such as alginate, chitosan, collagen, fibrin, 
silk, fibronectin, and decellularized ECM provide improved biocompatibility and can 
better mimic the native extracellular matrix compared to synthetic hydrogels [41-45]. Even 
DNA itself has been used to create natural hydrogel materials [46]. While naturally these 
materials have great biocompatibility, there exists several potential problems with their use 
including high chance of xeno-immunogenic response, difficulty in tuning their 
degradation due to the presence of native degradation enzymes, and the weak mechanical 
properties of the materials make them difficult to handle and process [47, 48].  
Generation of decellularized ECM began in the late 1940s with the first removal of 
cells to isolate muscle tissue ECM by Poel [49]. Use of decellularized ECM truly did not 
become in vogue until Stephen Badylak used decellularized pig small intestine ECM to 
enhance Achilles tendon repair strength in a canine model in 1995 [50]. Since then, there 
has been some clinical investigation of the usage of decellularized porcine heart valves and 
decellularized trachea, though in both cases some complications arose either due to 
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incomplete decelluarization in the case of the heart valves or development of stenosis in 
the decellularized trachea [51, 52].  
The extracellular matrix provides the structural support for cells throughout the 
body by providing the mechanical framework to help tissues maintain their shape and is 
generally produced by resident fibroblasts and epithelial cells in a given tissue [53]. 
Additionally, the ECM provides adhesive cues for cells to provide cues for migration, 
proliferation, and differentiation [54]. The ECM is under a constant state of remodeling by 
cells and is generally composed of fibrous proteins such as collagens and elastin serving 
as the main structural support and providing elasticity respectively [55]. Hydrophilic 
proteoglycans such as hyaluronic acid uptake water and provide tissues with resistance to 
compressive forces [56]. A critically important structure in the body, ECM takes up around 
25% of protein mass in mammals [57] with collagen types I, III, IV, V and XI being highly 
ubiquitous collagens within the ECM [58] providing structural support and sites for other 
ECM components to bind. Another role of the ECM is uptake and capture of soluble growth 
factors and adhesion molecules for cellular signaling [56].  
Adhesive proteins such as fibronectin and laminin are produced by fibroblasts and 
other cell types and captured by the ECM. Integrins in the cell membrane link signaling 
from ECM mechanical, directional, and adhesive cues to the cytoskeleton which can 
remodel itself in response to these cues [59, 60]. Fibronectin can bind to collagen and 
heparin sulphate proteoglycans through its fibronectin type III domain, a pair of anti-
parallel β-sheets containing RGD amino acid sequence (Arg-Gly-Asp) for cellular integrin 
binding and heparin binding domains; other smaller fibronectin binding domains help bind 
the adhesive cue to other fibronectin molecules or fibrin [61]. Laminins are found more 
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frequently in the basement membrane of the ECM and are composed of three subunits, α,β, 
and γ domains forming a cross-shaped structure that binds to other laminins and 
components of the ECM [62]. 
The final main component of the extracellular matrix are heparan sulfate 
proteoglycans (HSPGs) such as perlecan, collagen XI, syndecan, and others that consist of 
protein backbones containing heparan sulphate side chains that interact with other 
structural proteins and water. HSPGs can be either secreted from cells or cleaved from the 
cell membrane [63, 64]. HSPGs play a role much like glue in the ECM by binding to many 
different ECM proteins and capturing soluble growth factors to control their diffusion and 
release kinetics. Heparin binds an incredible number of ECM and soluble factors including 
VEGFs, GDNFs, HGFs, PDGFs, FGFs; cytokines like the interleukin series, interferons; 
and to adhesive cues such as laminin and fibronectin [65, 66].  
Mechanical properties of the extracellular matrix have a substantial impact on the 
cellular behavior, often providing a driving force for differentiation of stem cells to specific 
lineages [67]. Stiffness of the ECM directly impacts the organization of actin filaments 
within the cell that form the cytoskeleton by increasing filament organization with stiffness 
increases by altering the formation and organization of focal adhesion [68]. Additionally, 
stiffness of the extracellular matrix can affect the migration, proliferation, and survival of 
cells [69]. 
Cellular interaction with the ECM is primarily through transcellular membrane 
integrins that act as receptors for cellular adhesion for specific peptide sequences within 
adhesion proteins [70]. These receptors are heterodimeric composed of a combination of 
one of eighteen α subunits pairing with one of eight β subunits [71]. The pairing of the 
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specific α and β domains in the cell membrane determines the ECM proteins that it can 
bind with [72]. Primary integrin binding is through the RGD motif found in fibronectin and 
other ECM proteins such as laminin and vitronectin [70]. Specificity of integrin binding to 
RGD sequences are impacted by the amino acids surrounding the RGD site and the overall 
density and spacing between RGD binding sites [73, 74]. Integrin activation is driven by 
the polymerization and depolymerization of actin filaments within the cytoskeleton 
allowing cells to effectively deactivate integrin binding to the ECM when cells need to 
remain in circulation such as red blood cells or for turnover during extension of 
lamellipodia and its restructuring of the cytoskeleton during cellular traction to enable cell 
motility [60, 75, 76]. Addition of these adhesive motifs to synthetic biocompatible grafting 
materials has been found to substantially improve cellular response [77, 78].  
Proteins that make up the ECM have binding sites for not only adhesive cues, but 
also for growth factors to prolong their lifetime and control the spatial distribution and 
release for cell signaling. Capture of growth factor or adhesion peptides by the ECM as the 
factors diffuse away from their source provides a natural mechanism for generation of 
soluble growth factor gradients that play a particularly important role during wound repair 
and development [79, 80] as well as establishment of adhesive ligand gradients [81]. 
Soluble growth factors will frequently be captured by HSPGs and then released from the 
proteoglycan after cleavage of heparan sulphate by heparinase [82]. Integrins specific for 
particular growth factors such as the VEGFR2 receptor work together with adhesion site 
integrins to promote improves specificity to ECM captured signals based on the integrin 
expression profile of particular cell types [83].  
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Remodeling of the ECM is primarily driven by interaction of matrix 
metalloproteinases (MMPs) or heparanases with the matrix structure. There exists at least 
24 different types of MMPs that are either presented as transmembrane structures or 
solubilized and secreted by cells to cleave extracellular matrix proteins, captured adhesion 
cues, and growth factors [84, 85]. Tissue inhibitors of metalloproteinases (TIMPs) regulate 
the levels of MMP present to ensure excessive degradation of the ECM does not occur 
[86]. Heparanase also plays an important role in ECM remodeling by cleaving heparan 
sulphate groups from HSPGs, causing a reduction in the crosslinking of the ECM and 
releasing captured growth factors [87]. 
 
1.3 Structural anisotropy in biological tissues 
 
Anisotropy in biological tissue is critically important for the function many tissues 
including tendons, ligaments, muscle, nerves, cardiac, vascular, and bone. Tendons require 
high strength along their long axis and are composed of highly aligned collagen fiber 
bundles [88]. Loss of tendon function with age is generally due to changes in the collagen 
fiber structure, with additional crosslinking of collagen over time reducing elasticity by 
increasing collagen aggregation [89]. These issues are further compounded by slower 
degradation and remodeling of collagen as collagenases are generated in lower amounts 
with age [90].  
Alignment of the vascular epithelium with direction of blood flow is critically 
important to provide flexibility for blood vessels and give them sufficient tensile properties 
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to avoid rupture during pulsatile blood flow [91]. Circumferential alignment of the exterior 
ECM of vasculature provides the mechanical feedback during flow to maintain smooth 
muscle cells (SMCs) in a healthy contractile phenotype, as opposed to a repair phenotype 
present in several disorders that deposits ECM [92]. Longitudinal alignment in the blood 
vessel lumen helps enhance shear flow stress induction of endothelial cell alignment and 
polarization [93]. Disruptions in the ECM and therefore endothelial alignment can cause 
many issues including altered permeability, increased inflammation due to disruptions in 
flow, and other vascular problems [94]. 
Muscle cells require axial alignment for effective contraction [95, 96], thus any tissue 
engineering solution for implantable muscle must provide an aligned matrix or function 
will be compromised. The fusing of muscle cells into striated myotubes that run the entire 
length of the muscle needs alignment features to be a major consideration of design or 
muscle tissue will have function severely impacted [97]. Two dimensional substrates can 
provide the alignment cues needed for muscle cell organization but even so, function is 
highly limited without a consistent method for generation of muscle tissue in 3D [98]. 
The ECM of cardiac tissue has native alignment to it that provide organizes cardiac 
cells to ensure contractility is strong enough to pump blood throughout the body [99]. 
Conduction of the action potential propagates most rapidly along the direction of alignment 
and many pathological heart conditions are the result of disruption to the anisotropy of 
cardiac ECM organization [100]. Organization of engineered cardiac tissue is currently 
generated through several strategies including mechanical stimulate of cells [101], 
cardiomyocyte entrapment in fibrin gel scaffolds [102], or aligned collagen substrates 
[103]. Electrically conductive nanofibers have also been investigated to form 3D meshes 
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for cardiac tissue patches through the weaving together of multiple layers of aligned fibrous 
PCL-silk-carbon nanotube composites [104]. 
 
1.4 Topographical and neurotrophic guidance for nerve repair  
 
As the regeneration speed of axons act as a primary limiting factor for successful 
nerve regeneration, much of the recent work has been focused on improving the speed of 
axonal outgrowth and SC migration rates, as a primary function of immature SCs are to 
lead the axons across the injury gap through secretion of NFs [105]. Strategies employed 
to improve nerve guidance conduits (NGCs) include incorporation of growth factors, 
surface modification, substrate patterning, usage of porous foams, aligned fibers, and 
combinatorial approaches attempting to enhance regenerative speed [106]. Aligned 
electrospun nanofibers have previously been used to artificially provide topographical 
guidance cues for Schwann cell migration that are normally provided by the axon in healthy 
tissue [107]. Topographical alignment has been shown to have strong effect on the 
orientations of both axons and SCs relative to random fiber meshes or planar tissue culture 
surfaces and lead to an improved regenerative outcome due to the guidance cue they 
provide, although they have yet to reach the performance level of the autograft [108]. 
Topographical guidance by nanofiber-based conduits typically improves the number of 
myelinated axons throughout the conduit relative to empty tubes. Although topographical 
guidance could be provided by electrospun nanofibers, they fail to upregulate specific 
proliferative or phenotypic responses during their interaction with cells and typically do 
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not match the mechanical properties of the native microenvironment that the cells are 
accustomed to. Other methods of generating topographical guidance cues to improve nerve 
regeneration have included strategies such as forming oriented channels in scaffolds 
through use of degradable templates [109] and directed freeze processes [110] to mimic the 
endoneurial tube structure for guidance of axonal outgrowth. 
Guidance of endogenous SCs is of particular importance in enhancing nerve 
regeneration due to the numerous roles of SCs in the PNS repair process [111-113]. 
Immediately following nerve injury, SCs precede the axons into the lesion site, self-
assembling into cord-like structures, and secrete extracellular matrix to form tracks upon 
which regenerating axons grow while producing a cocktail of NFs that promote neuron 
survival and growth of regenerating neurons to the distal stump. To maximize neuronal 
infiltration into the nerve guide, it is imperative to design fibers that maximize SC 
migratory speed through a combination of fiber alignment and neurotrophic cues. 
Neurotrophic factor gradients  provide directional cues to maximize SC infiltration towards 
the distal end of the nerve guide where they can continue to secret soluble factors that drive 
axonal outgrowth. SCs have been shown to respond strongly to GDNF as a migratory cue 
[114] and gradient steepness plays an important role in cellular response such as in the 
study by Cao et. al. showing improved migratory rates of PC12 cells as NGF steepness 
increased [115].  
As a method of enhancing the regeneration of nerves, various approaches of 
delivering exogenous NFs to the injury site have been explored using hydrogels, 
microspheres, and viral-based gene transfection methods to promote neural survival and 
enhance axonal outgrowth across the injury gap [116-120]. Delivery of uniform 
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concentrations or excessively high concentrations of NFs have been shown to trap axon 
growth within the conduit, referred to as the “candy store effect”, results in poor functional 
outcome by limiting the number of axons that exit the conduit into the distal stump due to 
how beneficial the conduit microenvironment becomes for the cells [116-118]. Localized 
delivery and presentation of diffusible or immobilized NF gradients within nerve conduits 
could provide an avenue for improvement in regeneration of nerves compared to isotropic 
delivery of NFs by better driving a higher number of axons towards the distal portion of 
the nerve guide more rapidly. Depletion of gradient loaded soluble NFs, or degradation of 
collagen fibers loaded with immobilized NFs, over time provides a reliable mechanism to 
eliminate any “candy store effect” that might be present. 
While there are a myriad of neurotrophic factors beneficial to nerve regeneration, 
well studied heparin-binding factors include GDNF, PTN, and NGF as these have 
significant phenotypic dependent effects on regenerative outcome. GDNF has been shown 
to have many benefits for nerve regeneration including Schwann cell viability, motility, 
and myelination capacity, and primarily enhances neuron survival [121]. Upregulation of 
PTN expression after peripheral neuropathy enhances motor neuronal survival and leads to 
increased myelination [122]. NGF provides a similar overarching role as GDNF but has 
increased beneficial effects for sensory nerve outgrowth [120]. By selective usage of 
specific neurotrophic factors, we can selectively design fibers to maximize functional 
outcome for motor, sensory, and mixed neural populations. Several strategies for delivering 
GDNF and NGF gradients have been proposed to enhance unidirectional migration of 
axons in vitro over short lengths [123-125]. However, the lack of technical platforms for 
preparing and testing tuneable gradient patterns on a multi-centimeter scale has limited 
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advancement in applying gradient delivery methods in vivo, minimizing their potential use 
for long gap injuries where the therapeutic need is greatest. Our diffusion-based gradient 
method presents a technological advance that enables generation of multi-centimeter length 
gradients for use in critical nerve gap regeneration. 
 
1.5 Peripheral nerve regeneration and current clinical repair options 
  
Undamaged nerve tissue consists of numerous fascicles containing paired axons 
and Schwann cells (SCs) organized anisotropically within a protective endoneurial 
structure that acts as the blood-nerve barrier and is surrounded by an extracellular matrix 
consisting predominantly of collagen and laminin [126, 127]. Within the nerve fascicles, 
mature SCs will anchor themselves to the basal lamina and collagen IV and wrap 
themselves around their partner axon with multiple layers of myelin that prevent loss of 
signal during action potential conduction [128]. Disruption of the nerve structure following 
injury causes axons within the damaged distal nerve to die off through the process of 
Wallerian degeneration where SCs react to dying axons by dedifferentiating from a mature 
myelinating state, to an immature proliferative state as they, and macrophages, phagocytize 
the axonal and myelin debris [129]. Circulating fibrinogen accumulates in the wounded 
nerve due to blood vessel rupture to form a disorganized fibrin clot that guides the 
migration of the newly proliferating SCs across the injury site [130]. During their migration 
after injury, SCs form cellular tubes, known as bands of Büngner, that guide the growth of 
regenerating axons from the proximal region to reinnervate the distal target and secrete 
neurotrophic through contact and chemotrophic guidance [131]. Once the axons have 
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successfully reconnected with the distal target, SCs revert back to their mature pro-
myelinating phenotype in response to axonal membrane-bound NRG1 type III signaling 
amongst other factors including repair of the ECM [108, 132].  
The degree of functional recovery rapidly decreases with increasing gap size due 
to a combination of factors including: regenerating axons reestablishing connections with 
incorrect distal targets, atrophy of downstream motor targets due to prolonged lack of 
neural connection, and axons being unable to navigate through the buildup of collagenous 
scar tissue secreted by fibroblasts over time [133]. Due to these factors, the critical gap 
distance at which human nerves can no longer successfully regenerate unassisted is around 
5 cm which can take up to two months for repair at typical axonal outgrowth rate of 1-2 
mm/day [134-136].  
Over short injury gaps, up to 2–5 centimeters in length, treatment options include 
usage of commercially available nerve guides in the form of collagen (NeuroMatrix and 
NeuraGen) or porcine submucosa (AxoGuard) hollow tubes. These provide a protective, 
biodegradable environment for nerve regeneration but lack guidance cues or growth factor 
incorporation to enhance regeneration and are limited to use with injury gaps lengths of up 
to 3 cm. The gold standard for larger gaps are the nerve autograft and to lesser extent, the 
allograft.  The autograft provides a preconstructed extracellular microenvironment like 
healthy nerve but has several distinct disadvantages. Autografting requires donor nerve 
from the patient thus a second surgery to take out a graft nerve, which can result in donor 
site morbidity and loss of function for the donor nerves previously associated target, and 
typically a sensory nerve from the patient’s leg that has smaller caliber nerves than the 
motor nerve it replaces [137]. To date, the only long gap autograft alternative is processed 
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nerve allografts (Avance®), which uses decellularized nerve to preserve the axon-SC 
tubular structure for guiding axonal regeneration. However, it also has several 
disadvantages relating to potential immunogenicity, difficulty in storage and transport of 
the grafts, and limited availability of donor nerve tissue for decellularization; the latter two 
issues increase downstream cost to the patient. Moreover, structural mismatch between the 
graft nerve caliber and the damaged nerve also decreases the potential effectiveness of graft 
nerves.  
 
1.6 Electrospun hydrogel microfibers 
 
Electrospun hydrogel microfibers are created through a modification of traditional 
electrospinning processes where an electrical field is applied to an extruded polymer 
solution, drawing out a polymer jet that then lands on a grounded rotating collector (Fig. 
1.1).  To generate collagen or fibrin hydrogel fibers and sheets, collagen or fibrinogen are 
spun onto a rotating collection dish that contains aqueous crosslinking agents that rapidly 
form fibers and capture the electrically induced alignment of the biopolymer chains. 
Individual fiber diameters can be adjusted by variation in parameters such as flow rate, 
polymer concentration, needle size, and collector spinning speed (Fig. 1.2) [138]. Inducing 
molecular alignment (Fig. 1.3) of the biopolymer chains via electrospinning enhances the 
mechanical properties beyond that can be obtained with as-cast bulk isotropic hydrogels of 
similar composition and crosslinking properties. The tensile moduli of several biopolymer 
hydrogel fibers were measured using dynamic mechanical analysis and found to range from 
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10s to 100s of kPa when hydrated. Electrospun fibrin hydrogel tensile moduli after drying 
and rehydration are similar in range to sciatic nerve tissue (580 kPa) [139]. By varying the 
method of collection, an array of hydrogel fiber geometries can be generated, including 
collection as fiber bundles, filaments, sheets, and tubes (Fig. 1.4). The combined 
topographical guidance cues and tunable ECM-like mechanical properties of electrospun 
hydrogel fibers provide a material that can be applied to many tissue engineering 
applications such as nerve, cardiac, vascular, and skeletal muscle repair where direct 
interaction of cells with topographical guidance by the substrate is beneficial (Fig. 1.5).  
 
1.7 Study Design 
 
The study design was focused on development of electrospun hydrogel fibers and 
characterization of mechanical property changes with variations in spinning properties 
such as collector RPM, solution concentrations, additional crosslinking following the spin, 
etc. The basic, as spun, fibers will be applied to several tissue engineering applications to 
demonstrate the versatility of the material and its ability to be used in multiple geometric 
configurations. Next, several methods of modification of the base fibers will be 
investigated, targeting the development of these materials as a growth factor delivery 
vehicle to enhance cellular interaction. The effect of the hydrogel fiber materials on cellular 
outgrowth, using both modified and unmodified fibers, will be characterized along with 
the organizational capacity of the fibers to induce oriented cells along the topographical 
guidance cues presented. As an improved potential nerve guide carrier for hydrogel fibers 
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over electrospun nanofibers, an industrial collaboration with the Secant Group (Telford, 
PA, USA) was established and a poly(glycerol sebacate) (PGS) coated tube composed of 
poly(glycolic acid) (PGA) was implanted in a sciatic nerve defect to examine the effect of 
PGS on nerve regeneration, the local inflammatory microenvironment, and improvement 
in coated tube mechanical properties (Fig. 1.6). Finally, a collaboration with Sun Yat-Sen 
University (SYSU) (Guangzhou, P.R. China) was established to test PGS coated tubes 
containing electrospun hydrogel fibrin and collagen fiber materials with uniform and 
gradient loaded neurotrophic factor as a method of peripheral nerve repair of the sciatic 




Development of electrospun hydrogel materials enables the generation of ECM-
like materials that can be used to provide topographical guidance cues for the outgrowth of 
Schwann cells and the axonal growth cone. Use of native materials for these microfibers 
enables remodeling of the implanted materials using the same cellular mechanisms that are 
present during remodeling of the ECM. As these materials are at the intersect between 
traditional biologically derived hydrogels and electrospun nanofibers, techniques used in 









Figure 1-1: Electrospun hydrogel fiber generation. 
Electospun hydrogel fibers are prepared by electrospinning precursor solution onto rotating 
collection bath containing crosslinker (a) that provides additional mechanical strain to 
further align the hydrogel polymer chains during crosslinking, thereby improving strength 
compared to cast hydrogels to the point where hydrogel fibers can be directly manipulated 
(b). Several biologically derived and modified polymers are compatable with hydrogel 
fiber spinning including, but not exclusively, alginate (c1), fibrin (c2), collagen derived 





Figure 1-2: Individual distinct fibers formed during electrospinning of alginate 
hydrogel microfibers. 
Micron scale individual fibers aggregate together to form bulk electrospun hydrogel fiber 
structures. The size of the individual hydrogel fiber strands are in the same range as the 








Figure 1-3: Fiber alignment is enhanced by hydrogel fiber spinning compared to 
isotropic cast gels. 
Cast gels (a-c) show random orientation of fibrin, gelatin, and hyaluronic fibers, generating 
the isotropic bulk properties of these hydrogels. Electrospinning these materials into 
hydrogels (d-f) induced molecular alignment of the polymer chains, providing 
topographical guidance cues and anisotropic mechanical properties. Collection onto a 
rotating solution bath permits the generation of 3D structures such as fiber bundles for any 








Figure 1-4: Hydrogel fiber geometries that can be generated with the method. 
Depending on the method of collection following hydrogel fiber spinning, the material can 
be collected, going from top to bottom, 1) in the form of tubes by wrapping fibers or sheets 
around a secondary cylindrical structure, 2) straight or coiled dry strings by drying long 
fiber bundles in air for several hours to overnight, 3) sheets by spinning fibers with a 
rastering movement to distribute fibers across a wide band of the collection solution, and 
4) hydrated fiber bundles of various sizes by directly pulling hydrogel fiber strings off the 




Figure 1-5: Cells can directly interact and align with orientation of electrospun 
hydrogel fiber surfaces. 
False color images of neurites from DRG explants extending along collagen fibers 
aggregated in sheet form (left). Fibroblasts spreading along the length of fibrin filaments 
are able to extend filopodia between adjacent filaments and show elongation of the cell 











Figure 1-6: Improved mechanical properties of PGA multifilament braided tubes 
after PGS coating. 
Following coating with PGS, PGA braids show improved loading hysteresis (a) and can be 
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Chapter 2   Development and Modification of Fibrin, 
Collagen, Alginate, and Other Hydrogel 
Microfibers 
2.1 Background 
2.1.1 Alginate as a hydrogel material 
 
Alginate fibers form the basis of electrospun hydrogel fiber spinning due to the ease 
with which the material can rapidly gel through ionic crosslinking and has low cost due to 
it being a product typically derived from brown seaweed Alginate structure is composed 
of linear polymer with blocks of two different disaccharides, β-D-mannuronate (M) and α-
L-guluronate (G) [1]. The high negative charge from the carboxylic acid groups in these 
disaccharides forms an ionic crosslinking point with divalent cations. The distribution of 
alginate M and G blocks are highly dependent on seaweed source from which it is derived 
[2]. Control of the M to G block ratio and distribution of M and G blocks provide a 
mechanism to tailor pore size and mechanical properties of alginate hydrogels. Gelation is 
most frequently through interaction of the G blocks with Ca+2 though different divalent 
cations such as Mg+2 or Ba+2 can also induce gelation through interaction with M blocks 
or both M and G repeat units [2].  While not found physiologically, alginates are 
particularly good for cellular encapsulation and drug delivery [3]. The high hydrophilicity 
of alginate and lack of adhesive sequences minimizes protein adsorption and makes the 
material unable to directly interact with cells without conjugation of adhesion ligands. [4] 
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Mammalian cells do not naturally synthesize alginase to enzymatically break down 
alginates after implantation, instead, alginates slowly dissolve through a process of 
monovalent cation exchange with the divalent cations (Ca+2) crosslinking the G blocks in 
the alginate chain. 
 
2.1.2 Fibrin as a tissue engineering material and physiological role 
 
Fibrin plays a highly critical role in wound healing as part of the blood coagulation 
cascade. As part of the end phase of the blood coagulation phase, fibrin takes on the job of 
providing temporary extracellular scaffolding for cellular infiltration that is removed once 
more permanent extracellular matrix is deposited by fibroblasts and other carekeeper cells 
of the ECM. As a temporary scaffold, fibrin has the capacity to bind many cytokines that 
play a role in wound healing. Fibrin has a relatively short biological persistence as a matrix 
material due to the ease in which is degraded by plasmin and MMPs secreted from cells. 
Degradation is therefore an important factor to consider in any tissue engineering 
application where fibrin is used as the material must remain present until cellular 
infiltration is complete and homeostasis is obtained. 
Fibrin gels are easily formable at room temperature upon exposure to thrombin and 
have excellent clinical biocompatibility due to the ability to extract fibrinogen from a 
patient’s blood [5]. Aprotinin controls the enzymatic degradation of fibrin scaffolds and 
gels by inhibiting the activity of plasmin secreted as cells migration or during the wound 
healing process [6]. Fibrin plays a particularly important role in the ECM during wound 
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repair by capturing PDGFs and TGFβs to promote angiogenesis [7]. Due to its ubiquity, 
fibrin hydrogels have been successfully used in tissue engineering applications involving 
smooth muscle cells for vascular formation [8] and chrondrocytes for cartilage 
reconstruction [9]. 
Following injury to local vasculature, circulating platelets bind to collagen in the 
surrounding ECM, triggering a signaling cascade leading to the binding of fibrinogen by 
the platelets. Coagulation of blood in the wound proceeds through either an intrinsic 
pathway, caused by contact activation in associated with collagen by the platelets or an 
extrinsic pathway, caused by the rapid release of prothrombin and its activation to thrombin 
via prothrombin interaction with factors Xa and Va. This generation of thrombin promotes 
the activation of further downstream coagulation components, ultimately leading to the 
activation of factor X. Factor X is then activated by either factor VIIa and Ca+2 or the tenase 
complex formed by factor IX and VIII on the platelet surface through the extrinsic and 
intrinsic pathways respectively.  
Activated factor X interacts with the platelet cell membrane and its cofactor, factor 
V, and Ca+2, to form a prothrombinase complex that converts prothrombin to thrombin. 
The cleaving of the fibrinogen Aα and Bβ polypeptide regions by thrombin results in a 
drastic increase in fibrinogen hydrophobicity during its conversion to fibrin, causing 
precipitation of the protein [10]. As fibrin is formed, it is further stabilized by thrombin 
activated factor XIIIa which acts as a transglutaminase that chemically crosslinks 
glutamines within the fibrin amino acid sequence to lysine in other fibrin molecules, 
increasing its resistance to proteolytic degradation [11].  
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The biological role of fibrin as a sealant and temporary scaffolding has led to its 
clinical usage primarily as a hemostatic sealing agent with several FDA approved sealants 
available such as Tisseel® and Evicel™ by Baxter and Ethicon, respectively. Besides its 
usage as a fibrin glue, fibrin is also currently being used for tissue engineering applications 
in the form of hydrogels and microbeads. Due to its ubiquitous nature, fibrin has been used 
for cardiovascular, muscular, angiogenic, and neuronal tissue engineering applications 
amongst others.  
In particular, fibrin has been used in nerve guides as a luminal filler in short gap 
studies [12]. Neurites are particularly adept at navigating fibrin due to their ability to 
enhance fibrinolysis through plasmin secretion at the neurite tip as demonstrated by the 
reduction of neurite outgrowth of embryonic chicken dorsal root ganglia when aprotinin, a 
plasmin inhibitor, was added to cell culture media [13, 14]. In the late 1990’s, fibrin glues 
were shown by several groups to successfully reconnect dorsal root stumps to the spinal 
column [15]. 
 
2.1.3 Collagen as a tissue engineering material and physiological role 
 
Collagens have high levels of structural variation with at least 28 types having at 
least a single triple-helical domain [16]. A triple helical structure is a defining feature of 
collagen where three procollagen strands aggregate together through a combination of 
hydrogen and covalent bonds during their biosynthesis [17, 18]. Stabilization occurs 
through the combination of a glycine residue present every third amino acid in the chain 
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backbone resulting in characteristic ~65 nm banding structures repeat when viewed under 
TEM [19]; interchain hydrogen bonding caused by the high amounts of proline and 
hydroxyproline [20]; and electrostatic association between lysine and aspartic acid residues 
[21]. Collagen mechanical properties can be further enhanced through the addition of 
chemical crosslinkers [22], physical gelation treatments such as freeze drying [17, 23], and 
blending with other materials to form composites [24-26], making collagen a remarkably 
flexible biomaterials engineering material. Physiological collagen can be degraded 
enzymatically through collagenase secretion by cells, allowing the material to be 
remodeled after implantation. Collagen applications include use as a tissue culture 
substrate, in liver [27], skin [28], and nerve repair [29]. Following implantation, secretion 
MMP-1 by cells will preferentially degrade collagen I while denatured collagens such as 
gelatin are degraded by MMP-2 [30].  
Electrospinning of collagen is not new as several groups have shown the capacity 
to electrospin the material into nanofiber meshes using organic solvents. Deliberation 
exists within the literature as to the effect organic solvents have on the collagen during the 
spinning process. Some groups argue that the use of organic solvents denatures the collagen 
fibers into gelatin, yielding nanofibers meshes made up of gelatin rather than collagen, 
reducing some of the bioactivity and reducing the biomimicry of the electrospun collagen 
nanofibers to the native ECM [31, 32]. Others argue that electrospun collagen nanofibers 
still maintain good biological properties and that the striated structure of collagen remains 
even after electrospinning using organic solvents [33]. 
Denaturation of the triple helical structure of collagen into their individual fibril strands 
results in the formation of gelatin. Collagen denaturation is most frequently obtained via 
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combined acidic and thermal treatment or exposure to strongly basic solutions. It is simple 
to make hydrogels through decreases in temperature causing physical entanglement of the 
gelatin strands although these gels tend to have weak mechanical properties and need to be 
modified for improved strength [34].  
 
2.1.4 Hyaluronic acid as a tissue engineering material and physiological role 
 
Similar to collagen, hyaluronic acid is particularly prevalent throughout the body 
and found in most tissues to some degree [35]. HA is a particularly important 
glycosaminoglycan (GAG) composed of (1-4)-linked β-D-glucuronic acid and N-acetyl-β-
D-glucosamine repeats in a linear chain. Physiologically, it plays a role in wound healing, 
helping to promote hydration of the wound and helps lubricate load bearing joints. Its high 
level of hydration makes it highly compatible with collagen and alginate hydrogels to form 
composite materials [22, 36]. Hyaluronic acid hydrogels can be specifically degraded in 
vivo by hyaluronidase [37]. HA can be used in many applications including bone fracture 









2.2.1 Alginate hydrogel fiber spinning 
 
Alginate fibers form the basis of electrospun hydrogel fiber spinning due to the ease 
with which they rapidly gel for through ionic crosslinking to form highly aligned fibers. 
To generate these fibers, seaweed derived alginate (Sigma) or higher purity alginate 
(Pronova) is dissolved at a concentration ranging from 0.5 wt% to 3 wt% in a solution of 
0.2% polyethylene oxide (Mz 4,000,000, Sigma) in DI water. Lack of ions is highly 
important in the solvent for alginate to not only ensure clean electrospinning but to also 
prevent premature gelation of the material. Typical usage of the material is at 1.5 wt% 
alginate as this provides good mechanical properties without running into viscosity issues 
that may occur at compositions higher than 3.0 wt%. Alginate fibers are best spun into 
strings and filaments over sheets due to the low interaction between adjacent strings on the 
collection bath resulting from rapid saturation of the available negative charge site on an 
individual strand during its formation. Because of this, sheets tend to be difficult to make 
as the strands will easily slip past one another, preventing sheet formation of reasonable 
quality. 
Due to its rapid crosslinking capability, alginate makes an excellent sacrificial 
material when blended to form an interpenetrating network fiber with a secondary 
biomaterial that is crosslinked in a non-ionic manner, such as when alginate is blended with 
a secondary material like methacrylated gelatin that is crosslinked under UV irradiation 
when photoinitiator is added. As the ionic gelation of alginate with divalent cations are a 
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reversible form of bonding, a chelating agent such as sodium citrate can be used to strip 
away the crosslinking ions, allowing alginate to have a lower effective molecular weight 
and thereby can freely diffuse away from the remaining secondary structure, in this 
example the UV crosslinked gelatin.  
Alginate mechanical properties are primarily determined by the rotation speed of 
the collection bath and the divalent cation concentration in the bath at a given alginate 
molecular weight. Increases in collection bath rotation speed generate higher mechanical 
strain rates during fiber formation to better captures the initial alignment induced by the 
electric field. An upper limit on the mechanical strain that can be applied to alginate is 
present due to collector design as a balance must be struck between high alignment features 
versus risk of jettisoning the collection bath solution due to the centripetal force of the 
collector rotation. This is a limiting feature of the hydrogel spinning setup and restricts the 
minimum fiber size to diameters that are higher than the nanometer scales that can be 
achieved with a traditional dry electrospinning collector setup with its substantially higher 
collector rotation rates. Cation concentration can, to a minimal extent, affect the 
mechanical properties. Once minimum cation concentration in the collection bath is 
established to form stable alginate fibers, increases in cation concentration will result in 
additional crosslinking up until the point at which the available crosslinking sites are 
saturated, at which point no further gains in mechanical properties would be expected 





2.2.2 Fibrin hydrogel fiber spinning 
 
Electrospun fibrin hydrogels are primarily spun from a fibrinogen precursor 
polymer solution that is prepared just prior to spinning by dissolving fibrinogen in 0.2 wt% 
polyethylene oxide (Mz 4,000,000, Sigma) in DI water and placing the solution in a 37C 
water bath for a minimum of 15 minutes, using longer times for higher wt% compositions. 
Typical solution composition ranges from 0.5 wt% fibrinogen up to 3.0 wt%. Normally, 
fibrinogen solutions are solubilized in a saline solution such as 0.9% NaCl as they are only 
metastable in DI water and will precipitate over the course of a couple hours. This is a 
limitation for spinning fibrinogen due to the disruption of the polymer jet formation that 
occurs as additional charge carriers are added to the precursor solution, in this case Na+ 
and Cl-. Some batch to batch variability exists between different stocks of fibrinogen due 
to bovine sourcing differences. This manifests itself as differences in precipitation rates 
depending on fibrinogen batch. Should a batch of fibrinogen precipitate too rapidly, the 
user must filter the solution with a 0.22 µm filter prior to spinning else the precipitated 
material will disrupt the jet and/or yield significant amorphous regions within the fibrin 
hydrogel fiber. 
The collection solution used for forming fibrin hydrogel microfibers is based on 
mimicking the native blood coagulation pathway by using thrombin as a pseudo-
crosslinking agent. In the blood coagulation pathway, thrombin acts by enzymatically 
cleaving end peptides on fibrinogen to drastically increase hydrophobicity of the protein, 
causing rapid precipitation of the fibrinogen to form a fibrin clot [40]. The speed of this 
clot formation can be increased as thrombin concentration increases [41, 42], allowing the 
43 
 
formation of pure fibrin hydrogel fibers when thrombin concentrations of 10 U/ml or higher 
are used or blended fibrin-X fibers with thrombin concentrations of 2U/ml or higher. The 
resultant fibrin fibers have high elasticity and can be relatively rapidly degraded through 
treatment with plasmin, the native protein that fulfills this role, making it an excellent 
temporary scaffold material [43]. Degradation lifetime can be improved through treatment 
with Factor XIII, which stabilizes the structure via covalent crosslinking, without 
significantly altering the mechanical properties of the material. Crosslinking speed is lower 
relative to alginate spinning due to a combination of thrombin’s higher molecular weight 
reducing diffusion speed relative to calcium cations and the need enzymatic fibrinogen 
cleaving process being slower than ion capture.  
Fibrin fibers have highest amount of versatility amongst the big three materials used 
for electrospun hydrogel fiber spinning (alginate, fibrin, and collagen) as its ease of 
handling and relatively high hydrophobicity promote its use to form strings, sheets, and 
tubes. Additionally, as no component in the process is synthetic, there is very minimal 
chance of inducing inflammation processes associated with immunomodulatory cells 
interacting with chemical sequences they are unfamiliar with, typically a problem when 
non-zero length crosslinkers are used [44]. Fibrin strings collected can be air dried under 
strain to yield mm+ diameter fiber with very high alignment features and have been used 
for forming blood vessels in vitro [45]. Shorter spin times can yield fibrin filaments with 
low diameters in the range of 40 to 120+ µm that can be used as filler within nerve guidance 
conduits to provide topographical cues for Schwann cell and neuronal infiltration by 
providing a better physical guiding cue than found in a random fibrin clot. Through use of 
a linear stage, which rasters the landing position of the fibrinogen jet on the thrombin 
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collection bath, fibrin sheets can be generated. Fibrin sheets, once formed, can be collected 
as sheets using an end-over-end wrapping technique with a plastic frame, tubes when 
wrapped around a PTFE coated mandrel during collection, or pulled out of the solution 
directly with tweezers to yield strings with more ribbon-like characteristics relative 
compared to non-rastered fibrin string collection.  
 
2.2.3 Collagen hydrogel fiber spinning 
 
Electrospinning of collagen hydrogel fibers provides a biorecognizable substrate 
with the capacity to be more persistent upon implantation relative to usage of fibrin fibers 
with their relatively rapid degradation rate. Isolation of the type-specific metalloproteinase 
enzymes involved in collagen fiber assembly in the extracellular space is more difficult 
than isolation of thrombin used for the biological pathway mimicking assembling of fibrin. 
To get around this issue, the carboxylic groups of aspartic and glutamic acids within the 
collagen primary structure can be rapidly crosslinked to the amine groups of lysine and 
arginine using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) to 
form an aligned fiber. A drawback of this process is that a high amount of EDC is needed 
per spin due to the need to very rapidly crosslink to capture alignment. Additionally, EDC’s 
short half-life in aqueous conditions limits the collection bath usage time to ~1 hr before 
exchanging to a fresh collection solution. The short half-life of EDC by itself is usually 
remediated by addition of sulfo-(N-hydroxysulfosuccinimide) (NHS) which stabilizes the 
EDC for bioconjugation reactions. Experiments testing NHS addition to EDC for collagen 
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spinning did not yield successful fibers due to the increase in crosslinking reaction time 
with both EDC and NHS in the collection bath. 
To make the fibers, 1.2 ml of a stock of 1.0 wt% calf skin derived collagen 
solubilized in 0.075 M citrate solution at pH 3.7 with 0.01% NaN3 (Elastin Products Co.) 
is aliquoted into 2.0 ml round bottom Eppendorf tubes that have 2.4 mg dry PEO per tube 
in a biological safety cabinet several days before the day of spinning. Once aliquoted, the 
Eppendorf tubes are inverted to allow collagen to soak up any PEO powder that was above 
the solution line. Tubes are then oriented upright and briefly vortexed to ensure mixing of 
the PEO into the 1.0 wt% collagen solution. This adds bubbles to the solution which would 
impair spinning so collagen aliquots are placed in a rack and stored at 4°C for several days 
to remove air bubbles and allow time for the PEO to fully solubilize and mix with the 
collagen. 
A linear stage is setup as in the fibrin cardiac sheet spinning setup if sheets are 
desired, otherwise collagen fibers can be spun as a bundle. A single syringe pump is set to 
a flowrate of 3.25 ml/hr in either case, though this flowrate is tailorable to the application. 
Collagen fibers are spun onto a crosslinking solution consisting of 40 mg/ml EDC. A 
byproduct of the EDC crosslinking reaction is urea, which can cause a yellow discoloration 
of the collagen fibers. This tends to be more significant during second or third spins using 
the same collection solution, where more EDC has been reacted yielding more of the 
byproduct. Collagen fibers are soaked overnight in DI water to remove the urea before 
further processing. Collagen fiber sheets will be ready for use in most in vitro applications 
involving cell seeding following the overnight soak unless further drying is required for 
the downstream application. 
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2.2.4 Gelatin hydrogel fiber spinning 
 
Gelatin requires conjugation of photo-reactive groups and usage of alginate as a 
temporary scaffold to spin making it an excellent example of hydrogel fiber made through 
UV mediated crosslinking. Gelatin was first methacrylated by solubilizing porcine gelatin 
at a concentration 5g gelatin per 50 ml PBS at 60°C with stirring before reduction of 
temperature to 50°C and dropwise addition of methacrylic anhydride (Sigma) at 1.6 ml 
anhydride per 10 ml gelatin solution. The reaction is allowed to proceed for 1 hour to form 
methacrylated gelatin (GelMA). The GelMA is dialyzed against DI water at minimum 
overnight before being frozen down in a -80°C freezer and lyophilized for two days. 
Lyophilized GelMA is placed an Eppendorf round bottom tube before addition of 1.5 wt% 
AG with 0.2 wt% PEO in the same manner as HA spinning to yield a final GelMA 
concentration of 1 or 2 wt%. The photo initiator Irgacure 2959 is added to the GelMA + 
AG solution and collection bath at a final concentration of 1 wt% to eliminate loss of the 
photoinitiator to diffusion. 
Spinning of GelMA is onto a collection bath consisting of 50 mM CaCl+2 which 
has 1.0 wt% Irgacure added to balance out diffusion forces that would otherwise cause the 
photo initiator in the precursor solution to diffuse away. After the spin is complete, the 
GelMA-AG fiber is removed and placed on cell culture dish where it is exposed to a UV 
lamp for approximately 60 seconds at an intensity of 900 mW/cm2 to crosslink the GelMA. 
Once crosslinked, the GelMA-AG fiber is soaked in 250 mM sodium citrate overnight to 
remove alginate, leaving behind the soft gelatin fiber. GelMA is advantageous in that it can 
easily be mixed with alginate, unlike fibrin, and in a manner similar to the thiolated HA, 
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allowing the three to be potentially used as an AG-HA-Gel system. The crosslinking 
system is much cheaper for GelMA than HA enabling its use even with the high crosslinker 
bath solutions. Despite these advantages GelMA was latter supplanted by collagen fibers 
for cell culture use as the collagen is not denatured, can be spun as a pure material with 
better mechanical properties, and does not require the additional methacrylation step to 
enable cross-linking. While not used for a majority of experiments, there still remains 
potential GelMA use in applications where very soft materials and alignment are needed 
as the mechanical properties can be tuned by altering the relative proportion of alginate 
and GelMA mixed together in the precursor solution. It should be noted that due to the 
lower mechanical properties of gelatin relative to collagen, the EDC crosslinking bath 
method with collagen does not work with plain gelatin, as any potential gelatin fiber is too 
weak to handle. 
 
2.2.5 Hyaluronic acid hydrogel fiber spinning 
 
Hyaluronic acid (HA) is not directly spinnable as a pure material like alginate, 
fibrin, and collagen hydrogel microfibers. Instead, it must be mixed with alginate, which 
is used as a temporary scaffold while the HA is crosslinked. For our preliminary studies 
using HA, a thiolated HA was used to enable use of an acrylated poly(ethylene glycol) 
(PEG) as a crosslinking agent via Michael Addition. Lyophilized thiolated hyaluronic acid 
is added to a round bottom Eppendorf tube so that there is a final composition of 1 wt% 
HA when 1.2 ml of 0.75 wt% alginate in 0.2 wt% PEO solution is added. Mixed solution 
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was given at least 4 hours at 37°C to dissolve completely. High levels of negative charge 
in the repeat units of both alginate and hyaluronic acid enable their excellent mixing in 
aqueous solutions to form an interpenetrating network hydrogel fiber when exposed to the 
crosslinking agent without precipitation of the two materials in the precursor solution. The 
crosslinking bath for the thiolated HA consists of 50 mM Ca+2 for rapid crosslinking of 
alginate with addition of an eight armed acrylated PEG at 1.43 wt% 8 arm PEG. A 
diacrylated PEG (two armed) was also tested but did not yield mechanically sound HA 
fibers once the alginate was removed through treatment with 250 mM sodium citrate 
overnight due to the very soft mechanical properties native to HA hydrogels, even with the 
mechanical property enhancement that results from the polymer chain alignment during 
spinning. Unfortunately, the high cost of the acrylated PEG severely limits the use of HA 
hydrogel fibers due to the high volume of collection bath solutions required (typically 20 
to 50 ml). Recycling of the collection bath acrylated PEG reduces this cost somewhat but 
requires filtering and the solution can still only be used for a few spin sessions per 
collection bath. 
 
2.2.6 Synthetic 3D microfiber bundle spinning – PLGA 
 
The electrospun hydrogel fiber setup is not limited to biologically derived 
materials. The spinning method can also be used to generate loosely associated bundles of 
synthetic polymer microfibers that are normally electrospun onto a dry surface in nanofiber 
form. A proof of concept for this spinning variation is the generation of PLGA microfiber 
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bundles, where the polymer is soluble in organic solvents such as dichloromethane but not 
soluble in aqueous solutions. This allows the spinning of 3D PLGA bundles to be done by 
spinning onto a rotating bath of DI water in much the same manner as the biologically 
derived materials are spun, though this requires a much higher needle to wheel separation 
distance due to the higher viscosity of PLGA relative to alginate/collagen/fibrin/etc. The 
PLGA microfibers form and spread on the DI water surface, which can then be easily 
bundled upon removal from the wheel. The concept of spinning onto non-solvents is 
applicable to other synthetic polymers such as for the spinning of PCL onto aqueous media 
or even biologically derived polymers such as collagens and alginates onto non-aqueous 
medias like isopropanol if they are quenched in a separate crosslinking bath immediately 
following collection. To demonstrate this, 10% PLGA was dissolved in dichloromethane 
and then spun onto a DI water bath to generate 3D microfiber bundles for fiber analysis 
using SEM. 
 
2.2.7 Mechanical property testing of electrospun hydrogel fibers 
 
Mechanical testing of hydrogel fibers including those based on alginate, gelatin, 
collagen, fibrin, and hyaluronic acid were primarily done through use a Q800 DMA to 
measure the tensile properties. Although rheometers are typically used to measure the 
viscoelastic properties of hydrogels, for these materials it makes more sense to compare 
the tensile properties as this is the primary engineering advantage of the material and can 
be correlated to the ease at which cells can deform their local microenvironment and for 
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comparison to the application tissue, whether that is for neural, muscular, or cardiovascular 
applications. Tensions tests were always performed with the DMA in ramp force mode 
with increasing force applications of +0.05 N/min for hydrated samples and +0.25 N/min 
for dried sample. Generally, tests were performed on hydrogel fiber bundles or strings as 
opposed to sheets, which were more difficult to setup and whose cross-sectional 
dimensions were more difficult to quantify for engineering stress calculations. Dried fibers 
were dried at least overnight prior to testing. As the DMA lacked an environmental 
chamber for hydrated fiber testing, hydrated samples were stored in solution until just prior 
to testing so they could be loaded into the DMA clamps hydrated and remain so until testing 
was complete within four minutes of sample loading. All tests were run until failure and 
no cyclic testing was done due to limited lifetime of hydration of hydrated samples. Use of 
a custom built bioreactor enabled testing of fiber mechanical properties in fully hydrated 
conditions for measurements taken characterizing the effect of alginate-fibrin ratio and 
treatment of alginate-fibrin composite fibers with alginate lyase at 1-2 U/ml for 24 hours 
to remove alginate [46].  
 
2.2.8 Optical transparency measurements of electrospun hydrogel fiber sheets  
 
The ability to spin collagen and fibrin microfibers into sheet form enables these to 
be used as a backing for amniotic membranes (AM), which on their own have very weak 
mechanical properties despite their desirable growth factor capture and extracellular matrix 
structure. Collagen and fibrin sheets were spun and then the optical transmittance of the 
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two materials were measured using a plate reader (BioTek Synergy 2) at 50 nm wavelength 
intervals from 200 nm to 800 nm for comparison against water to encompass ultraviolet, 
visible, and IR wavelength ranges in hydrated conditions using n = 3 samples per fiber 
type. Following initial testing of transparency of the two materials, selection of the fiber 
sheet with best transparency was made and used for backing with the AM membrane 
though EDC/NHS crosslinking and high applied pressure to fuse the two materials 
together. For the collagen sheet-AM composite membrane, the optical properties were 
measured at 20 nm intervals from 200 to 800 nm wavelengths to ensure that the composite 
could enhance the mechanical properties of the AM membrane without reducing optical 
clarity for corneal patch applications. The effect of collagen fiber sheet thickness was also 
investigated to determine if there was a reduction in optical clarity as sheet thickness 
increases. 
 
2.2.9 Graded ethanol drying and lyophilization of fibrin fiber tubes for vascular 
graft preparation 
 
Fibrin fiber tubes for vascular grafts were dried through use of either lyophilization 
or a graded ethanol dry. Lyophilization of grafts were performed by freezing fibrin tubes 
in a -80°C freezer after several hours minimum soak in DI water to remove excess thrombin 
and salts. Once frozen, fiber tubes were placed in a lyophilizer for approximately one day. 
Once lyophilized, tubes were removed from the mandrel. 
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Graded ethanol drying follows the same salt and thrombin removal steps as 
lyophilization. At this point, fibrin tubes, while still on mandrels, are placed sequentially 
into increasing concentrations of ethanol for a minimum of 15 minutes at each step going 
from 0, 25, 50, 70, 80, and 90% EtOH. At 90% EtOH, fibers are soaked overnight to 
minimize cracking during drying. Once this is complete, fibrin fiber tubes are soaked for a 
minimum of 15 minutes each in 95% and triple soaked in 100% EtOH. Once the sequence 
is complete, the dehydrated fibrin tubes are left to dry in open air a laminar flow hood 
before being removed from the mandrel. 
 
2.3 Results and Discussion 
2.3.1 Effect of biological material type on mechanical properties 
 
Comparisons of the mechanical properties of alginate, fibrin, gelatin, and 
hyaluronic in the dry, hydrated-as-spun, and rehydrated states were made early on during 
development of the electrospun hydrogel microfiber platform to get an idea of the 
mechanical property range, and therefore tissue types, that these fibers could be potentially 
be applied to. Of the materials tested early on, alginate had the highest degree of stiffness 
in the dry, hydrated, and rehydrated states at stiffnesses of 104 MPa, nearly 1 MPa, and 100 
MPa respectively (Fig. 2.1). Fibrin had the second highest stiffness of the materials tested 
in the three conditions followed by gelatin gibers and finally hyaluronic acid fibers which 
were the softest. The resultant range of stiffness ranged from ~1 kPa to 1 MPa in the 
hydrated state depending on the material spun. Particularly useful mechanical properties 
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were measured with the rehydrated fibrin fiber group, which had elastic moduli very 
similar to the native sciatic nerve. The rehydrated mechanical properties for all four 
materials lie in between the hydrated and dry properties, making it very important to 
understand what properties are required for the final application of the fibers as the storage, 
whether staying hydrated or being dried first, will have an impact on the final fiber 
mechanical properties. It is hypothesized that the fibers do not fully regain their hydrated 
properties when rehydrated due to the increased Van der Waals interaction between fiber 
chains after drying limiting infiltration of solution and therefore decreasing cross sectional 
area when rehydrating, causing engineering stress to increase although the individual fiber 
mechanical properties on a micro-scale likely remain the same. Further tests could 
potentially be done use AFM for force analysis to determine if this is true on the micro-
scale, regardless the material type and hydration configuration can be used to match the 
mechanical properties of the target native tissue. 
 
2.3.2 Precursor solution weight % effect on fiber strength 
 
The elastic moduli of fibrin fibers could be easily tuned through alterations in the 
weight % of fibrinogen solutions spun. Resultant tensile properties increased as fibrin 
composition increased. 1 wt% fibrin fibers had lowest elastic moduli at 35 kPa which 
increased to 50 kPa, 62 kPa, and 68 kPa at 2, 3, and 4 wt% fibrin fibers respectively (Fig. 
2.2). Decreasing levels of increase with wt% change occurred when moving to higher wt% 
fibrin fibers as a result of the decreased fibrinogen solution stability, where solutions of 
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increased wt% fibrinogen tended to have reduced stability and more readily precipitate out 
as amorphous fibrinogen clumps. When spun, these clumps provide less mechanical 
strength increase compared to the aligned fibrin fibers formed, thereby the increasing 
proportion of clumps at higher wt% spun reduces incremental mechanical property gain 
otherwise expected from more material being spun. The tuning of fibrin mechanical 
properties in this range allows it to match the mechanical properties well of several tissues 
that are typically in the 10s of kPa range, such as skeletal muscle and cardiac tissue, in both 
homeostatic and pathological states. 
 
2.3.3 Effect of additional strain on fibrin fiber mechanical properties 
 
While there is significant strain induced during the alignment of the polymeric 
chains due the combined effects of the electric field and mechanical drawing effect of the 
collection bath rotation, additional strain can be induced during fiber drying to further 
enhance the tensile properties of the fibers by substantially increasing internal alignment. 
To test the effect of additional strain on mechanical properties, 2.0 wt% fibrin fibers were 
spun and subjected to additional strains of 0%, 33%, and 66% during drying by hanging 
fibers between wooden posts after applying the target level of strain to the fibers. Results 
are shown in Figure 2.3 where the 0% strain fibers had elastic modulus measured by the 
DMA at just under 400 kPa when rehydrated. Additional strain to 33% during drying 
resulted in rehydrated fibrin fibers with a modulus of 500 kPa. Most substantial increase in 
stiffness occurred with the 66% strain samples which more than doubled the rehydrated 
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stiffness at 950 kPa. This data demonstrates an easy way to further enhance fibrin 
mechanical and alignment properties for applications where additional stiffness or higher 
degrees of topographical guidance cues are needed. 
 
2.3.4 Collector rotation speed effect on resultant dry alginate fiber diameter  
 
Of the various spinning parameters, the rotation speed of the collection bath should 
also affect the resultant fiber bundle diameter by more efficiently packing together parallel 
strands of material as the mechanical strain of the collector rotation increases. To test this, 
1.5 wt% alginate solutions were spun onto 50 mM CaCl2 solutions are rotational speeds of 
30, 48, and 72 RPM for 1 minute before being collected, dried, and diameters characterized 
under a microscope. The results of Figure 2.4 show that increasing wheel rotational 
velocity causes a decrease in resultant fiber diameter with these short duration spins when 
alginate is used. The lowest RPM yielded fibers with 35 µm diameter, increasing RPM to 
48 yielded 24 µm diameter fibers, and 72 RPM had the smallest diameter at 19 µm. Fine 
tuning of the fiber diameter in the dry state can be achieved through manipulation of the 
wheel RPM although this method is less precise than using time for diameter variation. 
Although rehydrated diameter values were not measured, the effect of wheel RPM 
demonstrates that it is important to spin with consistent parameters as variation in RPM 
could confound the desired effects of spin time and solution composition when targeting a 




2.3.5 Effect of flow rate on diameter of short duration alginate fiber spins 
 
While fiber bundles have many applications for tissue replacement and bulk cell 
culture, the effects of high radius of curvature on cells when fibers have diameters similar 
to the cell (~10-20 µm) are important as this will evoke a different response than flatter 
surfaces and fibers with diameters in this range fill an important niche between fiber 
bundles and traditional synthetic electrospun nanofibers. To characterize fibers in this size 
range, diameters of alginate fibers at 1.5 wt% and 0.75 wt% and spun for 15 seconds were 
measured at several flow rates to determine how finely fiber diameter could be controlled. 
Figure 2.5 shows the resultant fiber diameters in the dry and hydrated state of the two 
alginate compositions at different flow rates. As expected, reduction in flow rate yielded 
lower diameter fibers with the rehydrated diameters reducing from 19 µm to 11 µm for 1.5 
wt% alginate as flow rate was reduced from 1 ml/hr to 0.25 ml/hr. Similar decreases were 
seen with 0.75 wt% alginate dropping from 14 µm to 11 µm as flow rate was reduced from 
1 ml/hr to 0.5 ml/hr.  
Particularly important is the demonstration with this experiment that relatively tight 
control of small fiber diameters can be achieved that are distinguishable from each other 
as separate sizes merely by changing the flow rate of the material being spun. Using 
flowrate as a tuning parameter helps to reduce the potential size distribution with very short 
duration spins compared to trying to modulate fiber size using small differences in time 
spun such as 14s vs 16s, where the high error in timing can obfuscate the effects of time 
differences when measuring fibers. Highly exciting from this experiment is the ability to 
generate very small diameter fibers such as the 6 µm drystate fibers when spinning 1.5 
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wt% alginate at a flowrate of 0.25 ml/hr. While possible to spin fibers of these diameters, 
the difficulty in handling increases exponentially as size decreases as even normally small 
effects such as solution surface tension and do much to disrupt the stability of the fiber 
structure when trying to use these for engineering applications. Additionally, a great 
difficulty of the sub 10 µm fibers is that unlike traditional electrospinning, it is not easy to 
prepare mats of fibers in this regime of diameter as the hydrogel nature of the fibers would 
cause them to merge together into a bundle rather than remaining distinct as in the 
preparation of PCL electrospun nanofibers meshes. Due to this, any applications using sub 
10 µm fibers need to have fibers prepared and handled separately which becomes 
immensely time consuming to the point of being prohibitive to use. Such an example is the 
preparation of fiber filaments for nerve guides where the squared term in circular area = 
πr2, results in massive increases in the number of fibers required to fill a given area. Going 
from even as small a difference as 25 µm diameter fibers down to 10 µm requires 6.25 










2.3.6 Effect of PEO and PVA composition on diameter of one-minute alginate fiber 
spins 
 
PEO is added to all biopolymers that are electrospun as hydrogel fibers and acts as 
the “secret ingredient” that enables fiber formation to occur by providing the long polymer 
chains that maintain the jet in string form by avoiding polymer jet breakage. Its primary 
role is as a viscocifier that is drawn along by the electric field application that uncoils the 
long PEO chain along with the biopolymer being spun. As PEO can be spun on its own 
without any additional components, it was of interest to see how variation in the PEO 
content could be used to alter the fiber diameter of electrospun biopolymers. To test this, 
increasing amounts of PEO were added to 1 wt% alginate fibers and the resultant hydrated 
fiber diameter was measured after 1 minute of spinning. The resultant fibers were found to 
increase in diameter from 24 µm to just above 30 µm as the PEO increased from 0.2 wt% 
to 0.6 wt% (Fig. 2.6). While this effect was relatively small, the effect leveled off as PEO 
content was increased to 0.8 to 1.0 wt% where fiber diameters remained in the low 30 µm 
range. 
During the early development phase of the electrospun hydrogel fiber materials 
protocols, PVA was investigated as an alternative viscosity agent to PEO due to its lower 
molecular weight potentially increasing its ability to diffuse out of the final hydrogel fiber 
over time more quickly than PEO, allowing cells earlier and more complete access to 
integrin binding sites that might otherwise be shielded by the long PEO chains. PVA 
inclusion to 1% alginate was compared using the same spinning conditions as the 
experiment with PEO, except where PVA composition ranged from 0.2 to 2.0 wt% of the 
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material being added to alginate due to its lower molecular weight (150 kDa Mw) compared 
to PEO (4,000,000 Mz). Results of PVA inclusion were less clear (Fig. 2.7) as the resultant 
fiber diameters ranged from 25 µm to 30 µm with high overlap in standard deviation ranges 
for all PVA levels tested. As PVA spun materials did not spin as cleanly as PEO precursor 
solutions and showed less potential for tuning fiber dimension, a conclusion was made to 
remain with 0.2 wt% PEO and make this standard for all precursor solutions going forward. 
 
2.3.7 Alginate as a porogen: effect on fibrin fiber mechanical properties 
 
Spinning blended mixtures of 2 wt% fibrin with varying amounts of 1.5 wt% 
alginate can be used as a method to introduce additional porosity into the fibrin fibers 
following removal of alginate during a post spin soak in 1-2 U/ml alginate lyase or 150 
mM sodium citrate solution overnight to 24 hours. Blended mixtures of fibrin with 0 to 
50% alginate were sectioned and stained with H&E to quantify overall fiber porosity and 
correlate this to the resultant fiber stiffness when mechanically tested using a custom 
developed bioreactor equipped with a force sensor for in situ mechanical testing in hydrated 
conditions.46 Unsurprisingly, increases in alginate composition yielded increases in fiber 
porosity up until a plateau is reached 42% alginate inclusion, above which there was no 
significant increase in porosity Figure 2.8. Likewise, fiber stiffness decreased from 8 kPa 
to 4 kPa going from 33% alginate to 42% alginate respectively. Higher porosity values did 
not further decrease fiber stiffness leading the 6 kPa to be the minimum value using 
porosity as a variation method with 2% fibrins.  
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2.3.8 Effect of total spin time on fibrin fiber diameter and swelling 
 
While small fibrin filaments are important for applications as nerve guide fillers, 
larger scale fibrin fiber bundles have use for applications involving culture of tubular 
forming vascular cells such as smooth muscle cells (SMCs), endothelial cells, and pericytes 
that can be seeded on the exterior surface of the fiber bundle. The radius of curvature for 
such cell culture systems can be important in regard to the cellular response and subsequent 
cellular alignment, organization, and extracellular matrix deposition. Alterations in the 
total spin time of fibrinogen can form fibrin fiber bundles of variable diameters when dried 
and rehydrated due to the buildup of material on the same landing position in the spinning 
crosslinking collection bath. To demonstrate this, 2.0 wt% fibrinogen was spun for times 
ranging from 1.0 to 12.5 min and the resultant dry and rehydrated fiber diameters were 
measured (Fig. 2.9). Fiber landing position was held constant throughout the entire duration 
of the spin. Increases in spin time were found to generate a nearly linear increase in fiber 
diameter up to 10 min total spin time, at which point decreases were much smaller for both 
the dry and rehydrated fiber bundles. The predictable behavior of additional spin time on 
fiber diameter allows fibrin filaments and fiber bundles to be formed tailored to the target 
engineering applications, such as luminal fillers in nerve guides or large fiber bundle sizes 
for skeletal muscle replacement. Higher spin times. The swelling ratio could also be 
determined by comparing the cross-sectional area of the dry and rehydrated states. The 
ratio was highest at the 1 min spin at nearly 1000% swelling while the remainder of longer 
spin times had swell ratios leveled off around 450% cross sectional area when rehydrated. 
Larger diameter fibrin bundles could be formed by altering the landing position of the 
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fibrinogen jet periodically to ensure thrombin accessibility of later-deposited material was 
not limited. 
 
2.3.9 Effect of flow rate at constant spin time on fibrin filament diameter 
 
For the preparation of fibrin filaments to be used as part of a nerve guide construct, 
characterization of the effects of fibrinogen solution composition and flow rate had to be 
characterized to determine the dry and rehydrated fibrin fiber properties as these would 
differ from the previous characterization done with short spin time alginate fibers due to 
the relatively higher hydrophobicity of fibrin fibers relative to the very hydrophilic alginate 
fibers. To develop a range of small fiber diameters, flow rates of 1.5 ml/hr to 4.5 ml/hr 
were used in conjunction with either 0.75 wt% fibrinogen or 2.0 wt% fibrinogen and the 
subsequent dry and rehydrated fiber diameters were measured under an optical microscope 
after being electrospun for 30 seconds. More variation in fiber diameter with flow rate was 
found with the 2.0 wt% fibrin fibers compared to the 0.75 wt% (Fig. 2.10). The lower wt% 
composition ranged from 10 µm dry diameter up to 17 µm with increasing flowrates and a 
similar trend in rehydrated diameter was seen with the rehydrated fibers increasing from 
25 µm to nearly 40 µm in diameter for a range of 15 µm between all three groups when 
rehydrated. The 2.0 wt% fibrin fibers had much more variation in the rehydrated diameters, 
jumping from 40 µm rehydrated at 1.5 ml/hr flow to nearly 100 µm rehydrated when flow 
rate was increased to 4.5 ml/hr. Dry fibers at 2.0 wt% ranged from 15 µm to 25 µm as flow 
rate increased from 1.5 ml/hr to 4.5 ml/hr. Differences between 0.75 wt% fibrin and 2.0 
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wt% fibrin are most likely due to differences in the total amount of material being spun, as 
more material per unit time is deposited during 2.0 wt% fibrin preparation, leading the 
higher wt% fibrin fibers to be more tunable based on flowrate for a given spin time. 
 
2.3.10 Effect of spin time at constant flow rate on fibrin filament diameter  
 
As an alternative to tuning fiber diameter with variations in flow rate, which 
requires resetting syringe pump parameters between conditions and potentially changing 
the drawing behavior of the polymer jet in response to the electric field due to changes in 
the solution viscosity profile with flow rate, investigation was made into the effect of spin 
time on dry and overnight rehydrated fiber diameter in DI water while keeping flow rate 
constant at 3.25 ml/hr. Spin times characterized were 30, 60, and 90 seconds for both 0.75 
wt% and 2.0 wt% fibrinogen precursor solutions. The fiber diameters measured in (Fig. 
2.11) show relatively small changes in fiber diameters between 30 sec and 60 sec spin time 
for 0.75 wt% fibers when rehydrated but a larger relative jump in rehydrated fiber diameter 
is seen going from 60 sec spin to 90 sec where diameter jumps from 30 µm to just over 60 
µm.  Higher variation rehydrated fiber diameter was seen at longer spin times for 0.75 wt% 
fibrin fibers although variation remained small for dried fibers, which increased relatively 
linearly with time. The 2.0 wt% fibrin fibers showed higher rehydrated fiber diameter jump 
going from 30 sec to 60 sec where diameter increased from 40 µm to nearly 100 µm, more 
than doubling diameter with a doubling in spin time (Fig. 2.12). Smaller increase was found 
continuing onto 90 sec spins where the rehydrated diameter only increased to 120 µm. As 
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with the 0.75 wt % fibers, the dry state 2.0 wt% fibers showed a relatively linear increase 
in diameter with increasing spin time. All rehydrated 2.0 wt% fibrin fibers showed at least 
+/- 10 µm variation in rehydrated diameter indicating that there is increasing variability in 
the ability of water to infiltrate between fibrin chains with differences in the total fiber 
diameter. 
 
2.3.11 Effect of drying method on fibrin tube mechanical properties 
 
Drying of fibrin for the testing done to compare materials type was done through 
air drying of strings after removal from the collection wheel but there exists other drying 
methods that can be used for other applications such as graded ethanol drying and 
lyophilization that have been used for investigation of fibrin tubes for vascular graft 
applications in vitro and in vivo. A comparison of the elastic modulus, strain to failure and 
ultimate tensile strength were made along with diameter measurements of the dry and 
rehydrated state for graded ethanol. Graded ethanol dried fibrin tubes were stiffer at 20 kPa 
than the lyophilized fibrin tubes at 7.5 kPa, most likely due to the walls of the tube being 
denser following drying with the graded ethanol treatment reducing cross sectional area for 
the engineering stress calculation (Fig. 2.13). UTS followed a similar trend with the ethanol 
dried tubes having a higher ultimate strength of 180 kPa compared to the lyophilized tubes 
at 50 kPa. Strain to failure was similar for both drying methods ranging from 120 to 130 
% strain. The swelling behavior of the two drying methods actually did differ. Ethanol 
drying led to the expected swelling in tube diameter of 600 µm dry to 900 µm when 
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rehydrated in DI water overnight. Surprisingly, the lyophilized tubes shrank slightly upon 
rehydration, going from 1300 µm dry to 1100 µm rehydrated, though the lyophilized results 
were not statistically significant. A potential reason for this could be the lack of shrinkage 
during lyophilzation, despite damage to the fiber alignment structure due to ice crystal 
formation during freezing, allowing water to fill the pores and exert a small pulling force 
due to the solid liquid interface. 
 
2.3.12 FXIII treatment effect on fibrin tube mechanical properties 
 
As coagulation factor XIII is a known covalent crosslinker of fibrin that imparts 
increased degradation resistance to the material, investigation was made into its viability 
as a method of improving the mechanical properties of fibrin based vascular graft tubes. 
Following normal fibrin tube production, the material was soaked in a solution of 10 mM 
CaCl2 in 0.9 wt% NaCl containing 20 µg/ml FXIII and 4 U/ml thrombin as a cofactor 
overnight at 37°C before mechanical properties were tested using the Q800 DMA. FXIII 
treatment was tested with both graded ethanol dried fibrin tubes and lyophilized tubes and 
were found to slightly increase the elastic modulus of the tubes from 21 to 24 kPa for 
ethanol dried samples and 8 to 11 kPa for lyophilized although neither were statistically 
significant (Fig. 2.14). Strain to failures were relatively unaffected, remaining around 120 
to 130% as seen with the previous mechanical property investigation of the two drying 
methods (Fig. 2.15). UTS for both materials were increased with FXIII treatment compared 
to the untreated samples, increase the UTS of the ethanol dried fibrin tubes from 180 to 
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260 kPa and increasing the lyophilized tubes from 50 to 100 kPa (Fig. 2.16). While the 
mechanical properties of the bulk fibrin tubes were not substantially increased through 
factor XIII treatment, treatment using the factor has been able to assist in stabilizing fibrin 
against proteolytic degradation as found by the increased lifetime of fibrin sheets in culture 
with neuronal cells, where sheets would remain mechanically robust for an additional two 
or three days compared to fibrin sheets that lacked both FXIII treatment or aprotinin 
addition to media. 
 
2.3.13 Layering and drying processing effect on fibrin tube stability and cracking 
 
Early in the fibrin tube project, investigations into the best method of drying were 
made to compare drying via ethanol dehydration and lyophilization. Ethanol drying was 
found to better preserve fibrin microstructure than lyophilization. Ice crystal formation 
during the freezing process in -80°C for lyophilization causes disruption to the fiber 
alignment structure (Fig. 2.17). There is potential to still use freeze drying as a method of 
drying of fibrin tubes and sheets if a cryoprotectant such as glucose is added at high 
concentration to reduce ice crystal formation, particularly if a more rapid freezing method 
is used. While modified lyophilization procedure remain a potential drying option if 
needed, the current protocol for graded ethanol dry is simpler to run and has proven itself 
to work for generating implantable fibrin tubes. 
The specific drying sequence used for implantable fibrin fiber tubes is a sequential 
ethanol drying starting at 25% EtOH and progression upward in EtOH concentrations of 
66 
 
50%, 70% and 80% for a minimum of 15 minutes each. At this point fibrin tubes are soaked 
in a 90% EtOH solution overnight before continuing with additional concentrations of 
95%, 100%, 100%, and finally a third 100% EtOH soak for 15 minutes each. Earlier 
protocols used 15 minutes for all dehydration steps but this led to some inconsistency in 
drying due to frequent crack formation (Fig. 2.18). Adjustment of the 90% EtOH step to 
overnight alleviated this problem, likely by allowing more diffusion time of EtOH into the 
fibrin tube and therefore improving the EtOH exchange deeper into the fibrin layers, 
causing more uniform drying to occur. While the specific mechanism causing the excessive 
cracking with 15 min cycles only has not been investigated, the overnight 90% has proven 
reliable for multiple batches of fibrin tube generation and can be considered standard 
practice for tube preparation. 
 
2.3.14 Comparison of fibrin fiber diameters holding total mass flow constant  
 
Variations in the resultant fiber geometric properties following spinning are 
predominantly controlled by three main variables. These are the weight percentage of 
material being spun, the flow rate, and the total spin time. The three factors can be used 
together to determine what is herein termed the “mass flow constant” (MFC) as defined 
by: 
𝑀𝐹𝐶 = (𝑤𝑡%) ∗ (𝑓𝑙𝑜𝑤 𝑟𝑎𝑡𝑒) ∗ (𝑡) 




𝑀𝐹𝐶 = (2 𝑤𝑡%) ∗ (3.25
𝑚𝑙
ℎ𝑟
) ∗ (10 𝑚𝑖𝑛) = 65 
By holding the MFC value constant, other variables can be changed to yield the same total 
amount of material deposition during a given spin. Say there is need to spin a material with 
MFC = 65 using a 1.5 wt% fibrinogen solution that has the same total spin time of 10 min 
as in the previous example. Rearranging the expression yields the required flow rate 
needed: 





(1.5 𝑤𝑡%) ∗ (10min )
= 4.33 𝑚𝑙/ℎ𝑟 
Likewise, using the same expression, changes in time to 14 min spin and keeping precursor 
solution at 1.5 wt% can be made to yield fibers with the same total amount of material in 
all three example spins using the following flow rate: 





(1.5 𝑤𝑡%) ∗ (14min )
= 3.10 𝑚𝑙/ℎ𝑟 
This demonstrates that the three variables can be tuned as needed if the MFC is held to a 
constant value allowing fair comparison of different spinning conditions without having 
variation in total amount of material. 
To test the validity of the MFC, several 2% fibrin fibers with a MFC value of 3.5 
were spun altering the flow rate and spin time to compare the resultant dry and rehydrated 
fiber diameters. (Fig. 2.19) shows that the dry fiber diameters in all cases were very similar 
at ~28 µm. Rehydrated values were all centered around 80 µm for flow rates up to 3.5 
ml/hr. Spins done for 15 seconds at 7.0 ml/hr showed slightly higher diameter when 
rehydrated at 90 µm, indicating that extreme conditions of very short spin times or high 
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flow rates may deviate from the predictability that the MFC value has. Despite this, the 
MFC value remains an excellent method to rapidly generate alternative spinning conditions 
for a given fiber spinning condition. Holding MFC values constant provides a potential 
method to investigate surface topography differences on cellular organization caused by 
flow rate effects generating larger or smaller diameter fibers during the spin at higher or 
lower flow rates. 
 
 
2.3.15 Swelling ratios of fibrin and collagen fibers during rehydration 
 
The amount of swelling during rehydration is an important material property to 
characterize for these electrospun materials as hydrogels are known to have high degrees 
of water uptake and therefore swelling. This is an important design aspect of hydrogel 
fibers to consider as their manipulation frequently involves a dehydrating step before being 
rehydrated for application. The volumetric swelling ratios of fibrin, Secant collagen fibers, 
and EDC crosslinked electrospun hydrogel collagen fibers were measured by comparing 
their dry and rehydrated diameters after overnight exposure to DI water. Fibrin spin time 
was varied to determine if the final swelling ratio was significantly impacted by changes 
in that parameter. (Fig. 2.20) shows the resultant fiber diameters and volumetric swelling 
ratios after soaking in DI water overnight. Changes in fibrin spin time has minimal impact 
as these fibers all showed swelling ratios in the high single digits despite increases in fiber 
diameter causing decrease in surface area to volume ratio. Secant collagen fibers showed 
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similar volumetric swelling ratios to the fibrin fibers. Small diameter EDC crosslinked 
electrospun hydrogel collagen fibers showed a dramatic increase in swelling with a 
volumetric swelling ratio just over 40. This is a result of the dramatic increase in fiber 
diameter to 400 µm from a dry fiber in the 60 µm range, similar to the dry fiber diameters 
seen with the fibrin and Secant collagen fibers. This result implies that the combined effects 
of what are likely to be increased crosslink mesh size and the greater hydrophilic properties 
of electrospun hydrogel collagen fibers relative to fibrin fibers. Surprisingly, the Secant 
collagen fibers and electrospun hydrogel collagen fibers had vastly different swelling 
properties, an indication that processing differences can have a massive impact on the 
resultant swell properties. 
 
2.3.16 Rehydration of alginate, fibrin, and collagen fibers with time  
 
The speed at which the hydrogel fibers swell to their maximum size is an important 
design consideration for any application where fibers may need to be applied dry such as 
applications involving injection of fiber filaments or potential blockage applications. 
Hydrogel fibers composed of 2 wt% fibrin, 1 wt% collagen, and 1.5 wt% alginate were 
spun and rehydrated in DI water for fibrin and collagen or DI containing 50 mM CaCl2 in 
the case of alginate. Measurements of the dry mass after overnight air drying were taken 
before rehydration and then masses of alginate, fibrin, and collagen (n = 6 each type) were 
taken within 10 minutes immediately after rehydration, at one hour, and after 24 hours. 
Percent hydration was calculated as the ratio of the hydrated mass to dry fiber mass. All 
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three materials showed relative little difference in hydration with time (Fig. 2.21). Primary 
differences between materials were the hydration level which is highly dependent on their 
relative hydrophobicity or hydrophilicity. Being relatively hydrophobic, fibrin only 
showed hydration levels in the low 80% range. Alginate fibers had higher hydration levels 
in the high 80%. Collagen fiber hydration level approached 95%, results which are not 
surprising considering the massive level of swelling seen with the material being highly 
hydrophilic. Notably all three materials have the high levels of hydration that define a 
hydrogel material, typically by having 90% or higher hydration levels. Alginate and 
collagen fibers clearly fit into the typical hydrogel hydration range while fibrin fibers could 
be defined as quasi-hydrogel fibers due to their relatively high hydrophobicity limiting 
solution uptake after rehydration. While data is not shown here, as-prepared fibrin fibers 
contain higher levels of hydration than those that have been air dried. It is hypothesized 
that the air drying of fibrin enables van der waals forces to play a larger role in the fibrin 
structure and prevent full rehydration by limiting the ability of solution to infiltrate the 
fiber core, hence reducing the total amount of solution uptake and fiber swelling, causing 









2.3.17 Degradation of alginate and fibrin fibers 
 
In vitro characterization of the degradation of alginate and fibrin were done by 
exposing the materials to alginate lyase and plasmin respectively. 1.5 wt% alginate fibers 
were spun and then exposed to DI water, Schwann cell culture media, PBS, 0.5 U/ml 
alginate lyase, 1.0 U/ml lyase, and 2.0 U/ml lyase in SC media for up to 72 hours (n = 3 
per condition). Mass measurements were taken of the fiber after removal from degradation 
medium at 12, 24, 48, and 72 hours. Results shown in (Fig. 2.22) indicate that exposure to 
alginate lyase has the greatest impact on degrading alginate fibers, with all three 
concentrations tested showing increased degradation at all time points compared to DI 
water, Schwann cell culture media, and PBS. Degradation in all three lyase groups were 
similar, showing no increased % mass degraded as lyase concentration increased from 0.5 
U/ml to 2.0 U/ml. Degradation for the lyase groups occurred rapidly, all showing 
approximately 60% mass loss after 12 hours with little change in mass loss at further 
timepoints. This is similar behavior to that seen with the DI water, media, and PBS groups. 
Surprisingly, of the three non-lyase groups, DI water showed the highest % mass degraded 
at > 40% mass loss compared to the 20-35% seen with media and PBS, indicating that 
some of the Ca+2 ions may be driven by diffusion out of the alginate chain and into the DI 
water, causing some degradation of the material. This indicates that unlike fibrin and 
collagen fibers, hydrated alginate fiber storage requires addition of Ca+2 ions to DI water 
or there is risk of weakening of the material over time due to degradation. 
2 wt% fibrin fibers were spun for comparison of plasmin concentration on 
degradation when fibers were placed in media. (Fig. 2.23) shows the resultant time to 
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degradation of fibrin fibers at plasmin concentrations of 0.1, 0.25, 1.0, and 15 CU/ml 
plasmin. As expected, increases in plasmin concentration resulted in shorter times required 
for full degradation of the fibrin fibers. Exposure to 0.1 CU/ml plasmin resulted in fiber 
degradation after 24 hours. Increasing plasmin concentration to 0.25 CU/ml showed fiber 
degradation after 12 hours; 1.0 CU/ml plasmin exposure degraded fibers within 6 hours. 
The highest plasmin concentration, 15 CU/ml, degraded fibrin fibers within 1 hour. The 
rapid degradation of fibrin shows the need to protect fibers from proteolytic degradation 
during in vitro cell culture studies by addition of aprotinin. (Fig. 2.24) shows the effect of 
axons on fibrin sheet degradation, where secretion of plasminogen from the axon tips 
rapidly degrades any fibrin fibers the axons come in contact with as they move outward 
from a DRG explant. 
 
2.3.18 Effect of landing position of fiber jet during sheet formation 
 
Alterations in the relative landing position of the fiber jet can have significant 
implications regarding the final sheet quality by changing the width of the resultant sheet. 
As the linear stage moves a constant distance per pass, the width of the fiber sheet can be 
tuned by changing to position of the needle tip relative to the collection wheel. Generally, 
these adjustments can be made between the 9 o’clock and 12 o’clock positions of the wheel 
when looking down from above. The relative positional differences cause the rastered fiber 
jet to pass through the collection bath width to differing degrees depending on whether the 
polymer jet is landing near 12 o’clock or 9 o’clock. The 12 o’clock position causes the 
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fiber jet to cut through the maximum possible width of collection bath during deposition 
to generate the maximum width sheets possible for a given linear stage raster distance. This 
can be highly important as the buildup of material can have negative effects if buildup of 
material is too high on a particular region of the wheel depending on material type and total 
spin time. Generally, issues are most prominent in long fibrin spins so 12 o’clock positions 
maximizes the spread of material as the raster moves perpendicular to the direction of fiber 
alignment at this position.  
Fiber sheet width is reduced as one adjusts the landing position of the fibers from 
12 o’clock towards 9 o’clock where width reaches a minimum as the raster is moving along 
parallel with the deposited fiber alignment in this position as illustrated in (Fig. 2.25). To 
avoid these maximum and minimum sheet width conditions, fiber sheets are most typically 
spun in the 10 to 11 o’clock range. This region allowed sufficient width of sheet to be 
formed that is easily wrapped using plastic frames or around mandrels for tube generation 
while also allowing some room for tuning sheet width as needed based on the amount of 
collection solution on the wheel and wheel RPM. Wider sheets closer to 12 o’clock can 
sometimes be a little too thin and the alignment during wrapping may be disrupted by air 
bubbles entrapped during the flipping of frames. Narrower sheets have more difficulty with 
stacking sheets over the same position over multiple wraps around a frame and are more 
difficult to wrap around PTFE coated mandrels during tube generation since fewer 
rotations of the mandrel can be completed, potentially skewing distribution of the fibers 





2.3.19 Optical properties of electrospun hydrogel fibers 
 
The comparative optical properties of collagen, fibrin, and water are shown in (Fig. 
2.26). Unsurprisingly, DI water has high transparency along all wavelengths tested. Six-
layer collagen hydrogel fiber sheets have excellent transparency on par with DI water in 
the visible and IR spectrum but had reduced transmittance in the UV range, particularly 
under 325 nm wavelengths in the UVB region. Six-layer fibrin fiber sheets show reduced 
transparency at all wavelengths compared to collagen fiber sheets with a maximum 
transparency of ~60% at the IR region which steadily decreased down to 5% transparency 
in the UVB region. This result is not surprising as the fibrin fiber sheets have typically 
always been more visually opaque than the highly transparent collagen sheets. Particularly 
exciting is the absorbance of collagen sheets of energies in the UVB range as this infers 
that use of collagen fibers as an AM membrane backing can help protect the internal 
components of the eye from UV damage caused by exposure to sunlight during the course 
of repair. 
The effects of collagen sheet thickness in (Fig. 2.27) show no significant difference 
between 7-layer and 12-layer collagen fiber sheets. It is possible that there exists a 
maximum thickness where the collagen sheets would begin to affect optical properties but 
it appears that anything under at least 12 layers of collagen will have similar optical 
properties. 
Transparency of fused collagen fiber sheets to the AM membrane were compared 
against AM membrane alone, PBS, and calcified rabbit cornea (Fig. 2.28). The AM 
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membrane and composite showed similar levels of transmittance in the tested range with a 
crossover point between the two occurring at 550 nm wavelength, where the lower 
wavelength ranges show slightly more transmittance of the composite membranes, likely 
due to the additional solution uptake of the collagen fiber sheet relative to the AM 
membrane upon rehydration. Calcified rabbit cornea showed the lowest levels of 
transparency showing that the replacement of calcified structures with AM membrane 
composites could improve optical clarity directly after implantation while cellular 
processes take over repair. 
 
2.3.20 Spinning of synthetic PLGA fiber bundles 
 
Despite the differences in equipment setup for generation of electrospun hydrogel 
fibers, mainly the use of a rotating collection bath, spinning of traditional synthetic 
electrospun materials such as PLGA can still be done. Spinning onto a non-solvent for the 
synthetic material allows generation of 3D fiber bundles composed of the synthetic 
material, such as PLGA spun onto DI water. Figure 2.29a shows the resultant PLGA 
microfiber bundle. As a Taylor cone is not established in the electrospun hydrogel fiber 
method, the fiber diameter is larger than those obtained in traditional electrospinning where 
the whipping instability that forms as solvent evaporates under high electric field 
drastically draws fibers down to submicron diameters. Escape of the solvent from PLGA 






Parameters important to characterize and tune hydrogel fiber physical properties 
were established to enable many options to specifically engineer hydrogel fibers for many 
potential tissue engineering applications and to establish standard techniques for fiber 
production. Mechanical properties can generally be tuned through compositional changes 
such as the biological polymer that is spun or the amount of material spun, which can affect 
both the properties and geometry of the material. Other equipment based operational 
parameters such as the wheel rotational speed or spinning time can be used to further fine 
tune mechanical properties and geometries. Swelling of hydrogel fibers are consistent with 
traditional hydrogels and the relative swelling behavior of the various materials spun 
respond based on the materials hydrophilicity, with fibrin being the least hydrophilic of the 
primary biological hydrogel fibers spun. Demonstration of enzymatic mechanisms of 
degradation ensure that hydrogel fibers have the capacity to be remodeled upon 
implantation and that their production and crosslinking does not prevent degradation. Post-
treatment of fibers can have a large impact on both the structure and properties of hydrogel 
fibers as shown by the effects of drying technique on fiber tube microstructure and post-
spin crosslinking of fibrin with factor XIII treatment. Materials selection can even have 
impact on optical transparency for applications involving ocular patch engineering where 







Figure 2-1: Effect of biological material type on mechanical properties. 
Elastic modulus, as measured by DMA using a repeat of at least n = 3 for each wet, dry, 
and rehydrated condition per fiber type shows stiffness is highest with alginate fibers in all 
three states. Rehydrated stiffness (c) were always at intermediate values between the as 
spun wet state (a) and dried (b) indicating that once dried, hydrogel fibers do not fully 
















Figure 2-2: Mechanical properties of fibrin fibers increase as wt% of fibrinogen in 
precursor solution increases. 
Hydrated fibrin fibers were mechanically tested using Q800 DMA. Higher wt% spinning 
solutions trended towards higher mechanical properties with highest gains seen when 












Figure 2-3: Effect of additional strain on fibrin fiber strength. 
Hydrated fibrin fibers were mechanically tested using Q800 DMA (n= 3 to 6). Higher 
strains attained anchoring fiber ends to wooden stakes set to 0, 33% or 66% strain during 
air drying show large increases in mechanical properties with 66% strain enhancing 










Figure 2-4: Increasing rotation speed of collection wheel reduces dried alginate fiber 
bundle diameter. 
Alginate fibers spun onto 50 mM CaCl2 for one minute with various wheel rotation speeds 
show over 40% reduction in alginate fiber bundle diameter when collector RPM changes 
increases from 30 to 72 RPM. Limitations of collection wheel design prevent RPM testing 
below 30 (motor cannot generate steady rotation) or higher than 72 (collection solution is 
jettisoned over wheel rim due to centripetal force). Fiber diameters were collected using 
an optical microscope by measuring least three fibers at three images per fiber and taking 







Figure 2-5: 1.5 wt% vs 0.75 wt% alginate fiber diameters after 15s spin time varying 
flow rate. 
Alginate fibers spun onto 50 mM CaCl2 for 15 seconds with flow rates ranging from 0.25 
ml/hr up to 1.0 ml/hr. Higher flow rates yielded larger diameter fibers in both the dry and 
rehydrated states. For matched flow rates, there tended to be no significant difference 
between fiber diameters when dry but higher wt% alginate had more swelling during 
dehydration than 0.75 wt%. Fiber diameters were collected using an optical microscope by 







Figure 2-6: Effect of PEO composition on 1 wt% alginate fiber diameters after one-
minute spins. 
Alginate fibers spun onto 50 mM CaCl2 for 1 minute at 2 ml/hr with increasing amounts 
of PEO. Higher levels of PEO yielded slightly more swollen alginate fibers up to 0.8 wt % 
PEO addition. Fiber diameters were collected using an optical microscope by measuring 









Figure 2-7: Effect of PVA composition on 1 wt% alginate fiber diameters after one-
minute spins. 
Alginate fibers spun onto 50 mM CaCl2 for 1 minute at 2 ml/hr with increasing amounts 
of PVA. Different levels of PVA all had similar levels of swelling and showed comparable 
swelling to 1.0 wt% alginate + 0.2 wt% PEO fibers (Fig. 2.6). Fiber diameters were 
collected using an optical microscope by measuring least three fibers at three images per 








Figure 2-8: Alginate lyase treatment of alginate-fibrin fiber composites increases 
porosity and reduces elastic modulus. 
Alginate-fibrin composite fibers were treated for 24 hours with 1-2 U/ml alginate lyase and 
then stained with H&E (a) for characterization of porosity (b) and mechanical property 
measurement in a custom bioreactor (c). Porosity increases reduced fiber stiffness once 
alginate was removed up to a composition of 42% alginate where further decreases in 








Figure 2-9: Fibrin bundle dry and rehydrated size as a function of spin time. 
2.0 wt % fibrin fibers spun onto 50 mM CaCl2 collection bath containing 20 U/ml thrombin 
for up to 12.5 minutes holding landing position constant. Fiber bundle diameter increases 
were seen in both dry and rehydrated state for spin times up to 10 minutes. Longer duration 
spins did not add much to fiber diameter due to lower fibrin aggregation efficiency as 
buildup of material at longer spin times limits the crosslinking capacity of fibrinogen after 
10 minutes of spinning. Fiber diameters were collected using an optical microscope by 









Figure 2-10: Flow rate effects on fibrin filament diameter. 
2.0 wt% or 0.75 wt% fibrin fibers spun onto 50 mM CaCl2 collection bath containing 20 
U/ml thrombin for up to 30 seconds holding landing position constant. Increases in flow 
rate did not have substantial effect on the 0.75 wt% fibrin fibers due to the low amount of 
material deposited per unit time. Flow rate had more noticeable effects on 2.0 wt% fibrin 
fibers, causing more swelling of fibers at higher flow rates. Fiber diameters were collected 
using an optical microscope by measuring least three fibers at three images per fiber and 










Figure 2-11: Small fibrin filament size as a function of spin time. 
2.0 wt % or 0.75 wt % fibrin fibers spun onto 50 mM CaCl2 collection bath containing 20 
U/ml thrombin for up to 90 seconds holding landing position constant. Fiber filament 
diameter increases were seen in both dry and rehydrated state with longer spin time. Fibrin 
fibers spun from 2.0 wt % fibrinogen showed higher degrees of swelling at a given spin 
time relative to 0.75 wt% due to the increased quantity of material deposited. Fiber 
diameters were collected using an optical microscope by measuring least three fibers at 









Figure 2-12: Fibrin filament swelling at different spin times. 
2.0 wt % or 0.75 wt % fibrin fibers spun onto 50 mM CaCl2 collection bath containing 20 
U/ml thrombin for up to 90 seconds holding landing position constant. Swelling of fibers 
is readily apparent after rehydration overnight. Fiber diameters were collected using an 
optical microscope by measuring least three fibers at three images per fiber and taking ten 











Figure 2-13: Drying treatment effect on fibrin fiber tube stiffness. 
Fibrin fiber tubes were dried through graded ethanol drying or lyophilization. Graded EtOH 
drying yielded higher stiffness when rehydrated (A) and ultimate tensile strength (C) when 
tested using a Q800 DMA. Strains to failure were similar between the two drying 
conditions indicating that mechanical property differences are mainly attributed to the 













Figure 2-14: Factor XIII effect on fibrin fiber tube stiffness. 
Treatment of fibrin tubes after overnight soak in 20 µg/ml FXIII and 4 U/ml thrombin show 














Figure 2-15: Factor XIII effect on fibrin fiber tube strain to failure. 
Treatment of fibrin tubes after overnight soak in 20 µg/ml FXIII and 4 U/ml thrombin show 














Figure 2-16: Factor XIII effect on fibrin fiber tube ultimate tensile strength. 
Treatment of fibrin tubes after overnight soak in 20 µg/ml FXIII and 4 U/ml thrombin show 














Figure 2-17: Comparison of lyophilization and ethanol drying of fibrin tubes. 
Lyophilization does little to preserve the aligned structure of fibrin tubes once the process 
is complete yielding tubes with a disorganized structure on the surface (top left) and 
thicker, highly porous walls (bottom left). Graded ethanol drying maintains longitudinal 










Figure 2-18: Cracking occurring in fibrin tube during drying. 
Cracks sometimes run along whole length of fibrin tube vascular graft when ethanol drying 
treatment is done without overnight soak in 90% ethanol, leading to rapid device failure 
upon implantation (a). Higher magnification image of crack showing folded-like structure 
















Figure 2-19: Application of mass flow constant to achieve similar fiber diameters with 
different spin conditions. 
Variation of flow rate and spin time when electrospinning 2 wt% fibrin hydrogel fibers 













Figure 2-20: Swelling ratios of fibrin and collagen hydrogel fibers. 
Fibrins show similar swelling compared to Secant collagen fibers but are at a much lower 
swelling degree compared to electrospun collagen hydrogel fibers. Electrospun collagen 
hydrogel fibers are more hydrophilic than fibrin fibers, Secant collagen are very dense 












Figure 2-21: Rapid rehydration of alginate, fibrin, and collagen hydrogel fibers. 
Measurements of the rehydration of alginate, fibrin, and collagen hydrogel fibers show that 
rehydration occurs quickly, within 10 minutes, and no significant additional rehydration or 














Figure 2-22: Degradation of alginate fibers in alginate lyase, PBS, Schwann cell 
media, and DI water. 
Mass loss of alginate fibers was highest in lyase solutions. Concentration differences in 
alginate lyase between 0.5 U/ml to 2.0 U/ml did not show significant difference from each 
other. Degradation was highest during the initial 12 hours. Schwann cell media, PBS, and 
DI water showed lower degradation than the lyase group with degradation in the lower 










Figure 2-23: Fibrin fiber bundle degradation with plasmin treatment ranging from 
0.1 CU/ml to 15 CU/ml. 
Plasmin treatment of fibrin fiber bundles show concentration dependent degradation with 
reduction in complete degradation time down to 1 hour when using high plasmin 















Figure 2-24: Degradation of fibrin fiber sheets by DRG explant without addition of 
aprotinin. 
Lack of aprotinin addition to cell culture media when DRG explants are seeded on fibrin 











Figure 2-25: Modifying fiber sheet width by changing landing position of fiber jet. 
Adjustment of fiber sheet width using constant linear stage raster distance is done by 
altering the clock landing position of the jet. Positions where the jet is traveling parallel to 
the tangent of wheel rotation (12 o’clock) will have wider sheet formation due to the jet 
raster cutting across a maximum width of collection solution when needle is horizontally 
oriented in the above figure and travels at a constant distance (indicated by green, blue, and 
red line). Narrower sheets form as landing position moves towards the 9 o’clock minimum, 
where the jet landing position is perpendicular to the flow and a minimum width of the 




Figure 2-26: Optical transparency properties of collagen and fibrin fiber sheets. 
Collagen shows greater transparency in solution throughout visible wavelengths compared 
to fibrin fiber sheets and has comparable optical properties to water due to the high levels 
of hydration characteristic of collagen hydrogel fiber sheets. Collagen sheets shows some 
absorption in the UVB wavelength range, leading these sheets to potentially provide a UV 
protective effect when used for ocular applications. N = 3 fiber sheets measured per type 











Figure 2-27: Effect of collagen fiber sheet thickness on optical properties. 
Effect of collagen fiber sheet thickness on optical properties do not show significant change 
in transparency properties when comparing EDC crosslinked collagen fiber sheets 
composed of seven or twelve wrapped layers. N = 3 fiber sheets measured per type in 










Figure 2-28: Comparison of optical properties of collagen, AM membrane, and 
calcified cornea. 
Collagen fiber sheet transparency was compared with AM membrane for potential use in 
optical patch applications as a mechanical support of the weak AM membrane. Collagen 
sheets have similar transparency to the AM membrane in PBS. Reduction in transparency 
of collagen compared to the previous two figures is predominantly due to the use of PBS 
as the solution rather than DI water. N = 3 fiber sheets measured per type in wavelength 









Figure 2-29: 3D PLGA microfiber bundle spinning. 
PLGA microfibers spun onto DI water, a non-solvent, precipitates on collection solution 
and can be collected as a fiber bundle (a). Fibers are several microns and larger due to lack 
of whipping instability during electrospinning (b). Escape of dichloromethane solvent from 
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Chapter 3   Cellular Organization and Migratory 
Effects using Aligned Hydrogel 




3.1.1 Interaction of cells with extracellular matrix 
 
Cellular interaction with the surrounding extracellular matrix is controlled by four 
primary effects: substrate stiffness, confinement, adhesion, and surface topology [1]. 
Substrate mechanical properties have a large effect on how integrin binding sites interact 
with the ECM and can drive differentiation due to the large differences in mechanical 
properties found in the native ECM of various tissues like adipose and neural (100 Pa) [2], 
muscle (1 kPa) [3], or bone (tens of GPa) [4]. Actomyosin stress fiber generation during 
mechanotrasduction of stiff substrates lead to cytoskeletal tension within the cell [5, 6]. 
When adhesions of the back side of the cell are released, the tension slides the cell body 
towards the leading edge that is still attached to the substrate, movement that is much in 
the same manner as that of a hungry caterpillar. Stiff substrates also upregulate the 
production of proteases such as MMPs to prevent the cells from remaining indefinitely 
under high tension [7]. Mechanotransduction signaling can additionally provide the cell 
with information to determine stiffness gradients present in the ECM, leading to the 
induction of durotaxis [8].  
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Softer substrates enables high levels of migration for cells through the matrix by 
enabling them to deform the ECM, opening up migratory pathways. Thus, it is important 
to consider that both the stiffness of the whole tissue engineered construct and localized 
stiffness play a role in cellular response as demonstrated by the differences in stem cell 
differentiation caused by changes in the local mechanical properties of collagen [9]. 
Cellular migration through soft substrates ultimately is controlled by the deformability and, 
in the case of hydrogels, the network mesh size formed by crosslinking as the nucleus of 
the cell can only be deformed to diameters as low as 4 µm [10].  
 
3.1.2 Topographical guidance cues 
 
Electrospinning provides a technique to generate ECM-like nanofiber materials 
with both synthetic and biologically derived polymers. The flexibility of the platform has 
led to the generation of ECM-like structures for vascular grafts [11], tendons [12], nerves 
[13], and others though it is difficult to create truly 3D structures with traditional nanofibers 
spinning processes. 
Topographical cues presented to the cells can be classified as those that provide 
continuous or discontinuous surfaces. Continuous surfaces would be planar substrates such 
as TCPS or dense electrospun nanofiber meshes that mimic the basement membrane where 
cells are able to broadly spread lamellipodia [14]. Discontinuous surfaces are those that 
have spacing of several hundred nanometers or more between adhesive cues that confine 
cells and reduce cellular traction [15]. Discontinuous topographical cues cause cells to 
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elongate along the cue direction due to the relatively linear directionality the actin filaments 
are forced into [16]. Confinement generated by discontinuous substrates necessitates the 
use of alignment features if migratory speed is an important design consideration as linear 
directionality will reduce the travel distance required compared to more disorganized 
discontinuous matrices [17].  
 
3.1.3 Cardiac tissue engineering 
 
The complex shaping, cyclic strain, and underlying structural ECM alignment of 
the heart presents a challenge to tissue engineers developing materials to treat pathological 
states like myocardial infarction and congenital defects [18]. An additional challenge is 
that there is very little cardiac cell replacement each year so acellular tissue engineered 
constructs will be unlikely to incorporate many native cells [19]. This area of research is 
particularly important as there are nearly a million deaths each year in the United States to 
cardiac disease [20]. Structurally, any sort of patch used should match the mechanical 
properties of the myocardium so that muscle contractility is not impeded [21] and there is 
no impedance of electrical signaling between cardiomyocytes, which can be affected by 
scaffold stiffness [22]. The general range of stiffness required for cardiomyocytes to 
function as they do in healthy tissue is in the range of 10 to 20 kPa. Such a scaffold stiffness 
range can be met using electrospun hydrogel fiber sheets very easily. 
Other considerations to be made with cardiac tissue engineering include the 
biocompatibility of the material and potential immune response. Should a cardiac patch 
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induce a significant inflammation response, the patch could possibly be degraded more 
rapidly than expected due to additional macrophage invasion [23]. Several natural 
materials have been used for cardiac tissue engineering due to their good biocompatibility 
and immune response properties. These include collagens, alginate, fibrin, and gelatin [24]. 
Synthetic polymers have also been used for cardiac tissue engineering but due to their very 
high relative stiffness, are most often used as a support structure for naturally derived 
materials [25]. 
 
3.1.4 Vascular graft engineering 
 
Incorporation of existing vascular (angiogenesis) or development of new vascular 
networks from cell progenitors (vasculogensis) is of critical importance for tissue 
engineering products as without adequate nutrient transport and oxygen, many tissue will 
fail to regenerate or repair [26]. Tissue engineered grafts have to take into consideration 
not only the mechanical properties of the graft, ideally matching that of the native 
extracellular matrix, but also to consider the adhesive cues required and the need to mimic 
the natural presentation levels of vascular signals such as VEGF, FGF, TGF, and other 
chemical cues to direct neovascularization [27, 28].  
Some current vascular grafts in development include hollow tubes composed of 
cast collagen gels that are very analogous to Integra’s NeuraGen nerve guide, in that there 
is no alignment tube provided and that the main advantage of the device is the native 
material usage. These collagen tubes have been shown to show stable blood flow through 
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the conduit for 20 minutes [29]. Other techniques for vascular grafting include using 
patterned PDMS substrates to induce alignment of fibroblasts to secrete aligned ECM over 
six week, which is then wrapped up into a tube [30] and elastin-PCL hybrid grafts where 
the composite materials provide the elastic and mechanical strength properties needed for 
a vascular graft [11],  
The ubiquity of fibrin(ogen) in the circulatory system and its intimate relationship 
with the clotting cascade following damage to blood vessels makes it an excellent material 
for use in vascular applications. A primary advantage of fibrin usage is its ability to be 
proteolytically degraded on a relatively rapid timescale compared to more persistent ECM 
components such as collagen and elastin. The alignment features of the fibrin fibers 
combined with the degradation properties make them an excellent scaffold material for the 
culture of pericytes, smooth muscle cells, and other endothelial cell types. The flexibility 
of the fibrin hydrogel fiber spinning platform enables the generation of scaffold systems 
with easily variable diameters for in vitro cell culture and organization of vascular cells, 
which later can degrade the luminal fibrin themselves or through addition of plasmin to the 
culture media. Additionally, fibrin sheets wrapped around Teflon coated mandrels can 
yield hollow, perfusable scaffolds that can be used as a biomimetic in vitro model for 







3.1.5 Skeletal muscle tissue engineering 
 
Tissue engineered constructs composed of fibrin hydrogels and skeletal muscle 
cells have been found to create a highly beneficial microenvironment for skeletal muscle 
repair [31]. Alginates have also been investigated for use differentiation of skeletal muscle 
cells after modification with RGD peptides [32]. A general requirement for the underlying 
structure of skeletal muscle is that the muscle must remain aligned along the entirety of the 
length of the muscle to ensure maximum contractile forces are possible. Such long-range 
3D alignment structures can be generated by electrospun hydrogel fiber bundles. 
Scaffolds for skeletal muscle tissue engineering fall into several types. Porous 
scaffolds with many of the same design parameters as seen with nerve guide design have 
been used with collagen and synthetics such as PGA [33] to orient skeletal muscle cells 
along a particular axis. Alignment of skeletal muscle through use of electrospun fiber 
meshes have also promoted myotube formation on PCL-collagen nanofibers [34]. 
 
3.2 Methods 
3.2.1 Spreading of primary Schwann cells along fibrin and collagen fiber sheets  
 
Primary Schwann cells were isolated from P2 rat pups and used to form spheroids 
of approximately 200 µm diameter using 36 sphere molds for 48 hours prior to seeding on 
electrospun collagen and fibrin fiber sheets. Once seeded, several samples were fixed and 
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stained at days 1, 3, and 6 for S100β (1:200), a marker of Schwann cells, to measure the 
spreading of the cells. Schwann cells were cultured in Schwann cell maintenance media 
containing 5% FBS (Invitrogen), 1% penicillin/streptomycin (Invitrogen), 200 µg/ml 
bovine pituitary extract (Sigma), and 2 µM forskolin (Sigma) without being supplemented 
with additional growth factors. Media was exchanged every 2nd day. 
 
3.2.2 Neurite extension from DRG explant as function of fiber alignment  
 
As the electrospun fiber sheets do not form discrete fibers distinguishable from one 
another as can be produced during traditional nanofiber electrospinning, characterization 
of neurite outgrowth from DRG explants was used to demonstrate that the topographical 
alignment effects remained intact in a sheet configuration. DRG explants were isolated 
from postnatal P2-P4 Sprague Dawley rat pups and cultured on random cast collagen gels, 
aligned collagen microfiber sheets, and aligned collagen fiber sheets that were soaked in 
matrigel overnight prior to seeding to demonstrated that electrospun collagen fiber sheets 
maintain cell motility characteristics without the need for additional modification.  
Collagen fiber sheets were prepared by electrospinning 1 ml of a 1 wt% collagen 
solution with 0.2 wt% PEO at a flow rate of 3.25 ml/hr onto a collection solution of 40 
mg/ml EDC using a linear stage to raster the landing position over an area of approximately 
1.5 cm width. Fiber sheets were collected using a mylar with outer dimensions of 15 mm 
square an inner centered cutout of 11 mm square. Cast collagen gels with random structural 
alignment were prepared by neutralizing 800 µl of 1 wt% collagen with 100 µl 7.5 wt% 
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NaHCO3 and 100 µl 10x PBS. A total of 8 ml collagen was prepared in order to cast 1 ml 
into each well of a 12 well multiwell plate for DRG explant seeding. Once cast, random 
collagen was gelled by incubating at 37°C for one hour. A single DRG explant was placed 
on each of eight random collagen gels, four Matrigel coated aligned collagen microfiber 
sheets, and four uncoated aligned collagen fiber sheets and cultured in DRG media lacking 
NGF for 14 days. Samples were fixed in 4% PFA after d14 and neurites stained with 1:200 
βIII-tubulin to characterize total outgrowth. Neurite outgrowth was characterized by 
measuring maximum neurite extension at each 5 degree interval off the axis of fiber 
alignment from the center point of the explant. The length of the explant itself along each 
direction was subtracted from the measured outgrowth so as to only count neurite 
extension. 
 
3.2.3 Outgrowth of neurites from DRG explants on uniformly loaded GDNF 
collagen fiber sheets 
 
Prior to utilizing loaded electrospun collagen fiber sheets for nerve guide usage, it 
was necessary to characterize the effect of neurotrophic factor loading on neurite outgrowth 
to determine the loading level most likely to result in a beneficial outcome on functional 
recovery once implanted. Collagen fiber sheets were spun using typical parameters of 1ml 
of 1% collagen spun at 3.25 ml/hr using a collector wheel rotation speed of 45 RPM using 
a linear stage for sheet formation with 6 layers of material per sheet collected and total 
sheet area of 1 cm2. Sheets were loaded with 0, 50, 100, 250, 500, or 1000 ng human GDNF 
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and sheets were then dried under laminar air flow within a biosafety cabinet prior to DRG 
explant seeding. Heparinized collagen sheets were not tested due to the more rapid GDNF 
release seen with that configuration. Dorsal root ganglia explants were harvested from P2 
Sprague Dawley rat pups and immediately seeded onto the dried collagen sheets. Ten 
minutes after seeding, 100 µl of DRG media was added to the sheet and then an additional 
20 minutes later the remainder of media was added to bring total culture volume to 1 ml. 
DRGs were cultured for one week to allow neurite extension with media exchange every 
other day prior to being fixed in 4% PFA and stained for βIII-tubulin (1:200). 
Each immunostained image of neurite outgrowth from the DRG explant after seven 
days were measured as follows. Images were split into two parts by taking the DRG explant 
and overlaying a vertical line through the midsection of the explant perpendicular to the 
direction of the alignment. Using this line as a starting point, the maximum neurite 
outgrowth was measured using ImageJ at 20 µm intervals as seen in Figure 3.1 on both 
sides of the DRG bisecting line for all samples. Distributions of neurite extension were 
generated from this data excluding the DRG explant radius and used to determine GDNF 
loading level usage for collagen fiber sheet loading with the SYSU in vivo nerve guide 
study. 
 
3.2.4 Consumption of free amines during collagen fiber sheet formation 
 
The rapid crosslinking of collagen fiber sheets requires a high concentration of 
EDC (210 mM) used in the collection bath. As this crosslinker will conjugate primary 
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amines with carboxylic acid groups, there is the important question of what proportion of 
free amines remain after sheet formation since these groups are commonly used for 
bioconjugation reactions such as in applications where growth factors are covalently 
tethering to a biomaterial surface. To investigate this, the quantity of free amines in the 
unadulterated collagen stock spinning solution was calculated and then a fluorescamine 
assay was used in conjunction with a plate reader to characterize the number of moles 
primary amine remaining both following crosslinking during fiber formation and after 
conjugation of cell adhesive peptide 945W. 
Briefly, each collagen sheet was submerged in 0.9 ml PBS and then 100 µl of 0.3 
mg/ml fluorescamine in acetone was added. Acetone was given 10 minutes to evaporate 
and then solution was vortexed gently for 25 minutes at room temperature. Collagen sheets 
were then triple washed in PBS and degraded in 1 ml of 1.0 mg/ml collagenase for 45 
minutes at 37°C. Once degraded, fluorescence using λex = 390 nm and λem = 475 was 
measured in a plate reader and compared against ethylene diamine standards using the same 
procedure. Peptide 945W was conjugated to collagen fibers using SMCC (succinimidyl-4-
(N-malemidomethyl)cyclohexane-1-carboxylate) to link 945W thiol groups to the 
remaining collagen primary amines.  
 
3.2.5 Release of GDNF from heparinized collagen fiber sheets  
 
While loading level effects of GDNF were characterized by the DRG neurite 
outgrowth response, it was also important to determine how tunable the release parameters 
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were by conjugating heparin to collagen fibers during the spin and using heparins affinity 
to bind soluble GDNF as a method of controlling release. The very high concentration of 
EDC required limits the capacity of collagen fibers to be post-modified by heparin 
conjugation using EDC crosslinking of heparin’s carboxylic acid groups to the collagen 
primary amines. To circumvent this, heparin was added directly to the EDC crosslinking 
bath to be activated and compete with EDC alone for reaction with the collagen primary 
amines. Heparin was added to the collection bath at several concentrations, characterized 
by the relative amount of heparin addition to mg of collagen spun as measured by TBO 
assay for COOH- (Fig. 3.2). Concentrations tested included a non-heparinized control, 7.6 
µg heparin per mg collagen, 17.6 µg hep/mg collagen, and 33.1 µg hep/mg collagen to 
determine how much heparinization would prolong GDNF release. GDNF was labeled to 
be fluorescent at 488 nm using a DyLight fluorescent labeling kit and loaded at 250 ng 
GDNF488 per collagen sheet. Collagen sheets were placed into 500 µl PBS for release and 
full PBS volume was collected and exchanged after 6 hour, 12 hour, d1, d2, d4, d5, d7, and 
after 12 days. A plate reader was used to compare GDNF488 in the collected solution for 
each timepoint and compared to a known set of GDNF488 standards. 
 
3.2.6 Effect of fibrin fiber sheet heparinization on neural stem cell spreading and 
FITC-lysozyme release  
 
Modification of fibrin fiber sheets with heparin to control growth factor release was 
investigated. To do this, neural stem cell spheroids were formed from MicroTissue 36 
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sphere molds seeded with 25k cells per mold for formation overnight and then cultured for 
seven days on heparinized and non-heparinized fibrin sheets in NSC maintenance media, 
neuron differentiation media, or GDNF that was preloaded into fiber sheets. Heparinization 
of fibrin sheets was done as a post-production step by soaking fibrin sheets in a 0.22 µm 
sterile filtered 0.1 wt% EDC-activated heparin solution in 0.05 M MES for one hour at 
room temperature while under agitation on an orbital shaker followed by triple washing 
with sterile DI water prior to cell seeding. GDNF was loaded into the preloaded group were 
soaked into fiber sheets overnight at a concentration of 10 ng/ml. The same concentration 
of GDNF was to media in the GDNF soluble group to compare the effects of freely 
solubilized GDNF with sheets that had GDNF presentation based on release from heparin. 
Heparinized sheets and non-heparinized sheets were examined after seven days for all four 
media types after being fixed in 4% paraformaldehyde and stained for βIII-Tubulin, Nestin 
or GFAP. 
 
3.2.7 Physical loading and release of FITC-lysozyme from fibrin and alginate fibers  
 
As an alternative to controlled release via post loading of heparinized fibers, 
investigation into direct inclusion of growth factor in situ during fiber formation was 
investigated using FITC labeled lysozyme. FITC-lysoszyme was added to the precursor 
solutions for 1.5 wt% alginate and 2.0 wt% fibrin to be captured during the crosslinking of 
the fibers in the normal 50 mM CaCl2 and thrombin collection baths respectively. 
Following the spins, fibers were air dried and fluorescence images of the fibers were taken. 
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Additional images were taken of the fibers after being placed in 50 mM CaCl2 solution for 
30 minutes and after days 1, 3, and 10. The relative fluorescence intensity of the fibers at 
these time points were measured using ImageJ and plotted to generate a relative release 
profile over 10 days. 
 
3.2.8 In situ spinning of live cells during formation of electrospun hydrogel fibers  
 
A particular advantage of electrospun hydrogel fiber spinning over traditional 
synthetic polymer nanofiber spinning is the lack of organic solvent usage and the lower 
wt% of materials that can be spun. To demonstrate this advantage, investigation was made 
into whether or not live cells could be viable if included in the precursor solution and 
electrospun. To test this, several types of fibrin and alginate-fibrin composite fibers were 
investigated with human immortalized Schwann cells added directly to the precursor 
solution and spun along with additional glucose to maintain solution tonicity. While the 
primary goal of these experiments were cell survival, the selection of fiber spinning 
conditions were also aimed at enabling cellular migration through the fiber so some 
migratory capacity would remain to those cells initially trapped within the matrix created 
by the electrospun hydrogel fiber. Fibrinogen solutions at the normal 2.0 wt% were 
expected to be too dense for ASC migration, which tend to only migrate through randomly 
oriented fibrin structures up to 1 wt% fibrin. As even 1 wt% electrospun fibrin fibers will 
likely have higher fibril packing efficiency compared to random gels of the same 
composition, it was desirable to spin the minimum possible fibrinogen composition that 
122 
 
could still successfully form a fiber. To this end, 0.4 wt% fibrin fibers were spun with a 
high cell loading density of 32k human immortalized Schwann cells per µl fibrinogen spun.  
An alternative experiment was also conducted utilizing a pair of y-syringe pump 
setups to spin alginate-fibrin composite fibers where pumps were placed on opposite sides 
of the collection wheel and spun simultaneously onto the same bath to create distinct 
regions of fiber containing different cell types. In this case, rather than different cell types, 
sets of Schwann cells were labeled with different fluorophores and imaged with a 
fluorescence microscope after seven days culture. Each set of pumps contained human 
immortalized Schwann cells labeled with either live cell tracker green or live cell tracker 
far red. Cells were spun at a density of 1000 cells per µl. Fibers containing cells were placed 
into Schwann cell media directly after spinning. During the first 24 hours, media was 
supplemented with 0.5 U/ml alginate lyase to remove alginate from the composite to 
improve motility of cells. 
 
3.2.9 Fibrin cardiac patch spinning 
Cardiac patches were formed using two different fibrinogen concentrations to 
mimic the mechanical properties of native tissue extracellular matrix during homeostasis 
and the stiffer state that is present following myocardial infarction as these two conditions 
will impact the contractile response of cardiomyocytes. Fibrin cardiac patch sheets are spun 
using two compositions of fibrinogen under sterile conditions. Homeostatic-mimicking 
sheets are spun using a precursor solution of 0.75 wt% fibrinogen in 0.2% PEO while the 
infarction model sheets are generated using 2.0 wt% fibrinogen. PEO is prepared as a 1.0 
123 
 
wt% stock in DI water that is dissolved over several days at 37°C. Once prepared, the 1.0 
wt% PEO stock is further diluted to 0.2 wt% PEO by mixture with additional DI water 
before use and briefly vortexed to ensure mixing. To prepare at 0.75 wt% fibrinogen 
precursor solution, ~9 mg of fibrinogen is added to an empty 2 ml round bottom Eppendorf 
tube (~24 mg added for 2.0 wt% fibrinogen). Once added, the fibrinogen is dissolved by 
addition of 1.2 ml of 0.2 wt% PEO to the 2 ml Eppendorf tube, which is placed in a 37°C 
water bath for at minimum 15 minutes to ensure dissolution. 
Following dissolution of the fibrinogen, the precursor solutions are transferred to a 
biological safety cabinet and sterile filtered into autoclaved round bottom Eppendorf 2 ml 
tubes using a 0.22 µm filter. The filtered fibrinogen is loaded into a 1 cc syringe and large 
air bubbles are dislodged by gently moving the syringe plunger back and forth while the 
syringe is facing upwards. The syringe is then loaded onto a syringe pump set to dispense 
at a rate of 5.0 ml/hr for 0.75 wt% fibrinogen or 3.25 ml/hr for 2.0 wt% fibrinogen. A 
collection solution of 20 U/ml thrombin in 50 mM CaCl2 is prepared by dissolving 1 ml of 
a 1000 U/ml thrombin stock solution into 50 ml of sterile filtered 50 mM CaCl2. The DC 
motor controller is turned on and the power to the collection wheel motor is increased until 
the wheel is rotating at ~45 RPM, at which point the 50 ml collection solution is added. 
The linear stage upon which the syringe pump sits is powered on and begins rastering at a 
rate of ~ 3 cm/min over a distance of 1.5 cm. The syringe pump is set to run and begins 
dispensing the fibrinogen solution at which point the power supply is turned on and set to 
4.5 kV to initiate jet formation. 
The solution is electrospun onto the collector for 17 minutes when using 2.0 wt% 
fibrinogen or 20 minutes total using 0.75 wt% fibrinogen with a pause in spinning after 10 
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minutes to refill the syringe. Upon completion of the spin time, the fibrin sheets are 
allowed, at minimum, two additional minutes in the crosslinking solution to ensure 
fibrinogen deposited later in the spin has had sufficient time to stabilize with the power 
supply off. A 1 cm x 1 cm plastic frame is then placed onto the resulting fibrin sheet and a 
cut is made along one side of the fibrin sheet (typically the side of the frame distal to the 
operator). The frame is flipped end over end towards the operator a total of six times, being 
careful to ensure entrapped air bubbles do not significantly disrupt alignment. A single spin 
will normally yield six frames with six fibrin layers. Once collected with the frames, fibrin 
sheets are placed in DI water to dilute residual thrombin for a minimum of 30 minutes 
before use. Sheets can be stored in DI at 4°C indefinitely should there be no contamination 
if sheets are not needed on the day they are spun.  
Prior to cell seeding, excess water is wicked away from the fibrin sheets by touching 
the frame edge against autoclaved kimwipes and then briefly touching the fiber sheet face 
against the same kimwipes. This has been found to enhance the adhesion of cardiac cells 
which empirically seem to be more sensitive to fiber hydration conditions compared to 
neuronal cell types. Once partially dried, sheets should be placed vertically in a 24 well 
plate and stored at 4°C until use to prevent sheets from drying out. Partially dried fibrin 
sheets must be used within a couple days or loss of hydration will be substantial enough to 





3.2.10 Fibrin fiber sheet alignment effects on microvessel formation and cardiac cell 
alignment  
 
Fibrin hydrogel microfiber sheets were formed by a modified electrospinning 
process where fibers were collected on a rotating bath containing a crosslinker bath. 
Briefly, a 2 wt% fibrinogen (Sigma, St. Louis, MO, USA) was dissolved in 0.2 wt% 
polyethylene oxide (PEO, 4 million Mz) (Sigma) and loaded into a blunted 27G tip syringe. 
The loaded syringe was then placed into a syringe pump and extruded at a flowrate 3.25 
ml/hr. A positive voltage of 4.5 kV was applied to the syringe tip to propel the fibrinogen-
PEO solution jet onto a grounded and rotating collection bath (45 RPM) containing 50 mM 
CaCl2 (Fisher Scientific, Waltham, MA, USA) and 20 U/ml thrombin (BioPharm 
Laboratories LLC, Bluffdale, UT, USA) in deionized water to form fibrin hydrogel fibers.  
Sheets were formed by rastering the landing position back and forth for 17.5 min after 
placing the syringe pump on a linear stage.  Upon completion of the spin, 1 cm2 sheets 
were collected by wrapping six layers of sheet from the collection bath onto PET frames.  
Samples were then soaked in DI water overnight to remove residual thrombin and calcium.  
To improve cell attachment during seeding, fibrin fiber sheets were partially dried by using 
sterile Kimwipes to briefly wick away excess water by placing the wipe against the edge 
of the PET frame. Once partially dried, fibrin sheets are stored at 4°C until seeding to retain 
moisture and may be stored in such a manner for at least two months. Fibrinogen and 
crosslinker bath solutions were filtered with 0.22µm filter before use and sheets were spun 
under sterile conditions in a biosafety cabinet. 
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The mechanical properties of fibrin fiber sheets are very similar to those of 
physiological cardiac tissue. For the formation of transplantable cardiac patches to treat 
regions damaged by myocardial infarction, it is important to not only have a similar 
stiffness value to native tissue but also induction of the alignment features seen with the 
cardiomyocytes and their corresponding vasculature to ensure the function of the construct 
matches as closely as possible with the native tissue. To check this with our fibrin sheets, 
experiments were done to characterize the alignment of microvessels formed from HUVEC 
cells and cardiomycytes to see if the resultant structure could be similar to the native 
pericardium of the heart. 
Fiber alignment effects on microvessel formation were characterized from HUVEC 
cultures on 2 wt% fibrin fiber sheets for one week before being fixed and immunostained 
for CD31, a blood vessel surface marker, to visualize the spontaneous alignment response 
of the cells.  For trophic support, human adipose derived stem cells were cultured in a 1:1 
ratio with HUVECs seeded onto the surface of aligned fibrin fiber sheets at different total 
cell densities to compare cell number effects on alignment after one week in culture. 
 
3.2.11 Electrospun hydrogel fibrin fiber bundles and tubes for generation of vascular 
grafts  
 
Early studies demonstrated that fibrin fibers made excellent candidates for culture 
of vascular cells including endothelial colony forming cells (ECFCs) and smooth muscle 
cells (SMCs). These studies showed excellent alignment response of the cells to the fiber 
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alignment and were found to promote generation of additional extracellular matrix 
components such as collagen IV [35, 36]. While these fibrin fibers proved to be highly 
beneficial for vascular cell culture, the system of culture around a solid fibrin fiber limits 
such a system to in vitro study. Thus, it was desired to develop a hollow fibrin fiber tube 
that could be perfusable and implantable as a vascular graft. 
There are two primary modes of electrospinning fibrin for vascular applications 
currently established. The original fibrin string methodology generating dried fiber bundles 
upon which the outer surface is seeded with endothelial cells. The more recent and 
advanced configuration is to apply the fibrin sheet spinning methodology in conjunction 
with Teflon coated mandrels to create hollow fibrin tubes with topographical alignment 
that can be perfused. 
Fibrin strings are generated by mixing alginate (AG) with fibrinogen (F) during the 
spin followed by stretch drying to enhance topographical alignment features beyond that 
which can be created from the “off the collection wheel” product. To generate the 
prepolymer solution for this configuration, 9.1 mg to 24.5 mg fibrinogen are added to 1.5 
ml round bottom Eppendorf tubes and then dissolved in a 1.2 ml of 0.2 wt% PEO solution 
in DI for 15 to 30 min at 37°C just prior to spinning. Alginate is similarly dissolved for 
several days prior at 37°C in 0.2 wt% PEO as it dissolves more slowly at physiological 
temperatures than fibrinogen. An additional syringe pump line is added to the standard 
spinning setup so that both fibrinogen and alginate have separate feeds into a “Y” shaped 
custom nozzle that mix the two components in line just prior to their jettison at the needle 
tip connected to the power supply alligator clip. The “Y” syringe consists of two 31 g luer 
lock needle “inlets” that merge to mix in a 20 g needle that has been cut and polished on 
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both ends. The a 25g “outlet” needle with cut and polished tip is inserted into the 20 g 
mixing section and then potential leakage sites are sealed with generous wrapping using 
thin, 1-2 mm diameter, parafilm strips (note that these early gen “Y” syringe needles have 
been supplanted by improved commercial “Y” syringes in the more recent work done by 
the lab of Prof. Warren Grayson for skeletal muscle engineering projects at the translational 
tissue engineering center at Johns Hopkins University using AG-F fibers). The flow rates 
of the two components can be independently modified to change the relative proportion of 
alginate and fibrin in the final as-spun fiber, usually characterized by an AG/F ratio.  
Fibrin fibers in the earlier study generated by using alginate-fibrin composite spins 
followed by alginate removal with 150 mM sodium citrate overnight and then stretching 
of the remaining porous fibrin fibers to strains of 50% during air drying. To generate hollow 
fibrin tubes, a modification of the fibrin fiber sheet spinning parameters was used. Fibrin 
fiber sheets were prepared as with the cardiac sheet preparation using 2.0 wt% fibrinogen 
as the precursor solution. The procedure diverges in the wrapping step. Rather than 
wrapping sheets around mylar frames, sheets are wrapped around teflon (PTFE) coated 
stainless steel mandrels (Applied Plastics). Wrapping around the stainless steel mandrel 
allows alignment of individual layers to be circumferential, perpendicular to the direction 
of blood flow, or longitudinal, in parallel with the flow of blood. Once wrapping of fibrin 
tubes are complete, they are stored in sterile DI water overnight to allow residual thrombin 
captured in the fibrin fibers to diffuse away. Following this, fibers are dehydrated in a series 
of ethanols up to 100% ethanol and then air dried. Once dried, tubes are able to be removed 
from PTFE coated mandrels and stored at 4°C dry or rehydrated. Despite not being stretch 
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dried like earlier generation fibrin strings, alignment features remain well aligned on the 
tube surface. 
 
3.3 Results and Discussion 
3.3.1 Spreading of primary Schwann cells on fibrin and collagen fiber sheets 
 
On collagen fiber sheets, Schwann cells showed a high degree of spreading over 6 
days with cells migrating up to 1750 µm and showing themselves to be highly responsive 
to the fiber alignment with a bias in orientation towards the direction of alignment (Fig 
3.3). Few Schwann cells migrated out from the spheroids after day 1 with most cell 
spreading a result of fibroblasts based on the faint non-specific staining seen. By d3, 
Schwann cells had spread up to 1000 µm away from their initial spheroid position. 
Fibrin sheets showed higher initial spreading of Schwann cells after one day culture 
(Fig. 3.4) with some initial spreading being seen outward from the spheroid. By day three, 
spreading had continued though not with the same extent of alignment as collagen fiber 
sheets. Some samples of fibrin sheet showed significant degradation of the sheet by the 






3.3.2 Neurite extension from DRG explant as function of fiber alignment 
 
Figure 3.5 shows the resultant extension for the three groups tested. Both aligned 
collagen fiber conditions clearly show increase in neurite extension along the fiber 
alignment direction with maximum extensions of nearly 5000 µm after two weeks culture. 
Little difference was seen comparing the matrigel and uncoated collagen fibers, indicating 
that the biological integrin binding sites of collagen are maintained during the electrospun 
hydrogel formation process and that coating with additional cellular adhesive cues such as 
matrigel, laminin, or fibronectin are not necessarily required to enhance neurite outgrowth 
on these materials (Fig. 3.6). Substantial difference was seen between the aligned collagen 
fiber groups and the random cast collagen gel. The random gel showed relatively consistent 
outgrowth in all directions of 1500-1750 µm. The horizontal axis in each random collagen 
image were arbitrarily defined as the “fiber alignment axis” for comparing outgrowth from 
each 5-degree interval. Surprisingly, while the outgrowth distance was much higher for the 
DRG explant neurites along the aligned fiber axis than the random gel, the outgrowth 
towards the direction perpendicular to the fiber alignment was actually less than the 
corresponding outgrowth on random collagen at only 1000 µm. This can be explained from 
the immunostained images on aligned collagen fiber samples showing some initial axon 
growth perpendicular to the fiber alignment that soon turns to follow the fiber alignment 




3.3.3 Outgrowth of neurites from DRG explants on uniformly loaded GDNF 
collagen fiber sheets 
 
Lack of GDNF loading yielded the lowest overall neurite outgrowth after seven 
days (Fig. 3.7). Inclusion of GDNF improved the spreading as illustrated by the shift 
towards higher neurite outgrowth. 50 ng GDNF shifted the distribution peak from around 
1800 µm with no GDNF loading to 2600 µm. Loading of 100 ng GDNF showed similar 
outgrowth distance from analysis of distribution peaks but the overall spreading was less 
pronounced at 100 ng compared to 50 ng GNDF due to the increased uniformity in neurite 
population percentage at a given outgrowth distance. Additionally, both 100 ng and 250 ng 
showed higher maximum outgrowth higher numbers of neurites present at 4000 µm or 
higher outgrowth. GDNF levels of 250 ng showed a distribution peak spread more towards 
the lower end of neurite outgrowth with 15% of neurites extending 1600 µm and an overall 
distribution peak around 2000 µm. Increasing the GDNF loading to 500 ng showed a shift 
in peak towards higher outgrowth at 3000 µm while maintaining close to 10% of neurites 
extending 4000 µm or more. Further increasing GDNF loading to 1000 ng started to show 
some minor bimodal behavior, with a small peak at 3400 µm but a larger peak also apparent 
at 2000 µm and another small jump being seen at 1000 µm outgrowth. 
The neurite outgrowth distributions show a clear benefit of GDNF inclusion 
compared to unloaded nerve guides based on the overall shift in distribution peaks towards 
higher outgrowth after seven days culture and a higher percentage of axons showing high 
outgrowth over 4000 µm compared to the unloaded collagen sheets that had at highest 3400 
µm extension. Less clear is the differences between GDNF groups. Ideally there should be 
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a point of maximal GDNF benefit while minimizing the total amount of growth factor, and 
therefore cost, required. While 50 ng GDNF distribution data showed a nice skew towards 
higher outgrowth, there was a relatively small proportion of neurites that grew more than 
4000 µmin one week. This is an important subpopulation to consider as better functional 
recovery would be expected with conditions that more rapidly allow initial reconnection 
with the distal nerve stump. While the 250 ng GDNF group had good high range spreading, 
the skew in peak towards lower outgrowth levels eliminated it from contention. The group 
with best combined high outgrowth performance and distribution skew was the 500 ng per 
sheet group and so this was the concentration selected for nerve guide inclusion. 1000 ng 
did not appear to offer significant advantage over 500 ng and while 50 ng showed good 
performance on an outgrowth per GNDF used metric, the reliability of 500 ng GDNF 
loading was expected to maintain an effective level of GDNF longer than 50 ng based on 
release rate studies of GDNF from collagen fiber sheets. 
 
3.3.4 Consumption of free amines during collagen fiber sheet formation 
 
Calculations of theoretical molar concentration of primary amines in 1 ml collagen 
stock solution yielded around 320 nmol of primary amines potentially available for 
crosslinking prior to collagen fiber formation. Following fiber formation, the number of 
free amines were drastically reduced to just 10 nmol, or just over 3% of the original free 
amines remaining available for bioconjugation through a primary amine pathway (Fig. 
3.8). Primary amine levels of collagen following 945W conjugation were even lower, with 
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only 3 nmol or just under 1% of primary amines remaining. While there was a relatively 
small concentration of primary amines remaining available after fiber formation, it was 
still possible to do a post-spin modification using amines. Due to only 3% of the original 
free amines remaining, there exists a limiting cap on the total potential conjugation that can 
occur and by consequence, a small window of potential concentrations that can be used to 
investigate effects of peptide conjugation density on cellular response. This currently is a 
great limiter on the potential tailoring of collagen fiber sheets post-spin. Potential 
improvements could be made in the bioconjugation capacity of collagen hydrogel fibers by 
introducing additional conjugation groups such as thiols to the precursor collagen to use 
other methodologies that do not involve amine groups, such as maleimide crosslinking 
chemistries. 
 
3.3.5 Release of GDNF from heparinized collagen fiber sheets 
 
Release rates for all four groups tested showed moderate amounts of burst release 
over the first 6 hours of release (Fig. 3.9) before showing a reduction in release rate after 
12 hours to more of a sustained release profile that lasted until experiment endpoint at 12 
days. Surprisingly, the addition of heparin sped up release rather than slowing it down as 
expected. Separating out the % GDNF release into burst release and sustained release 
categories (Fig. 3.10) shows variation in the burst release up to 6 hours as heparin levels 
change, with higher release correlating following higher heparin levels. Interestingly, after 
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the burst time period of 6 hours, all four groups had similar overall levels of sustained 
release between 6 hours and 12 days, with 10% GDNF released over this time period. 
The similar sustained release between all groups offers a potential explanation as 
to why the increased heparin levels unexpectedly cause higher initial release rates of 
GDNF. As part of its physiological role as a structural component of the extracellular 
matrix, collagen contains a heparin binding domain that can capture heparin which in turn 
binds many soluble growth factors and cytokines. It is very possible that rather than the 
EDC activated heparin being covalently conjugated to collagen fibers during their 
formation, that instead they are being temporarily electrostatically bound to collagens 
heparin binding domains due to the smaller EDC molecules having faster diffusivity than 
EDC-heparin. Heparin bound to the binding domain would still have the capacity to bind 
growth factors. What is likely happening in this case is that the heparin itself is unbinding 
from collagen over time, taking growth factor with it.  
Higher heparin concentrations added to the collection bath would result in higher 
levels of electrostatically bound heparin meaning more growth factor would be dislodged 
along with heparin, causing the higher release rates measured. This sort of behavior is 
consistent with the relative sustained release being so similar between all groups as after 6 
hours as the loosely bound heparin has all cleared itself from collagen. This leaves only 
GDNF bound directly to collagen for release and with heparin mostly gone, results in the 
similar % GDNF488 sustained release comparing all groups. This is potentially beneficial 
as conjugation of heparin using other chemistries might improve chance for successful 
covalent conjugation, allowing a method of delaying growth factor release relative to 
unmodified collagen fiber sheets. Should more rapid release than unmodified collagen 
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fibers be required, heparin can be added directly to the collection bath to control the initial 
burst release. 
 
3.3.6 Effect of fibrin fiber sheet heparinization on neural stem cell spreading and 
FITC-lysozyme release 
 
In all instances of heparinized sheets, cells showed very limited amounts of 
outgrowth from their initial spheroid seeding positions after 7 days culture (Fig. 3.11). 
Spreading was seen in all four non-heparinized sheet media and GDNF presentation 
conditions. Little differences could be qualitatively determined from the non-heparinized 
fibrin sheets other than the differentiation media group showed minimal spreading 
compared to the other three conditions, a result that was expected. Fibrin sheets lacking 
GDNF appear to have higher spreading based on the maintenance media group but this 
result could be confounded by a higher local NSC spheroid seeding density as seeding 
density was difficult to control with the spheroids. The primary takeaway from this study 
was that heparinization of the fibrin sheets can actually inhibit cellular spreading, likely by 
the high negative charge of heparin shielding integrin binding sites with from the cell 
surface. While this was not tested, an easy way to avoid this issue could be to have the 
inner layers of fibrin sheets be heparinized and then later on additional outer non-
heparinized sheets be wrapped over these. In such a scenario, growth factor binding and 
controlled release from heparin would still occur but the cells seeded on the outer non-
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heparinized layers would not have their attachment capabilities compromised, allowing 
enhanced spreading and migration from the cytokine release from underneath. 
Release rates from heparinized fibrin sheets were tested over one week using fibrin 
sheets heparinized by soaking in 0.1 wt% EDC-activated heparin for comparison against 
non-heparinized sheets. FITC labeled lysozyme was used as the model growth factor due 
to its similar molecular weight to GDNF at 15 kDa. Heparinization was found to slow the 
release profile of FITC-lysozyme from fibrin sheets unlike with collagen fiber sheet release 
of GDNF due to the easier heparin corporation into fibrin fibers (Fig. 3.12).  
 
3.3.7 Physical loading and release of FITC-lysozyme from fibrin and alginate fibers  
 
Alginate showed the highest level of release of FITC-lysozyme, with as much as 
80% drop in fluorescence intensity after 30 minutes compared to the initial hydrated state 
(Fig. 3.13). A further 10% drop was seen between days 1 and 3. By day 10, alginate fibers 
themselves were difficult to distinguish from background levels of fluorescence, which had 
shown significant increase compared to the early time points. Release of FITC-lysozyme 
from fibrin was much slower compared to alginate. Very little loss of fluorescence was 
seen after 30 minutes and only 10% loss seen after one day. Relative rate of release 
remained similar between days 0 and 1 compared with 1 and 3, resulting in just over 40% 




These results are consistent with the expected release behavior based on the 
differences in hydrophobicity and wt% of material spun. Alginate, being relatively 
hydrophilic, will swell to a higher degree than fibrin as it absorbs more water, as seen from 
swelling ratio data comparing the two materials. This swelling leads to an increase in the 
number diffusive pathways for FITC-lysozyme release in alginate compared to fibrin and 
its lower degree of swelling. This results in the prolonged release of FITC-lysozyme. 
Larger proteins or particles would be expected to have even better capture in situ. A prime 
example of this was the addition of fluorescent beads into fibrin fibers in collaboration with 
Pinar Huri and Colin Cook to track microscale changes in the fibrin structure during 
mechanical stretch in a custom designed bioreactor [37]. This relative behavior with release 
rate being dependent on fiber hydrophilicity would likely be maintained across different 
biomaterials spun. Fibrin is a unique case as it is relatively more hydrophobic than other 
hydrogel fibers spun so it would be expected that fibers made of hyaluronic acid, collagen, 
or gelatin would have similar release profiles. Synthetic fibers spun with the electrospun 
hydrogel platform, such as PLGA, would very likely have slower release profiles compared 
to fibrin due to their higher hydrophobicity and density although synthetic materials such 
as these have not been tested for release profiles in this system. 
 
3.3.8 In situ spinning of live cells during formation of electrospun hydrogel fibers  
 
Figure 3.14a shows the resulting fiber and cell loading after 4 days culture using 
live cell tracker to visualize fibers. Cells remained viable though the fibrin density still 
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remains high enough at 0.4 wt% to minimize spreading of the cells, particularly in the 
interior. 
Results after seven days show that Schwann cells minimally, if at all, migrated 
away from their home fibers as indicated high degree of segregation between the far red 
labeled and green immortalized Schwann cells (Fig. 3.14b). It is possible that while cells 
survived, their function was compromised as a result of in situ encapsulation within the 
hydrogel fibers. More testing would need to be done looking at functional assays or 
tracking metabolic activity to get a better idea if cells were damaged during spinning. 
Factors to consider for this sort of application are the osmotic pressure, electric field 
strength, and ionic concentration of the collection bath. Electric field strength can have 
amongst the highest potential impact on cellular viability. Exposure to the electric field in 
effect can temporarily cause electroporation of the cellular membrane during its travel 
along the polymer jet [38]. Due to the electric field strengths involved, it is very likely that 
the porosity in the cell membrane induced by the electric field will not have had a chance 
to recover by the time the cells and fiber make contact with the collection bath. This can 
lead an inrush of the collection bath, particularly the Ca+2 ions, into the cytoplasm of the 
cell, causing massive damage to normal cellular function. As even a small amount of Ca+2 
imbalance within the cell can cause mass dysfunction in cellular machinery [39], the high 
50 mM Ca+2 in the bath has a large diffusive driving force to rush into the cell if there is 
any electroporation remaining. Due to the ion imbalance between the cytosol and collection 
bath, it is important to minimize the overall electric field strength in order to reduce the 
magnitude of electroporation that occurs and improve the recovery time of the cell 
membrane. Additionally, it is important to minimize concentration of ions used in the 
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collection bath to minimize the diffusive driving force of the collection solution into the 
cell. 
For the two in situ cells experiments, cells were spun onto isotonic solutions by 
balancing solution ion levels with glucose. Another potential avenue of improving the 
reliability of cellular encapsulation is by increasing the tonicity of both the collection 
solution and precursor solution to hypertonic levels. Tonicity levels have been shown in 
studies by other labs [40] to affect the electroporation of the cell membrane upon exposure 
to the electric field. By making a hypertonic solution, cells in the precursor solution will 
exclude water from the cytosol to balance their internal tonicity with the exterior 
environment, causing a reduction in size of the cell. This has the effect of improving 
resistance to electroporation, which could potentially minimize the infiltration of collection 
solution and reduce recovery time of the cell membrane after exposure to the electric field. 
Future investigation into cellular encapsulation would likely include having a precursor 
solution that is somewhat hypertonic being spun with cells onto a collection bath that is 
even more hypertonic to minimize damage caused by the electric field. 
 
3.3.9 Fibrin fiber sheet alignment effects on microvessel formation and cardiac cell 
alignment 
 
Fibrin sheets wrapped end over end to generate 6 layers were seeded with various 
amounts of vascular and cardiac cells (Fig. 3.15). Figure 3.16 shows the alignment of 
HUVECS at densities of 100k, 200k, 400k, and 600k cells/cm2 on 1 cm2 fibrin fiber sheets 
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after seven days. Vessels showed good alignment in all four seeding conditions with 
particularly prominent alignment being seen at the 100k and 200k cells/cm2 densities. 
Higher cell seeding density still maintained good alignment but had much higher levels of 
interconnectivity between microvessels. To confirm that alignment induction would occur 
with other vascular cell types, human endothelial cell forming cells (ECFCs) were also 
cultured in a 1:1 ratio with ASCs on the surface of fibrin fibers. ECFCs showed a high 
degree of alignment even at a very high cell seeding density (Fig. 3.17). Comparison of 
HUVEC alignment was made with random fibrin gels (Fig. 3.18) showing the superior 
alignment induction of by the fibrin fiber sheets compared to the random structure seen 
with the random gel after one week culture. 
Rat ventricular cardiomyocytes were also cultured on fibrin hydrogel microfiber 
sheets and showed strong response to topographical alignment cues. Particularly exciting 
is the presence of α-actinin filament striation, indicating that not only are the 
cardiomyocytes aligning with the fibers, but are also showing features of mature 
phenotyping in vitro after seven days culture (Fig. 3.19). 
 
3.3.10 Electrospun hydrogel fibrin fiber bundles and tubes for engineered vascular 
grafts 
 
Organization of endothelial cells and their ECM deposition on large diameter fibrin 
strings 200-250 µm are shown in (Fig. 3.20). As can be seen in the images, there is a high 
degree of cellular organization along the direction of fibrin fiber alignment from the 
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directionality of the actin filaments within the cells and elongation of the nuclei in the 
direction of alignment. The topographical alignment cues are not only limited to the 
cellular structure but also the deposition of extracellular matrix components by endothelial 
colony forming cells including collagens I, III, and IV, fibronectin, and laminin along the 
direction of fiber alignment. All of these extracellular matrix components were found to be 
upregulated at least 3 fold on the three dimensional fibrin fiber surface compared to a two 
dimensional fibrin gel substrate [35]. 
Most commonly, 1.5 wt% AG is used with 2.0 wt% F at flow rates of 2 ml/hr and 
1 ml/hr respectively yielding an AG/F ratio of 1.5. Fibers are spun for ~15 to 35 minutes 
onto a collection solution containing 10 U/ml to 20 U/ml thrombin in 50 mM CaCl2 at a 
wheel speed of 30 – 45 RPM without rastering at an applied voltage of ~ 4kV and 
separation distance of 3 cm to yield an AG-F string. A maximum spin time of 10 to 15 
minutes can be achieved without rastering without the presence of ‘bulbing’, where 
fibrinogen deposited at later time points does not crosslink as rapidly as that deposited 
earlier in the run, causing small amorphous blobs to form on the fiber surface. Once spun, 
AG-F fibers are cut into 1/3rd and soaked in a 250 mM sodium citrate solution for five 
hours to overnight. The citrate acts as a chelating agent for the Ca+2 that form the ionic 
crosslinks in alginate, removal of which causes the alginate to dissipate into solution 
leaving behind a fibrin fiber. This fibrin fiber is rinsed several times in DI water and then 
dried in air strained to 150% of its initial length by anchoring the two fiber ends during dry 
to enhance the alignment properties further beyond those achieved with the mechanical 
rotation of the collection bath and electrically induced alignment. Prior to cell seeding, 
fibers are soaked in 75% EtOH for 10 minutes then dried again. 
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The second, more advanced, configuration for fibrin fiber usage in vascular 
applications is as a perfusable fibrin tube that has alignment features on the outer surface 
and in the lumen of the tubes (Fig. 3.21). Preparation is identical to the 2.0 wt% fibrinogen 
spinning for sheet formation used with cardiac patch applications before diverging in the 
method of collection. To collect the fibrin tubes, the sheets are wrapped with 0.5 mm ID 
or 0.6 mm ID teflon coated stainless steel mandrels. The orientation of the mandrel relative 
to the sheet can be used to control whether the alignment at the surface or lumen are 
circumferential or longitudinal, thereby allowing mimicry of the native vessel ECM 
alignment.  
Two different measurements terms are used for defining the amount of material 
wrapped depending on if the wrap is longitudinal or circumferential. Circumferential uses 
fractional ‘wheels’ to define the amount of sheet wrapped where the ‘wheels’ are defined 
as the fraction of sheet taken up relative to the collection dish. As an example, typical 
circumferential wraps will consist of 1/6th of a wheel, which corresponds to 1/6th of the 
sheet collected. ‘Layers’ are used for longitudinal wrapping where each ‘layer’ is defined 
by the uptake of fiber sheet with length equal to the Teflon coated mandrel at one position 
when the mandrel position is parallel with the aligned fiber direction. As a general rule, to 
obtain stable longitudinally aligned fibrin tubes, there needs to be a minimum of one ‘layer’ 
wrapped for every 0.1 mm ID of Teflon coated mandrel. Wrapping using either method 
yields a highly swollen tube on the mandrel that must be dried to reduce tube wall thickness 
and improve mechanical properties. 
The drying process used is a graded ethanol dry which begins with soaking the 
collected tubes on mandrels in steps of 25%, 50%, 70%, 80% EtOH for a minimum of 15 
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minutes each, followed by an overnight soak in 90% EtOH, then finally soaks in 95%, 
100%, 100%, and 100% EtOH for a minimum of 15 minutes each step. It has been found 
that the overnight soak in 90% EtOH helps to reduce the incidence of cracking during 
drying that occurs with some batches of fibrinogen due to batch-to-batch variability and 
bovine sourcing. Once the ethanol drying is complete, tubes are dried in air overnight, 
yielding a dry fibrin tube with reduced diameter compared to the as-collected state. The 
compression due to drying makes it difficult to remove the fibrin tubes from the Teflon 
coated mandrels. The work around to this is soaking the fibrin tubes briefly in 100% EtOH 
to act as a lubricant for tube removal. Once removed, dried fibrin tubes can be stored at 
4°C until use, making them an excellent potential off the shelf product. Such fibrin tubes 
have been successfully implanted in a rat aortic vessel replacement model with survival of 




Electrospun hydrogel fibers were demonstrated to be compatible with many cell 
types as could be expected with the use of biologically derived materials. In addition, 
methods for modification of the hydrogel fibers for use as a therapeutic agent delivery 
mechanism was assessed through physical loading of FITC-lysozyme or heparinization to 
modulate GDNF release. While heparinization showed some success with fibrin fibers, the 
common crosslinking-conjugation chemistries used for collagen fiber formation and 
heparin conjugation made it difficult to incorporate heparin covalently. Instead, it is likely 
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that heparin electrostatically interacts with collagen and release growth factor is mediated 
more by the dissociation of heparin from collagen rather than the factor from heparin. 
While this was an unexpected result, it does offer a methodology to increase release rate 
compared to the native fibers and more importantly, loaded heparin that dissociates is likely 
to form interaction elsewhere in the ECM so it is likely that growth factors would stay near 
the tissue target of interest. The varieties of applications, loading methods, and other fiber 
manipulations of this chapter offer potential avenues to further engineer hydrogel fiber 
materials for specific future applications as everything present is at least feasible with some 
additional investigation. In particular, most future work will ideally be aimed at 
conjugation of factors to the fiber surface to further modulate cellular interaction and 
research more highly focused on specific methods of factor release from the fibers as the 









Figure 3-1: Measurement method of neurite outgrowth from DRG explant.  
Outgrowth of DRG explant neurites (red) was through using bisecting line (green) which 
then had lines extending outward along the fiber alignment direction at 20 µm intervals 
(white lines). Maximum neurite along each white line was used to generate outgrowth 








Figure 3-2: Capture of heparin in collagen fibers during spin. Heparin was added 
directly to the EDC crosslinking solution at several concentrations to become activated and 
compete with EDC for access to the free primary amines of collagen. Mass of heparin, 
measured by TBO assay, captured in collagen fibers increase as more heparin is added to 









Figure 3-3: Spreading of primary Schwann cells from spheroid over 6 days on 
electrospun collagen fiber sheets. Primary Schwann cells seeded on collagen fiber sheets 
were fixed and stained for S100 (red) after one, three, and six days to characterize cell 









Figure 3-4: Spreading of primary Schwann cells from spheroid over 6 days on 
electrospun fibrin fiber sheets. Primary Schwann cells seeded on fibrin fiber sheets were 
fixed and stained for S100 (red) after one, three, and six days to characterize cell spreading. 
Cells were shown to migrate rapidly from the spheroid over the first three days but with 
less evidence of topographical guidance effect compared to collagen fiber sheets. Schwann 
cells in some instances were able to degrade fibrin sheets to high enough extent by 6 days 




Figure 3-5: Extension of neurites from DRG explants as function of fiber alignment. 
DRG explants seeded on Matrigel coated (n = 4), uncoated (n = 4) collagen fiber sheets or 
cast collagen gels (n = 8) were fixed and stained for βIII-tubulin (red) after 14 days to 
characterize neurite outgrowth as a function of alignment. Neurites clearly following 
alignment direction of aligned collagen fiber sheets while random collagen hydrogel shows 









Figure 3-6: Maximum neurite outgrowth and aspect ratio of outgrowth show 
Matrigel coating does not enhance untreated collagen fiber sheets. Fiber alignment 
promotes more extensive maximum outgrowth of neurites from DRGs after 14 days 
compared to random collagen gels (left). Aspect ratio and maximum extension are similar 






Figure 3-7: Distribution of neurite outgrowth as a function of GDNF loading level on 
aligned collagen fiber sheets after seven days. Collagen fiber sheets lacking GDNF had 
neurite outgrowth most skewed towards shorter distances. Addition of GDNF enhanced 
neurite outgrowth with bias towards high outgrowth most seen with 50 ng GDNF and 500 
ng GDNF. Other GDNF concentrations, 100 ng, 250 ng, and 1000 ng showed more 







Figure 3-8: Quantity of collagen free amines drastically depleted following 
electrospinning onto EDC-based crosslinking bath solution. Following collagen fiber 
formation, fluorescamine assay determined that only 3% of amines remained, leaving only 













Figure 3-9: Release profiles of GDNF488 from collagen hydrogel fiber sheets at 
different heparin levels. Surprisingly, addition of higher heparin to collagen fibers 
resulted in more GDNF release at a given time point compared to collagen fiber sheets 
lacking heparin. This is likely due to EDC activated heparin being unable to compete 
successfully with EDC for access to collagen primary amines. It is likely instead that 
heparin is electrostatically bound to the heparin binding domains of collagen and release 
rates measured are representative of heparin molecules releasing from collagen, taking 







Figure 3-10: Burst and sustained release of GDNF488 from collagen hydrogel fiber 
sheets at different heparin levels. Cumulative sustained release from 6 hours to 12 days 
for all conditions remain similar with main variation in release rate occurring with 
differences in burst release likely due to heparin unbinding from collagen fibers taking 











Figure 3-11: Outgrowth of NSC spheroids on fibrin and heparinized fibrin sheets 
after seven days. In all cases, heparinization leads to inhibited outgrowth of cells when 
















Figure 3-12: Conjugation of EDC activated 0.1 wt % heparin solution to fibrin fiber 
sheet surface reduces release rate of FITC-lysozyme. Burst and sustained release of 













Figure 3-13: Physical loading of FITC-lysozyme in situ during alginate and fibrin 
fiber formation. Alginate shows higher release over 10 days of physically entrapped 
FITC-lysozyme as a result of having higher hydrophilicity relative to fibrin fibers. Burst 











Figure 3-14: ASCs spun in situ during 0.4 wt% fibrin fibers are viable after four days 
culture. Schwann cells show minimal migration between fiber regions after one week. 
ASC spun in fibrin fibers at a concentration of 32k cells/µl remain viable at day 4 but show 
minimal spreading within fibrin fiber (a). Two distinctly labeled Schwann cell populations 
(green and purple) spun into AG/F 0.75 from separate syringes onto the same collection 
















Figure 3-15: Preparation of 6-layer fibrin fiber sheets for cardiac tissue engineering 
applications. Fibrin sheets are spun as described in chapter 2 for seeding of ASCs, 
HUVECs, ECFCs, and cardiomyocytes. Care must be taken in wrapping sheet onto plastic 
frame (progression from left to right) to ensure alignment of fiber sheets (outlined yellow 












Figure 3-16: Alignment of vasculature formed from different concentrations of 
HUVEC’s co-cultured with ASCs on fibrin fiber sheets. HUVECs seeded on 1 cm2 
fibrin fiber sheets at 100k, 200k, 400k, and 600k cells in 1:1 ratio with ASCs show 
alignment with fibrin fiber orientation (vertical) with good interconnectivity at higher 











Figure 3-17: Vasculature formed from ECFCs co-cultured with ASCs on fibrin fiber 
sheets show high alignment and interconnectivity. Like with HUVECs, ECFCs were 
also able to generate vasculature on fibrin fiber sheets with high interconnectivity. Scale 













Figure 3-18: Vessel organizational differences on random fibrin gels and aligned 
fibrin hydrogel microfiber sheets. 100 k : 100 k ASCs and HUVECs (CD31, red) show 
clear differences in alignment on random fibrin gels (left) and aligned fibrin hydrogel 
















Figure 3-19: Cardiomyocyte cultured on aligned fibrin fibers show striations 
indicating maturity is promoted by fiber sheets. Cardiomyocytes show striations in α-
Actinin (green) organization in cells positive for the cardiac marker αSMA (red) with 
successful gap junction formation detected (Connexin 43) after seven days culture and 















Figure 3-20: Pericytes secrete several cell adhesive molecules and collagens along 
direction of alignment of 200+ µm diameter fibrin bundles after 5 d culture. Pericytes 
secrete collagens I, III, IV, laminin, and fibronectin along direction of fibrin fiber bundle 














Figure 3-21: Hollow vascular graft tubes made from aligned fibrin fiber hydrogel 
sheets. Fibrin fiber sheets are formed into hollow, perfusable tubes by wrapping around 
PTFE coated stainless steel mandrels and then drying (left). Drying is through a graded 
ethanol process involving soaks for minimum of 15 minutes in 25%, 50%, 70%, 80% EtOH 
followed by overnight in 90% EtOH followed by 95% for 15 minutes and finally a triple 
15 minute soak in 100% EtOH. Once fully dehydrated, tubes are air dried to yield highly 













Figure 3-22: Perfusable hollow fibrin fiber tube with longitudinal alignment as 
vascular graft in rat aortic replacement model. 5 mm length fibrin tubes implanted as 
aortic vessel replacement has been able to maintain animal viability for up to 10 days post 
implantation before rupture and have sufficient strength to be directly sutured with aortic 
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Chapter 4   Poly(glycerol sebacate) (PGS) Coated 
Braided Poly(glycolic acid) (PGA) Nerve 
Guides 
4.1 Background 
4.1.1 Academic nerve guide designs 
 
Regeneration of peripheral nerves following injury are currently limited primarily 
to use of the autologous nerve graft as a repair method of best prognosis despite advances 
in the materials used for synthetic nerve guides. Many strategies exist for generating nerve 
guidance to enhance axon outgrowth in the peripheral and central nervous system based on 
providing topographical guidance cues including interconnected collagen pores[1], 
orienting collagen gels by magnetic alignment [2], using conductive [3] or nonconductive 
synthetic nanofibers [4]. 
Besides providing a protective environment, the nerve guide can contain other 
engineered features to enhance regenerative outcome such as inclusion of growth factors 
such as GDNF [5, 6], NGF [7], BDNF and NRG1 [8] to induce more rapid migration of 
Schwann cells or improve survival of neural subpopulations. Introduction of stem cells into 
the nerve guide can also provide a powerful technique to control the local 
microenvironment through secretion or over-expression of chemotrophic cues and other 
cytokines [9-11]. Stem cells can be used in conjunction engineering of substrate properties 
within the nerve guide to control differentiation [12-14]. Selection of materials to be used 
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within the nerve guide can provide a major impact on resultant regenerative outcome such 
as the inhibition of myelination in the presence of fibrin [15, 16] or regulating survival of 
engrafted cells as seen with improvements in viability of neural stem cells in hyaluronic 
acid [17]. 
 
4.1.2 PGS coatings 
 
The Secant Group, LLC, a biomedical textiles company has developed a braided 
biodegradable conduit using poly(glycolic acid) (PGA) microfibers, and coated it with 
biodegradable poly(glycerol sebacate) (PGS), a crosslinked elastomer, previously 
developed by R. Langer and Y. Wang. [18, 19] In collaboration with Secant, we have 
engineered a configuration for use as a nerve guidance conduit (NGC). The relatively fast 
degradation of PGS, approximately 30% mass loss over 9 days in vitro [20], enables 
generation of increased porosity after the initial inflammatory period, is advantageous in 
promoting nutrient transport to the regenerating nerve within the NGC. While degradation 
is relatively rapid, PGS is degraded through surface erosion rather than bulk so mechanical 
properties are maintained for much of the lifetime of the coating [21] and is degraded into 
metabolically resorbable glycerol and sebacic acid. PGS has been shown to have excellent 
cellular biocompatibility through improved SC mitotic activity and reduced apoptotic 
activity when comparing cell culture on PGS sheets relative to PLGA sheets and reduction 
in inflammatory response compared to uncoated PLGA [18]. The elastic property of PGS 
renders the braided PGA conduit more kink-resistant, while the underlying braid provides 
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a superior suture anchor point.  Polypropylene suture pullout tests using ISO 7198 yielded 
suture failure before the braid up through 3.0 size sutures.  Uncoated PGA braids failed at 
18.6 N load compared to 20.2 N loading with PGS coated braids when 2.0 size sutures 
were used (Fig. 4.1). 
 
4.1.3 Role of macrophages in nerve regeneration 
 
The presence of macrophage has an increasingly appreciated role in nerve 
regeneration, playing many support roles to promote regeneration. Such roles include 
inducing the growth of new blood vessels to act as natural guidance cues for Schwann cell 
migration [22] and contributing to the late Wallerian degeneration by assisting Schwann 
cells in clearing myelin debris [23]. Recent studies have concluded that not only do 
macrophages play an important role in clearing debris following injury, but that reduction 
in accumulation of macrophages in slow Wallerian degeneration mice resulted in a 
reduction in neurite outgrowth [24]. Sciatic nerve transection neuropathy studies have 
demonstrated that the transection triggers a downregulation of IL-10 production, 
improving macrophage M2 polarization [25]. Additionally, during the first several days 
after injury, M1 macrophages begin the process of polarization to the M2 phenotype with 






4.2.1 Macrophage isolation and culture for PGS contact effect on differentiation  
 
Mouse bone marrow derived macrophages (BMDM) were isolated from 6 to 8 
week old C57BL/6J mice for seeding on TCPS or PGS coated coverslips at 50,000 
cells/well in either M0 medium (LPS: 0 ng/ml, IFNγ: 0 ng/ml), low concentration M1 
induction media (LPS: 10 ng/ml, IFNγ: 2 ng/ml), or high concentration M1 induction media 
(LPS: 100 ng/ml, IFNγ: 20 ng/ml) to determine PGS coating effect on M1 vs M2 
differentiation of M0 macrophages after two days culture. Phenotyping was characterized 
through use of Q-PCR using primers for IL1b, IL6, TNFα, and iNOS as M1 genetic 
markers with CD206 and ARG1 expression for M2 phenotype. BMDM derived M0 
macrophages were seeded at a density of 100k/well for PGS samples and 50k/well on 
TCPS, both in 24 well plates. 
 
4.2.2 Effect of PGS degradation product on macrophage phenotype 
 
BMDMs were additionally cultured on TCPS in the presence of PGS degradation 
product (DP) at increasing concentrations for 48 hours in the presence of M1 or M2 
stimulation media to distinguish the immunomodulatory effect of soluble PGS leachables 
from direct contact with PGS coating. Q-PCR primers for M1 (IL1b, iNOS, and TNFα) 
and M2 markers (CD206, ARG1, and FIZZ1) were used to characterize macrophage 
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differentiation under media with differing strengths of M1 bias (0, 10, and 100 ng/ml LPS) 
and M2 bias (0, 2, and 20 ng/ml IL-4). The effect of degradation product on cell viability 
was assayed fluorescently through incubation with alamar blue assay for three hours and 
monitoring medium pH. 
 
4.2.3 Preparation of PGS coated braided PGA conduits and glass coverslips 
 
Poly(glycerol sebacate) coating of braided poly(glycolic acid) tubes were provided 
by Secant Biomedical (Telford, PA) as part of their role as a collaborator in the 
investigation of the potential of PGS coated PGA braids as nerve guidance materials. The 
preparation process is roughly as follows as the precise preparation methodology is 
proprietary of Secant Biomedical and shall not be disclosed here. Briefly, multifilament 
PGA threads are braided together around a mandrel at a braid angle of 130 degrees using 
an industrial braiding machine to form a 1.5 mm ID tube. The braided tube is then dipcoated 
into a PGS 10-20% w/w solution in ethyl acetate in such a way that the lumen remains 
open and unclogged (Fig. 4.2). Curing of the PGS is done at elevated temperatures of 
around 120°C for times of approximately 36 hours under a low vacuum of 10 torr. The 
degree of polymerization can be tuned by altering the curing temperature and/or time of 
cure to yield PGS coatings with varying degrees of tackiness. Lower curing times and 
temperatures results in increased tackiness as a lower amount of PGS fully polymerizes to 
in these conditions. Following preparation, coated braids were sterilized using gamma 
irradiation (STERIS Isomedix Services) at 25-40 kGy dosing using a Nordion Cobalt-60 
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Irradiator for seven hours. After sterilization, coated braids were stored at 4°C until use. 
Coverslips used for in vitro cell culture studies investigating the effect of PGS coating on 
cellular adhesion and macrophage response were prepared using the same methodology as 
the nerve guides regarding coating and sterilization. 
 
4.2.4 Nerve guide preparation  
 
Poly(glycolic acid) multifilament braids were manufactured and coated with 
poly(glycerol sebacate) to a thickness of several µm by The Secant Group, LLC (Telford, 
PA) with a 130 degree braiding angle and cut to a length of 17 mm per nerve guide. Prior 
to implantation, PGS coated PGA braided tubes were sterilized using γ-radiation. 
Dehydrated collagen fibers were loaded into the NGC lumen for one experimental group 
at a level such that ~25% of the interior would be filled with fiber upon rehydration to 
ensure adequate porosity remained for cellular infiltration (Fig. 4.3). Uncoated PGA braids 
were used as negative control and functional recovery assays were compared against the 







4.2.5 Outgrowth of neural stem cells as function of fiber filler density and luminal 
filler preparation for nerve guide usage 
 
To characterize the level of collagen fiber filler to be contained within PGS nerve 
guides, bundles of Secant collagen fibers were formed for in vitro cell culture of neural 
stem cells to ensure outgrowth could occur all along the fiber bundle in confined space. 
Secant collagen fiber bundles were formed by wraping collagen fiber from a spool 
lengthwise around a 1.5 cm by 3.0 cm mylar frame 25, 50, or 100 times to correspond with 
25%, 50%, and 100% fiber loading within a 1.5 mm ID PGS braided tube nerve guide after 
swelling from rehydration from a dry state (Fig. 4.4). After wrapping around the mylar 
frame, the ends of the collagen fiber bundle were tied with 7-0 nylon suture and the bundle 
was cut free from the frame. Samples were sterilized for 30 minutes in 70% ethanol and 
dried prior to cell seeding. To ease imaging, rather than PGS braided tubes, troughs were 
made of 1% agarose gel prepared in 0.9 wt% NaCl using 1.5 mm ID stainless steel mandrels 
cut to 1.5 cm length for culturing NSCs with the Secant collagen fiber bundles in each well 
of a 6 well plate. Particularly advantageous of the Secant collagen fibers were their 
production from four parallel needles depositing material into an acetone bath for 
precipitation resulting in the aggregation of fibers with a cloverlike cross section (Fig. 4.5). 
This provides additional grooving as a topographical guidance cue for migrating Schwann 
cells and neurite outgrowth. Higher magnification SEM images show the surface features 
of the collagen fibers to have a particularly nice aligned texture on a cellular scale, 
providing excellent anchor points for filopodia during progression of the growth cone into 
the nerve guide. 
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Neural stem cell spheroids were prepared by seeding 50 µl of NSC cell pellets 
diluted to 5,000 NSC/ul for a total of 250k cells per 35 spheroid mold (Microtissues, Inc) 
to yield spheroids ~ 250 - 300 µm in diameter. Culture plates containing molds were placed 
on an orbital shaker operating at low RPM inside a cell culture incubator for 72 hours to 
allow NSCs to form spheroids. Following spheroid formation, molds were inverted and 
briefly centrifuged down at 200 g to dislodge spheroids, which were then transferred to 50 
ml tubes. Tubes were centrifuged down at 200 g and supernatant was aspirated before 
collected spheroids were diluted down to a concentration of approximately 1 spheroid per 
µl. 
Prior to seeding, the dried Secant collagen fiber bundles were transferred to the 
agarose troughs. Once placed, 10 µl of NSC spheroids were seeded on one end of the 
collagen bundles and were left in a 37°C incubator for 30 min for spheroids to attach. 
Following attachment, a small volume, 100 µl, of media was added to each bundle to 
maintain hydration for the second set of 30 minutes in the incubator, following which 4 ml 
of maintenance media was added to each well of the 6 well plate. After 48 hr in NSC 
maintenance media containing 20 ng/ml bFGF and 20 ng/ml EGF, media was switched to 
differentiation media lacking bFGF and EGF. Culture was continued for three more 
additional weeks. After culture, samples were fixed for 10 minutes in 4% 
paraformaldehyde and stained with DAPI (1:1000, Roche) and rabbit anti-βIII-Tubulin 





4.2.6 In vivo sciatic nerve critical gap defect animal model  
 
A total of 32 adult male Sprague-Dawley rats were used in this study with surgeries 
and functional assessment being done in accordance with protocols approved by Johns 
Hopkins Institutional Animal Care and Use Committee and internal review board. Animals 
were sacrificed after seven days for inflammatory studies or three months for assessment 
of functional recovery. Nerve guide groups include: (1) uncoated PGA multifilament braids 
as a comparison to (2) PGS coated PGA multifilament braids with empty lumen and (3) 
PGS coated PGA multifilament braids containing collagen fibers in the lumen, all for 
comparison against (4) the gold standard autograft, prepared by cutting out a portion of 
sciatic nerve and inverting the proximal and distal ends before suturing back to the nerve 
stumps. 
 
4.2.7 Presence of autophagy in nerve guide groups  
 
Irritation in the transected nerve can cause Sprague Dawley rates to exhibit signs 
of autophagy, where they will chew at the digits of or even whole foot distal to the injury 
site. Precautions were taken to minimize this by daily application of bitter nail polish 
(Mavala Stop) during the first month post-op. The presence of autophagy was compared 
between groups after 12 weeks prior to sacrifice. Autophagy positive animals in this study 
were considered to be those that showed one or more digit chewed off or significant signs 
of wounding on the bulk of the foot itself.  
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4.2.8 Foot angle of inclination and characterization of atrophy 
 
To confirm the results of the atrophy data, we made measurements of the foot angle 
of inclination, or bending movement, prior to animal sacrifice. As the muscles of the soleus 
and gastrocnemius atrophy, a seizing of the foot becomes present, preventing full range of 
motion as muscular atrophy proceeds. Measurement of the angle of inclination is made by 
using photos of the maximum forward bending range of the foot from the ankle and 
drawing straight lines parallel to the foot and the tibia using ImageJ where the angle is 
measured. Data was collected from all 8 animals in each group on the operative side and 8 
randomly selected positive control side legs from all groups. Additionally, the 
gastrocnemius and soleus muscles were weighed for all animals and compared to the non-
operative control side to determine the level of muscular atrophy after three months. 
 
4.2.9 Electrophysiological assessment of functional recovery using Secant PGS 
nerve guide 
 
Electrophysiological analysis of functional recovery was made of the uncoated 
PGA braid, PGS coated braid, PGS coated braid containing collagen fibers, and autograft 
groups after 12 weeks implantation for comparison against the non-operative leg opposite 
the defect leg by measuring compound muscle action potentials (CMAP) using LabChart 
8 Reader software (AD Instruments). Electrical probes were placed proximal to the nerve 
guide along the sciatic nerve with the downstream probe places into either the ankle or foot 
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for signal propagation characterization with a probe separation averaging 7.5 cm. 
Characterization included measurements of action potential duration, peak latency, action 
potential amplitude, and signal onset latency were made for both the operative and non-
operative control legs of each animal included in the study. 
 
4.2.10 Histological analysis of axon and myelination characteristics 
 
The axons in the median section of the nerve guides were characterized from 
histological cross-sectional slices using a minimum of three higher magnification images 
per animal that had 150 to 200 axons per image. Images were analyzed using an inverted 
microscope (Nikon) using magnifications of 10 for gross cross section imaging and 63 
for characterizing axon calibers and myelin thickness. 
 
4.2.11 Immunofluorescence imaging 
 
Longitudinal sections of all study groups were imaged using either a LSM 510 
confocal microscope (Zeiss) or epifluorescence microscope. Macrophages were stained for 
cell membrane surface markers using mouse anti-CD68 (1:200, Abcam), goat anti-CD86 
(1:200, Abcam), rabbit anti-CD206 (1:200, Santa Cruz) using donkey anti-mouse Alexa 
Fluor-555 (1:500, Invitrogen), donkey anti-goat Alexa Fluor-488 (1:500, Invitrogen), and 




4.2.12 In vivo inflammatory response 
 
The inflammation profile present following seven days implantation was 
characterized through analysis of histological sections, qPCR analysis of the proximal and 
distal stumps, and ELISA for determining inflammatory cytokine levels present in the 
proximal and distal tissues. General analysis combines both the proximal and distal data 
for clearer elucidation of the coating effect while secondary analysis maintains separate 
proximal and distal subgroups within each nerve guide type to examine the spatial 
differences in inflammatory response. 
The macrophage population was characterized via counting of CD68 (general 
macrophage marker) positive cells and making comparison to the number of cells that were 
co-positive for CD86 (M1) or CD206 (M2). Total macrophage population fraction was 
determined comparing CD68+ cells with DAPI stained nuclei that were CD68-.  
Three animals from each group were sacrificed after one week for characterization 
of the immune response to the various nerve guide configurations. Tissue homogenates 
from the proximal and distal ends of the nerve guide were collected and analyzed by qPCR 
for RNA expression of M1 markers using Taqman primers (Invitrogen) for iNOS, TNFα, 
CD86, and IL-1b.  Analysis of M2 markers included primers for: ARG1, PPARG, IL-10, 
and CD206. Both M1 and M2 macrophage gene expression was compared to the uncoated 
PGA braid and autograft. ELISA was used to confirm qPCR results by analyzing cytokine 




4.3 Results and Discussion 
 
4.3.1 Attachment of BMDM to PGS 
 
BMDMs cultured on PGS showed rounded morphology with no significant 
spreading and low attachment strength as indicated by higher frequency of detached cells 
found floating in the culture media (data not shown) for the PGS coverslip groups (Fig. 
4.6) where cells showed an abnormal morphology even on the TCPS adjacent to the coated 
PGS coverslip. This provides indication that some combination of soluble cue and poor 
attachment are both affecting BMDM morphology and health. Culture of BMDMs on 
TCPS that did not contain PGS in any form showed normal cell morphologies after 2 days 
culture in either maintenance, M1, or M2 differentiation media with expected upregulation 
of M1 or M2 genetic markers in the matched differentiation media (Fig. 4.7). 
 
4.3.2 PGS coating effect on BMDMs in M1 differentiation media  
 
QPCR analysis of RNA expression of BMDMs cultured on TCPS and PGS in the 
presence of increasing differentiation bias are shown in Figure 4.8. In M1 differentiation 
media, PGS coating shows resistance to differentiation compared to TCPS as indicated by 
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lower levels of expression of M1 markers at 0, 10, and 100 ng/ml LPS M1 differentiation 
media. This result was consistent amongst the four M1 markers characterized: IL-1b, IL6, 
TNFα, and iNOS. M2 markers CD206 and ARG1 showed more variable response to the 
PGS coating with additional reduction in CD206 found at 10 ng/ml LPS despite less 
reduction being seen compared to TCPS with CD206 at 100 ng/ml LPS (Fig. 4.9). ARG1 
expression also showed variable expression levels on PGS relative to TCPS with higher 
ARG1 expression present with the PGS coating group at 10 ng/ml LPS compared to the 
reduction in expression seen at 0 and 100 ng/ml LPS. 
 
4.3.3 Effect of PGS degradation product on macrophage differentiation and 
viability in vitro  
 
BMDMs cultured on TCPS in the presence of increasing concentrations of PGS 
degradation product (DP) show reduction in attachment of BMDMs after 48 hours as 
degradation product levels increased (Fig. 4.10). The buffering capacity of the culture 
media was surpassed at DP concentrations higher than 1.0 mg/ml with acidity increasing 
to pH 6.8 with higher DP concentrations. A subsequent decrease in BMDM viability 
followed with increasing media acidity as measured by relative fluorescence using an 
alamar blue assay toe measure cellular mitotic activity against BMDMs cultured on TCPS 
at 0 mg/ml PGS degradation product (Fig. 4.11). 
When cultured in a combination of M1 differentiation media and various levels of 
DP, iNOS expression was upregulated when cultured with 10 // 2 ng/ml and 100 // 20 ng/ml 
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LPS // IFNγ and DP concentrations up to 2.0 mg/ml (Fig. 4.11a). M0 media with 0 ng/ml 
LPS // IFNγ showed minimal effects of degradation product until 2.0 mg/ml DP. In all 
instances, DP concentrations of 4 mg/ml showed reduction in iNOS expression. IL-1b 
expression was reduced in M0 media except at 0.8 mg/ml DP (Fig. 4.11b). Expression at 
10 // 2 ng/ml and 100 // 20 ng/ml LPS // IFNγ M1 media showed increases in IL-1b at 0.1 
mg/ml DP and further reduction as PGS DP increases. Trends were similar for TNFα where 
LPS groups show mRNA expression increases at low DP levels relative to unbiased media 
with a similar decreasing trend in expression as DP concentration increases to 4 mg/ml. 
Response was more variable in unbiased media where only 0.1 and 2.0 mg/ml showed 
increases in TNFα expression relative to the control (Fig. 4.11c). 
Addition of PGS DP to M2 differentiation media showed minimal differences in 
ARG1 expression with addition of up to 2.0 mg/ml DP compared to 0 mg/ml DP (Fig. 
4.13a). In unbiased media, 4.0 mg/ml DP increased ARG1 expression while there was 
significant downregulation in 2 ng/ml and 20 ng/ml IL-4 M2 biasing media. CD206 was 
downregulated in all media at 4.0 mg/ml DP but did not show significant difference at other 
DP levels compared to 0 mg/ml DP (Fig. 4.13b). Unlike expression of ARG1 and CD206, 
expression of FIZZ1 decreased with more sensitivity as DP levels increased (Fig. 4.13c). 
 
4.3.4 Outgrowth of neural stem cells as function of Secant collagen fiber density 
 
Figure 4.14 shows the neurite spreading from differentiated neural stem cells after 
three weeks of culture. Spreading was most prominent in the 25% collagen fiber fill group 
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where high levels of βIII-Tubulin (red) can be seen throughout the whole length of the 
Secant collagen fiber bundle. Neurons are highly present on the surface layers of the 
collagen fiber bundle as there was no chemotactic driving force for them to further infiltrate 
into the center of the collagen fiber bundles. 50% collagen fiber fill shows a moderate 
amount of spreading of neurons along collagen fibers but most spreading was localized 
towards the end of the fiber bundle where seeding had occurred, unlike the 25% collagen 
fiber fill density group. The 100% collagen fiber fill group also showed some spreading 
near the seeding site, although this had the least total spreading of all groups visible. This 
led to the conclusion that a fill density around 25% would be best in vivo usage as a nerve 
guide fill density to maximize the potential cellular infiltration and axonal extension along 
the Secant collagen fibers. 
 
4.3.5 Presence of autophagy in nerve guide groups 
 
Significant autophagy was seen in 7 of the 8 uncoated PGA braided nerve guide 
groups. PGS coating dramatically reduced the presence of autophagy to 1 out of 8 animals 
in the PGS coating only group while addition of the collagen fibers increased incidence of 
autophagy to 2 of 8 animals (Fig. 4.15). The autograft did not show any signs of autophagy 
after 12 weeks. The large difference in autophagy seen comparing the coated and uncoated 
nerve guides implies that the PGS coating helps to reduce irritation in the surrounding 




4.3.6 Foot angle of inclination and characterization of atrophy 
 
Inclination data in Figure 4.16 shows low ranges of mobility with all three nerve 
guide groups where the angle of inclination average was around 120 ± 15 to 20 degrees. 
The autograft showed improved range of motion relative to the nerve guide groups with an 
average angle of inclination of 138 ± 8 degrees. Control sides showed maximum range of 
motion of the ankle joint at 160 ± 5 degrees. These results are consistent with that seen 
from the gastrocnemius and soleus muscle atrophy data, where weakening of the muscles 
will drastically reduce mobility of the ankle joint, limiting the foot range of motion (Fig. 
4.17). 
 
4.3.7 Onset latency measurements 
 
Latencies were taken at both the foot and ankle n = 8 rats per group prior to 
sacrifice. Due to the potential issue with autophagy of the rat digits, and in extreme cases 
whole foot, potentially impacting foot data relative to ankle, higher weight is given towards 
the ankle CMAP data results. Onsets in all cases were higher along the foot than the ankle 
due to the increased signal propagation distance required for the foot compared to the ankle. 
For the foot, signal onset latency was highest in the PGS coated group at 8.0 ms with the 
addition of collagen fibers only reducing the latency by a small amount to just over 7.0 ms 
(Fig. 4.18). Surprisingly, the PGA braid alone had an average onset latency in the foot that 
was comparable with the autograft at ~5.5 ms although the PGA braid had a high degree 
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of variance in data due to the autophagy seen within the group. The positive control group 
had lowest onset latency in the foot at 3.0 ms. 
Ankle onset latency data shows a differing trend that the PGS coating is highly 
beneficial. Onset latency was lower in the ankle of both PGS coated groups at 1.5 ms 
compared to 1.9 ms seen with the positive control indicating the quality of axons 
regenerating across the defect are good and that they are successfully bridging with the 
distal nerve stump. The autograft did slightly worse than the positive control at around 2.3 
ms latency while the uncoated PGA braid did the worst at 2.6 ms, though both the autograft 
and uncoated braid showed a high variance in onset latency. 
 
4.3.8 Peak latency measurements 
 
While the onset latency helps to characterize the speed at which the fastest neurons 
fire, the peak latency gives a better idea of the propagation speed of the action potential. 
Like the onset latency, peak latencies were higher in the foot than the ankle due to being 
more distal to the probe placed proximal relative to the sciatic nerve defect site. The same 
overall trends were seen with the peak latencies (Fig. 4.19). The autograft and uncoated 
PGA braid had lower latencies in the foot at around 6.0 to 7.0 ms compared to the PGS 
coated nerve guides with their latencies of 8.0 ms and 9.0 ms for collagen fiber containing 
ones and empty respectively. All four groups unsurprisingly fared poorer than the positive 
control leg at just under 4.0 ms. 
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Ankle peak latencies were faster than foot and showed similar relative behavior to 
the onset latencies. In this case, the peak latencies of both PGS coated nerve guide groups 
were around 2.8 ms, the same speed at which the positive control peak latency was 
measured. Both the uncoated PGA braid and autograft were around 4.5 ms peak latency 
with high variation in results seen again with the uncoated braid. 
 
4.3.9 Action potential amplitudes 
 
The amplitude of the action potential peaks gives an indication of the total number 
axons that form an electrical connection with the distal nerve stump after crossing the nerve 
guide and are analogous the other overall strength of signal conduction. Foot and ankle 
amplitudes for the positive control leg were measured to be an average of 6.0 mV with 
some variability from animal to animal. In all cases for both the foot and ankle amplitudes, 
the values measured were substantially lower for all nerve guide groups and the autograft 
compared to the positive control leg due to the significant damage in the defect model used 
for the study. To better compare the action potential amplitude between groups, 
comparisons were made as a percentage relative to the positive control leg. 
The foot amplitude data shows the lowest conduction strength with the uncoated 
PGA braid at around 3% of the positive control value, which is much lower than both PGS 
coated groups, which were at 7% of the positive control. Best action potential performance 
was seen with the autograft, coming in at 16% of the positive control amplitude after 12 
weeks (Fig. 4.20). 
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Amplitude data for the ankle showed similar poor values relative to the positive 
control. Uncoated PGA braid was around 4% of the positive control, similar to relative 
value seen with the foot data for this group. The two PGS groups had relatively lower 
performance measured at the ankle than the foot at 2% for the PGS coated group and 4% 
of the positive control amplitude for the collagen fiber containing PGS coated group. The 
autograft also showed poor conduction amplitude relative to the positive control at 9%. 
The poor signal conduction amplitude of all three nerve guide groups and autograft relative 
to the positive control show how poorly even the gold standard autograft is and perfectly 
illustrates the strong clinical need for nerve guide designs that not only match, but can 
surpass the performance seen with the autograft. 
 
4.3.10 Histological analysis of axon and myelination characteristics 
 
Counts of the axons per total nerve cross section from mid-graft toluidine blue 
stained cross sections (Fig. 4.21) show the lowest counts in the uncoated braided PGA 
nerve guide group at just over 4000 axons per cross section (Fig. 4.22). Improvements were 
seen in axon count with the PGS coating groups, with the unfilled lumen having higher 
axon count at over 7000 per cross section. Addition of collagen fibers reduced the average 
axon counter per cross section of that group to 6000, likely due to the large proportion of 
fiber remaining after three months implantation taking up space in the lumen. Autograft 
had the highest degree of axons per cross section at just under 8000. Higher magnification 
images show the presence of capillary formation inside collagen fibers (Fig. 4.23) along 
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with some fibroblast infiltration and axon outgrowth along the edge of the fibers. 
Capillaries containing red blood cells are particularly noticeable at the lumen wall near the 
PGA braid. 
Cross sections of the individual regenerating axons were measured and compared 
(Fig. 4.24). Due to the oblong shape of many regenerating axons, axon caliber and myelin 
thickness measurements were made by measuring along both the long axis and axis 
orthogonal to this. Average values of these two measurement directions were taken as the 
caliber of an individual axon and at least three high magnification images per nerve guide 
were measured using a minimum of 150 axons per image for characterization. Similar 
average cross-sectional areas were seen between all nerve guide groups where average 
values ranged from 8.0 µm2 for the collagen fiber group to 10.0 µm2 in the autograft. Axon 
calibers were typically around 2 to 3 µm average diameter with average myelin thickness 
in the 500 nm range for all three nerve guide groups (Fig. 4.25). Autograft had slightly 
higher myelin thickness at approximately 900 nm (Fig. 4.26).  
Axon diameter distributions are shown in Figure 4.27. Axon diameter distributions 
were highly similar for all three of the nerve guide groups and were skewed towards smaller 
caliber axons with highest clustering in the 1.0 to 2.5 µm range. Autograft showed a higher 
spread in axon diameters with a largest population of axons with diameters of 4 µm or 
greater at 24.6%. Nerve guide groups only had populations of 4 µm+ axons at 17%, 18.6%, 
and 14.9% for uncoated PGA, PGS coated, and PGS coated groups containing collagen 
respectively. Larger caliber axons tend to be motor neurons so this could be a secondary 
explanation along with the higher axon count per nerve as to why the action potential 
amplitudes were higher in the autograft than other nerve guide groups. 
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Myelination quality was determined by the average g-ratio values, defined as the 
ratio of axon diameter to axon + myelin sheath diameter. Average values were relatively 
similar between nerve guide groups with the average g-ratio values being around 0.65 (Fig. 
4.28). Autograft showed the lowest g-ratio at 0.59 due to the thicker myelin seen in the 
histological preparations for the group. There were no statistically significant differences 
between groups for the average g-ratio despite these small differences. This can be 
explained by looking at the distributions of axons diameter to g-ratio (Fig. 4.29). 
Distributions are highly similar between all three nerve guide groups with most clustering 
of data ranging towards the 0.5 to 0.8 g-ratio range between 1.5 and 4.0 µm. G-ratios for 
these groups begin to level off around 7.5 at axon diameters greater than 4 µm. The 
autograft group shows more spread in the data both in terms of g-ratio and the measured 
axon diameters, matching the data analysis from the axon distribution plots. Fitting the 
distribution data to logarithmic fits shows tight clustering the overall behavior of the three 
nerve guide groups with a noticeable decrease and separation of the autograft from the 
other groups, particularly as axon diameter increases (Fig. 4.30). 
 
4.3.11 Secant PGS braided tube in vivo macrophage response 
 
The highest overall macrophage levels were found to be present in the uncoated 
PGA braid group with a 50% fraction of macrophage compared to total cells present (Fig. 
4.31). PGS coating reduced the relative macrophage population to 35%; and the inclusion 
of collagen fibers slightly increased the population fraction to 40%, but was not found to 
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differ in a statistically significant manner relative to the PGS coating alone. The autograft 
group exhibited the lowest macrophage population fraction at 25%. 
PGA alone showed little difference in total macrophage population fraction when 
comparing distal to relative ends, as both were around 50% (Fig. 4.31). Both PGS coated 
groups and autograft showed higher proportion of macrophages relative to other cells in 
the distal end compared with the proximal region. The highest difference occurring with 
the PGS coating alone group which jumped from 25% macrophage fraction in the proximal 
end to nearly 50% in the distal. Inclusion of collagen showed similar distal macrophage 
fractions to as the PGS alone but had higher fractions in the proximal region at just over 
30% macrophage fraction. Distribution of M1 and M2 macrophages are shown in Figure 
4.32. 
With the exception of uncoated PGA braids, the aggregate cellular infiltration in 
the proximal regions were higher than the distal regions with only small drop-offs in 
infiltration occurring in the distal portion of the PGS coated groups compared to the 
autograft which had a much larger decrease in cellular infiltration relative to its proximal 
end (600 vs. 300) (Fig. 4.33). Distal end infiltration was similar amongst all four groups, 
which ranged from 300 to 400 cells. Total macrophage counts tended to be higher in the 
distal nerve stumps in the nerve guide groups but similar between proximal and distal for 






4.3.12 Pro-inflammatory M1 macrophage population 
 
The M1 population amongst the macrophages present, as indicated by those 
macrophages positive for both CD86 and CD68, showed similar levels across groups (Fig. 
4.35) ranging from 50 to 60% with no significant differences between groups. PGS coating 
with luminally loaded collagen fibers were at the higher end of the range with the PGS and 
autograft showing nearly identical M1 population fraction at the lower end of the range. In 
all four groups, the M1 population fraction was higher in the proximal end compared to the 
distal end (Fig. 4.35) with proximal M1 ranging from 55 to 70% and distal from 45 to 50%. 
Primers for iNOS, TNFα, CD86, and IL1β were used to characterize the expression 
of M1 related markers in the proximal and distal regions of three nerve guides per group 
after being explanted. The levels of iNOS were highly upregulated in all three nerve guide 
groups relative to the autograft, showing around 100-fold increases in iNOS expression 
(Fig. 4.36) and consistent with the histological analysis, the proximal regions show 
upregulation of iNOS relative to the distal in all four groups (Fig. 4.37). Quantification of 
iNOS cytokine levels from tissue homogenate collected from the distal and proximal 
regions via ELISA were consistent with the PCR data collected (Fig. 4.38). The ELISA 
data shows similar levels of iNOS present in the PGS coated groups and autograft while 
the PGA alone had elevated levels of the cytokine by comparison. Additionally, the 
quantification of iNOS levels in the non-operative control leg sciatic nerve had 
significantly lower levels present at 20 pg iNOS per mg tissue compared with the nerve 
guide and autograft groups, which had iNOS levels ranging from 80 to 110 pg per mg 
tissue. While there is some discrepancy in the PCR data relative to the ELISA, this is likely 
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due to the fact that there will be accumulation of iNOS at the wound site over the initial 
seven days of implantation and the gene expression for iNOS could be more rapidly be 
downregulated in the autograft compared to the nerve guide groups at day seven. This 
behavior could be better characterized in potential future studies where earlier and later 
time points were examined for inflammatory profile to better determine the temporal 
effects the different nerve guide configurations have on the level of local inflammation. In 
the case of the ELISA iNOS data, the differences between proximal and distal were less 
prominent as there were small increases in the proximal region cytokine level compared to 
distal for the PGA braid and PGS group that included collagen fiber fillers. 
TNFα, CD86, and IL1β showed less dramatic fold difference relative to the 
autograft though differences were still present between groups. Comparing groups, PGA 
had the highest relative TNFα mRNA expression difference at 8- to 5-fold compared to the 
autograft (Fig. 4.39). PGS and the collagen fiber containing groups showed less TNFα 
expression compared to the uncoated braid, with the collagen fiber group surprisingly 
showing the lower expression at 3- to 5-fold than the PGS only group at 6-fold despite 
having similar M1 macrophage population profiles, iNOS expression, and cytokine levels 
between the two PGS groups. Proximal versus distal differences were nearly non-existent 
for the PGA and PGS with collagen fiber groups (Fig. 4.40). A small decrease in TNFα 
expression at the distal nerve stump was seen with the PGS alone while the autograft had 
a small increase in expression at the distal relative to the proximal. CD86 expression was 
less clear cut than that for TNFα. Expression of CD86 was most elevated in the PGA braid 
alone with similar expression levels seen with the PGS only and autograft groups. Addition 
of collagen very slightly elevated CD86 expression compared to the autograft and PGS 
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coating alone. Similar levels of CD86 expression were seen comparing proximal and distal 
regions with only PGA showing elevation in the distal end. In all cases for CD86, the fold 
difference was very small (< 2-fold difference) leading this particular dataset to be 
inconclusive. IL1β unlike TNFα, showed increased expression in the PGS coated groups 
compared to the uncoated PGA braid. All three nerve guide groups had at least 5-fold 
expression increase for IL1β compared to the autograft. In this case, inclusion of collagen 
fibers increased mRNA expression relative to the PGS coated braid by itself. For all four 
experimental conditions, the proximal region had higher expression levels of IL1β with the 
highest difference between regions being seen in the PGS with collagen fiber group. Distal 
expression of IL1β was similar amongst all three nerve guide groups with variation 
primarily in the proximal region. 
 
4.3.13 Pro-regenerative M2 macrophage population 
 
The M2 macrophage subpopulation was more responsive to changes in nerve guide 
configuration compared to the responsiveness of M1. Of total macrophages, the M2 
population subfraction from isolating cells positive for both CD86 and CD206 were lowest 
in the uncoated PGA braided tube nerve guide at 20% of the macrophage population (Fig. 
4.41). Coating with PGS increased the M2 population to 30% and addition of collagen 
fibers increased this further to 40% of the macrophage population. The autograft 
demonstrated highest M2 population at 60% after seven days of implantation.  Distal 
regions in all groups had higher M2 population fractions. Similar proportional levels of M2 
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macrophages were found in the distal region for both PGS nerve guide groups, the primary 
difference between these two being the proximal portion of the PGS collagen fiber group 
having higher M2 population than the PGS group lacking fibers (30% vs 10%). The PGA 
braid and PGS coating only groups had similar M2 population fractions (10%) with the 
differences between these two groups being a result of the higher M2 fraction in the distal 
end of the PGS coating group. 
Primers for ARG1, CD206, IL10, and PPARγ were used to characterize the 
expression of M2 related markers in the proximal and distal regions of three nerve guides 
per group after being explanted. ARG1 mRNA expression was increased in all three nerve 
guides relative to the autograft (Fig. 4.42). Interestingly, the PGA braid by itself had higher 
ARG1 expression than the PGS coating by itself at 9.5-fold expression increase and 4-fold 
increase respectively compared to the autograft. Highest ARG1 expression was seen with 
the PGS coating group containing collagen fibers at 12-fold increase relative to the 
autograft indicating that collagen fiber inclusion is potentially beneficial to the local 
inflammatory environment. In addition to PCR analysis, ELISA was used to determine 
ARG1 cytokine levels in the same manner as iNOS. Results of this assay were mixed as 
similar levels of ARG1 were detected ranging from 80 ng ARG1 per mg tissue for the PGS 
group and autograft compared to PGA braid and PGS with collagen fiber groups that 
showed 100 ng ARG1 per mg tissue and 140 ng ARG1 per mg tissue (Fig. 4.43). Despite 
small differences, there were no significant differences between nerve guide groups and 
the autograft and all four groups had at least 8-fold increase in ARG1 cytokine levels 
compared to the nonoperative control. 
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As with the M1 markers assayed with PCR, there were substantially lower fold 
differences for M2 markers CD206, IL10, and PPARγ compared to the differences seen 
with ARG1 analysis. CD206 expressions were similar across all groups with PGS only and 
PGA showing a 0.4-fold decrease in expression relative to the autograft (Fig. 4.44). The 
proximal and distal regions for PGA and PGS were similar while the proximal had higher 
relative CD206 expression in the collagen fiber containing group and autograft. IL10 
expression was slightly increased in the PGA group relative to the autograft with the two 
PGS groups showing highest expression at around 3-fold increase relative to autograft. 
Again, proximal regions for the PGS containing groups showed a relative increase in 
expression levels compared to their distal regions although the difference is not significant 
in the PGS group containing collagen (Fig. 4.45). Very slight increase in IL10 expression 
was found in the autograft group. Unlike CD206 and IL10, PPARγ expression was found 
to decrease in the nerve guide groups relative to the autograft although the fold difference 
was small with the PGS braid group having the largest difference at 0.5-fold expression 
relative to the autograft. Also unlike CD206 and IL10 expression, higher mRNA 
expression levels of PPARγ were found in the distal regions for both the PGA braid, PGS 








4.3.14 Comparative M1 and M2 macrophage populations 
 
The relative proportion of the M1 and M2 macrophage populations could be 
calculated from the M2/M1 ratio. Figure 4.46 shows the M2/M1 subpopulation ratios to 
give an indication of the overall pro-inflammatory (M1 type) and pro-healing (M2 type) 
environment in the proximal and distal regions. The overall environment of the autograft 
was the most pro-healing being the only condition that had a M2/M1 ratio > 1. Uncoated 
PGA braid was the most pro-inflammatory environment with an M2/M1 ratio around 0.5, 
which is consistent with the high levels of M1 marker and cytokine expression seen with 
this group. Both PGS groups were pro-inflammatory but to a lesser extent relative to the 
uncoated PGA braid based on their M2/M1 ratios around 0.7. The most pro-healing region 
based on the M2/M1 criteria occurred with the autograft distal region where the ratio took 
on a value of 2 to counteract the pro-inflammatory environment in the autograft proximal 
region with a ratio value of 0.7. In general, distal regions were more pro-healing inclined 
compared to the matching proximal nerve stumps with distal regions for both PGS coating 
groups being near or slightly above a M2/M1 ratio of 1. Proximal regions in all groups 
were found to be pro-inflammatory based on M2/M1 ratio which is consistent with the 
PCR results for iNOS, IL1β, and to a lesser extent TNFα which were all elevated in the 








Axon count differences between the coated and uncoated PGS nerve guide groups 
can be attributed to the differences in compression amongst the groups. The PGS coating 
provides additional mechanical reinforcement to the underlying PGA braided structure that 
help it to resist compressive forces that can reduce the available cross section available for 
axonal outgrowth from the proximal nerve stump. This can be seen where the total nerve 
cross sectional area of the PGA braid alone is reduced relative to the PGS coated braid and 
even the autograft. As a consequence of this, the reduction in axon number crossing the 
gap results in lower action potential amplitude and therefore strength. This leads to much 
lower functional recovery and more pronounced negative secondary effects such as 
increases degree of muscular atrophy. 
The uncoated PGA braid also appears to have a higher level of connective tissue 
formation compared to other groups as indicated by the regions lacking axon ingrowth. 
This is likely due to the increased permeability of inflammatory cells and fibroblasts 
through the gaps in the PGA braid that are not filled by the PGS in the other nerve guide 
groups and the lack of immunomodulatory PGS coating. Some connective tissue is still 
present in the two PGS coated groups but not to the extent seen in the uncoated as these 
groups have cellular infiltration origins limited to the proximal and distal nerve stumps.  
Differences between the PGS coated groups are likely a result of the persistence of 
collagen fibers after 12 weeks implantation. Infiltration of axons into the collagen fibers 
was much lower than that seen in the interstitial space between fibers, leading to a lower 
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effective available cross-sectional space for infiltration of the axonal growth cone. Higher 
magnification images of the nerve cross sections show that the space between collagen 
fibers shows similar density of axons in the two PGS coated nerve guide groups per unit 
area. Higher magnitude images also show more prominent myelin sheath thickness in the 
autograft compared to all three nerve guide groups, although all groups had g-ratios close 
to the often cited value of 0.6 in healthy nerve tissue [27]. The autograft had a distribution 
of axon calibers skewed towards larger relative sizes, further providing evidence into the 
factors responsible for the improved regenerative response seen with the autograft leading 
to the conclusion that increased axon count per nerve is a critical factor that nerve guides 
need to be designed to maximize through creating a microenvironment that minimizes 
connective tissue formation and maximizes the infiltration of the axonal growth cone. 
Interestingly, the PGS coating appears to have a beneficial effect on the formation 
of new vasculature. This is particularly prominent along the region directly interior to the 
PGA braid in the PGS coated groups, where large capillaries can be seen to form that have 
significant presence of red blood cells. High magnification views of collagen fibers show 
some presence capillary formation within the collagen fibers after 12 weeks implantation. 
Collagen fibers also show infiltration of fibroblasts (dark spots) through the core structure 








Figure 4-1: Suture retention test for PGS coated and uncoated PGA multifilament 
braided tubes. Load to failure of PGS coated and uncoated braids, given by peak load 
force following ISO 7198 standards show PGS coating enhances retention strength, 
requiring 20.2 N load force to tear braid compared to 18.6 N for uncoated braids. 





Figure 4-2: Coating of multifilament poly(glycolic acid) (PGA) braided tubes with 
poly(glycerol sebacate) (PGS). Multifilament PGA fibers are braided into a tubular shape 
by the Secant Group, LLC (a) and then coated with PGS (b), filling in porous gaps between 














Figure 4-3: Collagen fiber loading into PGS coated PGA braided tubes. Nerve guide 
preparation. A strand of collagen fiber is tied to the end of a plastic frame (a) and then 
wound around until total filament count in the bundle is at a count of 25, 50, or 100 (b), 
which corresponds to the approximate percentage of luminal space taken up by the collagen 
fibers upon rehydration. Ends are tied off with suture (b) and the bundle is then cut free 
from the frame (c), loaded into the braided nerve guide conduit (d). Dry fiber bundle 
expands to fill the lumen of the NGC when released from the suture tie (e). Upon 
rehydration, fiber bundle takes on gel-like characteristics and fills the conduit (removed 











Figure 4-4: 25, 50, and 100% Secant collagen filament fill density within PGS coated 
nerve guide conduit. Loading of Secant dry collagen fibers within coated nerve guide 
clearly show difference in loading density moving from 25% to 100% rehydrated fill 
density, corresponding to approximately 25 and 100 collagen filaments respectively. 
Relatively high initial dry collagen filament diameter of ~ 90 µm and degree of swelling 
limits fill amount to relatively few discrete sources of topographical guidance relative to 





Figure 4-5: Topographical guidance features of Secant collagen filaments. Secant 
collagen fibers show clover-like aggregate shape (a) due to four outlets dispensing collagen 
precursor solution into an acetone bath. This results in micron scale topography that is 














Figure 4-6: Poor attachment of BMDMs on PGS coated coverslips. BMDMs cultured 







Figure 4-7: Healthy attachment of BMDMs and successful differentiation in absence 
of PGS coating. BMDMs cultured in maintenance (a), M1 macrophage (b), or M2 
macrophage differentiation media (c) show expected healthy cellular morphology in the 
absence of PGS with more rounded and spindle-like morphologies seen as expected for M1 
and M2 macrophages respectively. PCR analysis shows that M1 markers are highly 
upregulated in the presence of M1 differentiation media and that M2 markers show 








Figure 4-8: Effect of PGS coating on M1 differentiation of BMDMs in vitro using 
different levels of M1 differentiation cytokines LPS and IFNγ. Expression of M1 
markers were quantified using qPCR with increasing levels of LPS and IFNγ added to 
differentiation media to determine PGS coatings ability to resist BMDM differentiation 
into M1 phenotype. For all four M1 markers, PGS coating resulted in decreased expression 
relative to TCPS at all concentrations of LPS and IFNγ. Increases in LPS and IFNγ 
concentration increased the fold difference in all M1 markers relative to the unbiased 0 
ng/ml LPS // IFNγ control though the fold difference was much higher on TCPS compared 






Figure 4-9: Effect of PGS coating on M2 differentiation of BMDMs in vitro using 
different levels of M1 differentiation cytokines LPS and IFNγ. Expression of M2 
markers were quantified using qPCR with increasing levels of LPS and IFNγ added to M1 
differentiation media to characterize promotion of differentiation towards the M2 
phenotype. For both M2 markers, PGS coating resulted in decreased expression relative to 
TCPS at all concentrations of LPS and IFNγ except for the ARG1 expression increase seen 






Figure 4-10: PGS degradation product (DP) interferes with normal cell morphology 
and attachment on TCPS as concentration increases. 
PGS degradation product was added differentiation media at various concentrations for 48 
hours to determine effect of PGS DP on cell viability. Attachment and morphology of cells 
did not begin to be noticeably impacted until concentration exceeded 1 mg/ml where 
increasing numbers of cells had a rounded morphology. At the maximum concentration of 





Figure 4-11: PGS degradation product (DP) reduces BMDM viability due to 
increased media acidity. Culture of BMDMs in differentiation media for 48 hours shows 
the acidity of PGS DP surpassing the buffering capacity of the culture media as DP 
concentration exceeds 1 mg/ml. Beyond this point, rapid decrease in cellular mitotic 
activity was detected as pH dropped when comparing the relative fluorescence of Alamar 






Figure 4-12: Relative mRNA expression of M1 markers when BMDMs are exposed 
to PGS degradation product and M1 differentiation media. Exposure to both M1 
differentiation and PGS degradation product had an affected mRNA expression most 
prominently at higher DP concentrations above 0.8 where cell viability and morphology 
were compromised. This relative drop in mRNA expression occurred only at the highest 
tested DP concentrations for iNOS (a) while IL1b and TNFα showed reduction in their 
respective expression above 0.2 mg/ml DP (b, c) with even larger expression drops 






Figure 4-13: Relative mRNA expression of M2 markers when BMDMs are exposed 
to PGS degradation product and M2 differentiation media. Degradation product 
concentrations had little effect on CD206 and ARG1 mRNA expression until degradation 
product levels reached 4 mg/ml and cell viability was affected (a, b). Fizz1 expression 
showed higher sensitivity to DP concentration, showing a small decrease in expression at 






Figure 4-14: Differentiated neural stem cells show higher outgrowth as collagen fiber 
fill density decreases. Differentiated neural stem cells (βIII-Tubulin, red) show highest 
degrees of outgrowth along less densely filled 1.5 mm diameter agarose troughs (a-d). 
Nucleus dense NSC spheroids (DAPI, blue) were mostly found near seeding site on left 
side of collagen fiber bundle and along fiber bundle surface if carried by media during 
seeding (b). Less pronounced neurite spreading was seen with denser fiber fill (c,d) with 
neurites primarily found near collagen fiber bundle surfaces rather than maneuvering 






Figure 4-15: Increased incidence of autophagy in uncoated PGA braided nerve guides 
after implantation using rat sciatic nerve defect model. Wounds resulting from 
autophagy of the foot and/or toes was present in 7 of 8 animals in uncoated PGA braided 
nerve guide groups (a). Addition of PGS coating showed significant autophagy in only 1 
of 8 PGS coating only animals and in 2 of 8 animals when collagen fibers were included 
in the lumen of PGS coated braids with most animals in the two PGS groups showing only 














Figure 4-16: Nerve guide groups show reduced mobility of ankle joint after three 
months compared to autograft and positive controls. All three nerve guide conduit 
groups showed similar levels ankle joint mobility three months post-implantation. 
Autograft showed some improvement but this was still well short of the non-operative 






Figure 4-17: Combined atrophy of gastrocnemius and soleus muscle is highest in 
uncoated PGA braid nerve guidance conduits. Atrophy was highest in the uncoated 
PGA braid at only 26% of the muscle mass remaining after three months implantation 
though the PGS coated braids were not statistically significantly better at 33% of the 
control side muscle mass. Results are consistent with the trends seen with foot angle of 
inclination data where nerve guide groups yielded similar results that were less positive 










Figure 4-18: Onset latency measurements of foot and ankle for all nerve guide groups 
after 12 weeks implantation in rat model. CMAP measurements of onset latency show 
higher latency in foot compared to ankle due to the increased travel distance between 
electrodes placed proximal to the sciatic nerve defect site and the foot compared to ankle. 
Higher weight should be placed on ankle data as the foot measurements can be disrupted 
by autophagy, particularly seen by the large deviations seen in the uncoated braid group. 
Surprisingly, ankle onset speed was actually more rapid in both PGS groups, averaging 
1.59 ms and 1.42 ms for the unfilled and collagen filled PGS respectively, compared to the 
autograft and positive controls having an average of 2.24 ms and 2.01 ms respectively, 






Figure 4-19: Peak latency measurements of foot and ankle for all nerve guide groups 
after 12 weeks implantation in rat model. The propagation speed of the action potential, 
characterized by the peak latency, shows slower signal propagation in the foot, matching 
the onset latency data trends relative to the ankle. Similar onset latency speeds were seen 
in the PGS coated group ankle measurements around 2.9 ms for both unfilled and collagen 
fiber filled and these were very similar to the average value of 3.07 ms measured in the 
positive control. Autograft and the positive control had the lowest differences between foot 
and ankle measurements, consistent with the average level of autophagy in these groups 







Figure 4-20: Action potential amplitudes of foot and ankle as % of control leg for all 
nerve guide groups after 12 weeks implantation in rat model. Action potential 
amplitudes provide one of the best measurements of functional recovery due to the 
requirement of robust regeneration with many axons bridging the defect to occur for high 
signal amplitude. Even autograft results are relatively poor at only 8.8% of the amplitude 
measured in the control ankle, illustrating the need to not only meet, but surpass the 
autograft with nerve guide strategies. Collagen fiber filling in PGS coated PGA braids 
provided better signal amplitude in the ankle compared to the empty PGS coated nerve 
guide. Surprisingly the PGA braid (3.77%) had similar signal amplitude measurements to 
the collagen fiber group (3.71%). These best performing nerve guide groups were still only 






Figure 4-21: Representative mid-graft cross sections of nerve guide explants after 
three months. PGA braid remains visible to provide mechanical support to the nerve guide 
as nerve continues to regenerate in all three groups. Some compression of nerve guide seen 
in uncoated braid (top left) leading to a reduction in nerve cross sectional areas compared 
to PGS coated braids (top right, bottom left). Collagen fibers remain present even after 
three months, reducing some of the potential area available for axonal outgrowth (bottom 
left). Autograft shows darker staining due to more maturation in myelin formation (bottom 
right) and shows similar total nerve cross sectional area to the PGS coated groups. Scale 





Figure 4-22: Axon count per whole nerve cross-section. Higher axon count per nerve 
was seen in the two PGS coated groups (averages of 7263 axons unfilled lumen, 6117 
axons in collagen fiber filled) relative to the uncoated (4260 axons) due to the compression 
seen in the uncoated nerve guides. Coating with PGS provided similar axon count levels 
compared to the autograft (7766 axon average) but addition of collagen fibers slightly 
reduced axon count levels due to the space taken up by the fibers limiting axonal outgrowth 






Figure 4-23: Higher magnification images showing capillary formation within 
collagen fiber and vessel formation near PGA braid. Capillary infiltration seen within 
Secant collagen fibers (top row, red arrows) and also by fibroblasts (yellow arrows). 
Surface of collagen fibers have myelinated axons present implying that some axons are 
following the alignment cues provided by the fibers. Blood vessel formation was seen near 
the PGA braid (bottom row, purple arrows – PGA braid, red arrows – capillaries) leading 
to the possibility that PGS is promoting angiogenesis and the PGA braid alignment is 






Figure 4-24: Average axon cross sectional area in nerve guide conduit and autograft 
after three months of nerve regeneration. The average individual axon cross sectional 
area for all three nerve guide groups were very similar at 8.52, 8.17, 8.24 µm2 for the 
uncoated, PGS coated, and collagen fiber filled nerve guides. These were all lower than the 





Figure 4-25: Calibers of axons with and without myelin layer inclusion for nerve guide 
groups and autograft. Axon diameters were very similar amongst all nerve guide groups 
with autograft being slightly higher as expected from the axon cross section area data. 
Myelin thickness for nerve guide groups were similar at 0.61 to 0.64 µm which were lower 





Figure 4-26: Higher magnitude histology of nerve guide groups and myelin. 
Representative images showing myelin sheath more prominent in the autograft group with 
little scar tissue formation. Minimal scar tissue was seen in the two PGS coated groups but 






Figure 4-27: Distribution of axon diameters for nerve guide groups and autograft. 
Higher spread of axon diameters was seen in the autograft relative to the nerve guide group 
with the autograft having the highest population of axons with diameters of 4 µm or larger 
with 24.6% of the axons having diameters in this range. Nerve guide groups only had at 






Figure 4-28: Myelin sheath g-ratio measurements. The ratio of axon diameter to axon + 
myelin layer diameters, or g-ratio, highly consistent in the nerve guide groups at values of 
0.64, 0.65, and 0.64 for uncoated, PGS coating, and PGS coating with collagen fiber filling 
the lumen respectively. The autograft g-ratio was lower at 0.59 due to the overly thick 
myelin visible in the histological sections. All groups were similar to the typical healthy 






Figure 4-29: Distribution of g-ratios and axon diameters. Thinner myelin sheaths were 
found as axon diameter increased for all groups as indicated by the increase in g-ratio (top 
left: uncoated, top right: PGS coating w/collagen fibers, bottom left: PGS coating only, 
bottom right: autograft). Data spread of the distribution was similar in the three nerve guide 
groups while much more variation and spread was seen in the autograft distribution, 





Figure 4-30: Logarithmic fit of G-ratio - axon diameter distribution. Curve fits of the 
distribution from Figure 4.29 shows clear separation of the autograft distribution profile 






Figure 4-31: Total macrophage population in proximal and distal sections of nerve 
guide groups. The number of CD68+ cells co-stained with DAPI were compared against 
the total number of cells in proximal and distal sections of explanted proximal and distal 
nerve stumps after seven days implantation. In all cases but the uncoated braid, which had 
the highest overall macrophage activity, the distal regions showed elevated macrophage 





Figure 4-32: Immunostaining of representative proximal and distal cross section 
slices after 7d. Macrophages (CD68) in proximal and distal sections for all implanted 
groups after seven days shows highest presence of M2 macrophages (CD206) most 
localized at the surface of the grafts, particularly with the autograft. M1 macrophages 






Figure 4-33: Aggregate cellular infiltration into proximal and distal nerve stump 
regions. Cellular infiltration trended towards being slightly higher in the proximal region, 
particularly in the case of the autograft. The only exception to this trend was the uncoated 
PGA braid. This datum is important to correlate with the total macrophage population data 
graphs of Fig. 4.31 for the autograft because while there were a higher proportion of 
macrophages infiltrating the distal regions, the total number of cells were lower so similar 
absolute macrophage population numbers would be present in both the proximal and distal 
end. With smaller differences in cell population in distal vs proximal nerve stumps for the 







Figure 4-34: Absolute macrophage infiltration into proximal and distal stumps. 
Autograft shows similar levels of macrophage at either stump. All nerve guide groups show 








Figure 4-35: M1 subpopulation of macrophages in proximal and distal regions. 
Proximal regions showed higher proportions of pro-inflammatory macrophages compared 
to distal nerve stumps (top). When combining proximal and distal data, similar overall 
proportions of M1 subpopulation macrophages were seen in the PGS coated group and 
autograft while the uncoated group and collagen fiber group had slightly elevated M1 






Figure 4-36: Expression increase of iNOS after seven days in nerve guide groups. All 
three nerve guide groups show at least 100-fold increases in iNOS expression compared to 






Figure 4-37: Increase of iNOS expression in proximal regions after seven days. All 








Figure 4-38: ELISA of tissue homogenate to measure iNOS levels in proximal and 
distal nerve stumps. Quantification of iNOS levels via ELISA match the results seen with 
the PCR analysis of mRNA expression in regard to the comparative behavior between 
groups and their proximal vs distal behavior. The non-operative control shows background 





Figure 4-39: M1 macrophage marker mRNA expression of TNFα, CD86, and IL-1b 
after seven days. PGS coating resulted in reduced expression of TNFα but increased 
expression of IL-1b. CD86 expression as relatively low in all nerve guide groups, showing 












Figure 4-40: Proximal and distal M1 macrophage marker mRNA expression for 
TNFα, CD86, and IL-1. Little difference was seen comparing the proximal and distal 
nerve stump mRNA expression for TNFα, CD86, or IL-1 due to the low fold differences 










Figure 4-41: Increased M2 subpopulation present in PGS coated nerve guide groups 
compared to uncoated NGCs. All study groups showed a noticeable increase in pro-
healing M2 macrophage subpopulation fractions in the distal region when compared to the 
proximal (top). Increases in relative M2 populations were seen with PGS coated nerve 





Figure 4-42: Higher levels of ARG1 expressed in PGS coated nerve guides containing 
collagen fibers as measured by qPCR. All three nerve guides showed higher expression 






Figure 4-43: ELISA of tissue homogenate to measure ARG1 levels in proximal and 
distal nerve stumps. Quantification of ARG1 levels via ELISA show mixed results where 
only small differences were seen between groups due to the large variation present in the 
proximal cytokine levels of ARG1 detected. While it is difficult to determine differences 
between nerve guide groups on ARG1 expression, all three nerve guides and autograft 





Figure 4-44: M2 macrophage marker mRNA expression of CD206, IL-10, and PPARγ 
after seven days. Expression of CD206 was similar amongst all groups with very low fold 
differences seen. Highest variation in mRNA expression occurred with IL-10 expression, 
where PGS coated groups upregulated expression of the cytokine by several-fold. Like 







Figure 4-45: Proximal and distal M2 macrophage marker mRNA expression for 
CD206, IL-10, and PPARγ. Expression of M2 markers were generally decreased at the 
distal end relative to proximal for CD206 and IL-10. PPARγ expression had high variation 






Figure 4-46: Relative inflammatory environment of NGCs given by M2/M1 ratio. PGS 
coating provided a similar M2/M1 ratio environment that was biased towards M1 
macrophage phenotype with an M2/M1 ratio value of 0.73 without collagen fibers and 0.72 
with. The lack of PGS coating further biased the macrophage phenotype towards M1 with 
an M2/M1 ratio of 0.47 for that group. Only the autograft was highly biased towards M2 
with a ratio of 1.36 (top). Distal nerve stumps in all cases were biased more towards M2 
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Chapter 5   In Vivo Study of Fibrin-Collagen 
Hydrogel Fiber Based Nerve Guides to 
Promote Peripheral Nerve Regeneration 
 
5.1 Background 
5.1.1 Use of fibrin and collagen in nerve guide design 
 
Fibrin and collagen hydrogel fibers loaded in the luminal space of the NGCs 
provide physical guidance for infiltrating SCs instead of the disorganized fibrin clot that 
forms within commercially available hollow NGCs following implantation. The relatively 
rapid proteolytic degradation of fibrin in vivo is advantageous by generating additional 
porosity as the bulk of the growth cone advances through the conduit. Collagen promotes 
cellular attachment as it makes up the bulk of the nerve basal lamina but is less rapidly 
degraded in vivo, resulting in a more persistent material choice for neurotrophic factor 
loading [1]. By using these two fiber types, the duration of the contact guidance and 
temporal porosity present to the cells can be modulated for short- and long-term effects. 
Specific integrin based signaling effects will be triggered using naturally derived collagen 
and fibrin that are not possible with synthetic fibers such as poly(caprolactone) or 
poly(lactide-co-glycolide). The ability to induce phosphorylation of ERK1/2 by fibrin thus 
enabling SC to re-enter the cell cycle and proliferate are added advantage of choosing such 
materials as these for luminal fillers [2, 3].  
Fibrin has frequently been used for nerve regeneration in a variety of ways 
including use as a 3D gel for endometrial stem cell derived neurons [4], a depot for GDNF 
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containing microspheres [5], as a conduit itself [6]. Fibrin is frequently used as a surgical 
glue and even this version of the material has been used for enhancing peripheral nerve 
regeneration [7-9]. Collagen has been investigated for peripheral nerve regeneration 
including as a platform for containing VEGF transfected stem cells [10], along a long gap 
using laminin coated collagen fibers and filaments within a PGA-collagen tube [11, 12], 
and as a composite with chitosan [13]. Collagen has been used as a protective outer conduit 
with clinical success [14, 15]. The structure of collagen has been engineered to contain 
oriented longitudinal pores [16] or to release GDNF and NGF [17]. 
 
5.1.2 Gradient platform modification and development 
 
Preparation of gradients were developed using a modified version of the diffusible 
gradient platform developed by Kellin Krick as presented in his dissertation (May 2016, 
Johns Hopkins University Department of Biomedical Engineering) which were based on 
concepts developed in collaboration with the Khademhosseini lab [18, 19]. Gradient 
developments in the previous work were based on using cast random collagen gels of 
thinner widths (3-5 mm) than the electrospun collagen fiber sheets (10 mm) but similar 
lengths of material at ~10 mm. The original system consisted of a PDMS channel with a 
single source inlet and single sink inlet. While a single inlet worked well for the narrow 
collagen gels used in the process development, attempts at using single pairs of source and 
sinks led to poor gradient quality due to the lateral diffusion that occurred from the central 
position of the inlets. To alleviate this, two additional inlets were added to each of the 
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source and sink sides so that gradients could be prepared using, in essence, a triplet set of 
gradient channels.  
 
5.2 Methods 
5.2.1 Rat sciatic nerve defect repair model and study overview using electrospun 
hydrogel microfibers 
 
As the investigation of PGS coated PGA braids as a nerve guide showed beneficial 
effects in the studies of Chapter 4, we were determined investigate the potential addition 
of electrospun hydrogel fibers as a technique to further enhance nerve repair. To do this, a 
collaboration was formed with SYSU in Guangzhou, China to investigate PGS nerve 
guides containing combinations of fibrin filaments, collagen fiber sheets, and growth factor 
loading in a 17 mm Sprague Dawley rat critical gap sciatic nerve defect model. 
Specifically, nerve guide groups consisted of: 1) Empty PGS coated braids for comparison 
and confirmation of results from the previous in vivo study, 2) unloaded 8 layer collagen 
sheet only, 3) unloaded collagen sheet with 100 µm hydrated diameter fibrin filaments, 4) 
collagen sheet containing 500 ng GDNF with fibrin filaments, 5) collagen sheet containing 
a shallow gradient of 2500 ng/ml/cm steepness with fibrin filaments and 6) collagen sheet 
containing a steeper gradient of 16,666 ng/ml/cm steepness with fibrin filaments. All six 
of these groups were compared against the autograft after 2, 4, 8, and 12 weeks post 
implantation for cellular infiltration and functional recovery (Fig. 5.1). All groups 
containing fibrin filaments were filled with 60 filaments. This is a higher filament count 
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than the 20 collagen filaments used in the previous Secant in vivo study in order to provide 
increased surface area for topographical alignment as that initial study showed such few 
filaments having small impact on regenerative outcome. 
 
5.2.2 Preparation and growth factor loading of fibrin-collagen composite nerve 
guides 
 
Electrospun fibrin filaments were prepared as described in Chapter 2 to a dry 
diameter of 30 μm so that upon loading into the PGS coated PGA braid (Fig. 5.2), the 
swelling degree would fill approximately 95% of the luminal cross sectional area once 
implanted when the fibrin filaments hydrate to 100 μm diameters (Fig. 5.3). Collagen fiber 
sheets were also prepared as described in Chapter 2 for the purpose of providing to a 
platform for loading and release of GDNF and as a secondary source of topographical 
guidance cues for infiltrating neuronal cells. Collagen sheet dry thickness of 60 μm was 
prepared by wrapping 8 layers of EDC crosslinked collagen fiber sheets followed by drying 
in a laminar flow hood after an overnight soak in DI water to remove residual urea from 
the EDC reaction. Collagen sheets were loaded with GDNF via two differing methods 
based on whether gradient or uniform loading was needed. Uniform GDNF loading of 500 
ng sheet was done by taking the dried collagen sheets and applying 500 ng of GDNF in 30 
µl DI and allowing the sheet to rehydrated with this solution and dry again within the 
laminar hood. GDNF was freshly prepared from lyophilized stock before usage so no 
stabilizers such as bovine serum albumin.  
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Gradients of GDNF were loaded into the collagen fiber sheets at both a shallow and 
steep gradient steepness while maintaining a total loading of 500 ng GDNF per sheet. Initial 
preparation for both gradient steepness included initial rehydration of the collagen fiber 
sheets within the PDMS mold chamber by adding 10 µl DI water into each of the three 
source wells and three sink wells for a total rehydration volume of 60 µl. This is to ensure 
that the gradient is formed in a controlled manner via diffusion rather than being soaked 
up by the collagen sheets during rehydration. The shallow gradients with a steepness of 
2500 ng/ml/cm were then prepared by adding 10 µl of 7.0 µg/ml GDNF in each of the three 
sink wells followed by addition of 10 µl of 9.5 µg/ml GDNF in each of the three source 
wells. Steep gradients were prepared to a steepness of 16,666 ng/ml/cm by loading each of 
the three sink wells with 10 µl of DI water and each of the three source wells with 10 µl of 
16.7 µg/ml GDNF. The plastic frames used for collagen fiber sheet collection were marked 
with a dot on the high concentration end of the frame prior to sheet collection to keep track 
of gradient orientation in the sheet during later manipulation to load sheets into the PGS 
coated PGA braid. Gradients were allowed to form over four hours before the collagen 
sheets were removed from the PDMS mold and air dried under laminar flow. 
 
5.2.3 Hydrogel fiber loading into PGS coated nerve guide luminal space 
 
Dried collagen fiber sheets were loaded into the PGS nerve guides in the following 
manner. First, collagen sheets were carefully cut free from the plastic frames using a razor 
blade, taking particular care with the gradient loaded sheets to keep track of the gradient 
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orientation. Sheets were then carefully folded in half and placed over the top of three taped 
down 7-0 nylon or 6-0 plain gut sutures. The folding of collagen fiber sheet is an important 
step for loading into the nerve guide as this “twins” the sheet layers providing additional 
surface area for topographical guidance and eases the loading of the collagen sheet into the 
nerve guidance conduit relative to an unfolded sheet. The collagen sheet is then gently and 
loosely tied along all three suture positions to form an initial tube-like structure with the 
sheet. It is important to not completely tie the sutures during this step as their purpose is to 
better control the tie of the suture in the next part of preparation and will need to be later 
removed (Fig. 5.4a). Once the loose tube is formed, one end of the collagen sheet is tightly 
tied with the suture, leaving several cm extra length of suture available for pulling through 
the PGS nerve guide. This extra length of suture is threaded through a small bore sewing 
needle and tied. As the PGS has some residual tackiness even after curing, there is 
sometimes risk of the collagen sheet sticking to the walls of the nerve guide midway 
through being loaded. To alleviate this, the collagen tube can be briefly dipped into 70% 
EtOH, which acts as a lubricant to improve loading efficiency of the collagen sheet. The 
needle is drawn through the PGS braid until the tied collagen sheet is just about to enter 
the nerve guide. At this point, corrections to alignment can be made with a pair of sharp 
point tweezers and the initial mm or so of the tied end of the collagen sheet can be manually 
loaded into the nerve guide. Once all alignments and initial partial load are complete, the 
needle can be carefully pulled until the collagen sheet is completely pulled through the 
nerve guide. At this point, the needle is cut free along with any residual suture ties (Fig. 
5.4b). Centrally located sutures are difficult to reach without disrupting the collagen sheet, 
so in these cases, the plain gut sutures must be used as they will rapidly degrade upon 
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implantation. The EtOH in the tube is allowed to evaporate and then the completed nerve 
guides are stored at 4°C until use. 
A small variation in conduit preparation must be made when fibrin filaments are to 
be used as a secondary source of topographical alignment. In this instance, fibrin filaments 
are placed on top of the folded collagen sheets when those sheets are positioned on top of 
the tie sutures. When positioned in this way, the fibrin filaments are removed from their 
collection frames so they are spread across the collagen sheet. When sufficient fibrin 
filaments are positioned, ~60 filaments in this study, the fibrin sheets are bundled together 
inside the collagen sheet as it is tied. This combined collagen-fibrin construct can then be 
loaded into the PGS braided tubes using the same procedures as with the collagen sheets 
alone. 
 
5.2.4 Examination of implanted nerve guides following 8 weeks implantation  
 
Gross histological examination of nerve guides was made after 8 and 12 weeks 
implantation in order to visualize the overall structure of regenerating nerve tissue and 
qualitatively assess the stability of the PGS coated PGA braided tubes containing 






5.2.5 Functional recovery assessment 
 
Assays to characterize regenerative potential include electrophysiological 
characterization of compound muscle action potential (CMAP) measurements of the signal 
conduction through the nerve guide. Measurements of functional recovery included 
muscular atrophy, electrophysiological CAMP measurements, along with histological 
analysis of axon caliber, myelin thickness, g-ratio, and cellular infiltration. Gait analysis 
was also conducted using SFI scale. 
 
5.2.6 Gait analysis using Sciatic Functional Index (SFI) after 8 weeks implantation 
 
Functional recovery of the rat sciatic nerve was assessed after 8 weeks using Sciatic 
Functional Index (SFI) measurements of foot spreading along a walking track for all nerve 
guide groups for comparison with the autograft at prior to surgery and at 1, 4, 6, and 8 
weeks for four animals per group. SFI values were calculated as follows: 
𝑆𝐹𝐼 = (−38.3 ∗ 𝑃𝐿𝐹) + (109.5 ∗ 𝑇𝑆𝐹) + (13.3 ∗ 𝐼𝑇𝐹) − 8.8 






5.2.7 Histological analysis of implanted nerve guides after 8 weeks implantation 
 
Longitudinal sections of nerve guide region tissue were collected after 8 weeks for 
histological analysis of the cellular infiltration. Sections were stained using Masson’s 
trichrome to visualize collagenous connective tissue (blue), cell cytoplasm (pink) and 
nuclei (dark red). Myelination properties were characterized using standard staining of 
mid-graft nerve cross sections with toluidine blue to stain the myelin for characterization 
of myelin thickness and for assistance in counting myelinated axon density. 
 
5.3 Results and Discussion 
5.3.1 Gradient formation in collagen hydrogel fiber sheets 
 
Establishment of gradients in aligned collagen fiber sheets (Fig. 5.5) were tested by 
making steep and shallow FITC-lysozyme gradients over 6 hours. Fluorescence 
microscopy shows that this process was able to successfully generate gradients with 
different properties when source and sink wells were loaded with differing concentrations 
of FITC-lysozyme (Fig. 5.6). As the testing of gradient formation using a modification of 
the original Krick diffusible system was successful, gradients were prepared using GDNF 




5.3.2         Examination of explanted nerve guides following 8 and 12 weeks implantation 
 
Fibrin fiber containing groups showed a high degree of variability in tissue 
thickness along the nerve guide (Fig. 5.7). Some regions were particularly narrow to the 
point of pinching off the potential avenue for cellular migration across the gap. In these 
cases, little sign of the PGS braided tube still remains after 8 weeks. This is surprising as 
there were no issues with catastrophic degradation in the earlier preliminary study using 
PGS braided tubes in chapter 4. It is possible that a higher magnitude inflammatory 
response caused by contamination of fibrin fiber containing groups accelerated the 
degradation of the PGS coating and PGA braided tube due to increased hydrolysis of the 
ester linkage in the PGS backbone caused by an decrease in the local microenvironment 
pH due to the increased inflammatory response allowing the PGA to be more readily 
degradable. While there were several regions of very narrow tissue, others were swollen 
much beyond the expected nerve diameter seen in other groups. In these cases, there was 
prominent incidence of yellow discoloration throughout the vicinity of the nerve guide with 
particularly high amounts in the lumen region of the NGC. This severely inhibited the 
ingrowth of neuronal cells through the nerve guide, resulting in no successful functional 
recovery being detected by electrophysiological analysis and severe levels of atrophy seen 
of the gastrocnemius muscle compared to the non-operative positive control side in all 
fibrin fiber containing groups. 
Based on the extra swelling seen in the fibrin containing nerve guide groups and 
the extensive yellow discoloration, it appears that the groups were contaminated at some 
point prior to implantation. To test this, a repeat of fibrin containing groups was run for 8 
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weeks after additional sterilization using Co60. Unfortunately, these results will not be 
completed prior to submission of this dissertation. Once results are known, it should be 
better clarified if the issue had been due to contamination causing infection or if the 
discoloration is due massive fibrosis caused by fibrin fibers degrading too slowly and 
inducing a large fibrotic graft versus host response that blocks the pathway to the distal 
nerve stump. This swelling response and discoloration was seen in all groups containing 
fibrin filaments regardless of the GDNF loading conditions. 
Gross examination of the PGS groups lacking fibrin filaments appear to be much 
better. Tissue structure is more uniform in diameter, particularly in the region of the PGS 
braided tube. There is some buildup of connective tissue at the distal nerve stump which is 
consistent with what was seen in the previous nerve guide study of Chapter 4 (Fig. 5.8). 
Both of these groups show significant reduction in the yellow discoloration seen with the 
fibrin fiber filament groups. PGS tubes in both the unloaded collagen fiber sheet and empty 
lumen groups showed lower degrees of degradation compared to the fibrin filament 
containing groups.  
 
5.3.3 Gait analysis results after 8 weeks implantation 
 
SFI data are plotted for all groups in (Fig. 5.9). There is a clear drop in all groups 
during the first week after sciatic nerve removal and replacement with nerve guides or 
autograft. Improvements in SFI are seen at each time point compared to the previous for 
all groups. All groups showed similar levels of recovery to the autograft, a surprising result 
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given that the electrophysiological data from CMAP measurements were so poor after 8 
weeks in fibrin containing groups and the atrophy was so significant in these groups. By 8 
weeks, SFI had recovered to values between -65 and -55 for all groups, but results were 
not different enough to conclude that there was any difference between groups for SFI 
recovery. 
 
5.3.4 Histological analysis of explanted nerve tissue after 8 weeks NGC implantation 
 
Figure 5.10 shows a longitudinal section taken from the steep GDNF gradient and 
no GDNF groups, containing fibrin filaments within the PGS coated PGA braided tube. A 
large clump of material is seen in the median section of the nerve graft that correlates with 
the bulging seen with the gross histological examination. There seems to be two separate 
regions of cellular behavior in this case, where broken up material is seen on the proximal 
side (left) compared to a large collagen positive stained clump on the distal (right) portion 
of the median region. It is very likely that the collagen positive region is the collagen sheet 
that has been compressed, either through the action of cellular traction or compression 
during initial loading. The fragmented region is likely the remains of the fibrin fibers, 
particularly if these were separated from the collagen sheet during loading as this material 
would be expected to degrade much more rapidly than the collagen once implanted. 
The entire bulge region shows significant incidence of fibrosis surrounding the 
material clump in the median region. The precise cause of this incidence of fibrosis is 
unknown at this time as it could be the result of several potential causes. The high fibrosis 
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seen could be a result of the host response to the potential contamination of the nerve 
guides. This will be better understood once the small repeat 8 week group is completed 
following Co60 irradiation to re-sterilize the samples. Should high fibrosis still remain 
present after the additional sterilization, the source of fibrosis would likely be a result of 
either extended persistence of fibrin filaments or host response to the xenograft materials 
used in the study. While it looks like fibrin fibers are possibly degraded in this histological 
slice, more slices will need to be analyzed to determine if this behavior is seen in other 
samples and to compare other timepoints to better see the persistence of fibrin filaments 
within the nerve guides at 4 and 12 weeks. The distal side of this slice shows higher 
incidence of scar tissue formation compared to the proximal end as seen by the higher 
levels of blue staining. This is consistent with our previous study using PGS coated PGA 
nerve guides, where distal ends were generally larger than the proximal end when gross 
histological analysis was performed. Cellular infiltration into the never guide looked very 
good until reaching the electrospun hydrogel fiber materials, which effectively acted as a 
plug preventing connection of the cellular ingrowth to the distal end. 
Toludine blue stained cross sections (Fig. 5.11) show some shrinkage of the PGS 
coating only group nerve guide, which is somewhat unexpected given the results of the 
study from Chapter 4. It is possible that the coating of this batch degraded more rapidly or 
was thinner, causing the PGA braids to be exposed more rapidly and enabling the nerve 
guide to be susceptible to compressive forces. The unloaded collagen fiber sheet group 
shows no distinguishable region of collagen that lack cellular infiltration meaning that the 
density of collagen fiber sheets were low enough to enable cellular migration through the 
material. High magnification images of the cross sections (Fig. 5.12) show thicker myelin 
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sheaths in the autograft, as seen in the previous study. The two nerve guide groups show 
similar myelin thicknesses with the collagen fiber sheet group having slightly higher 




While it is unfortunate that the potential contamination or graft versus host response 
to fibrin filaments led to the loss of potential data demonstrating the effectiveness of GDNF 
uniform and gradient loading in collagen fiber sheets, this study has still been able to 
demonstrate that aligned electrospun collagen sheets do not prevent cellular migration 
through the material. This is important in that future studies can focus on usage of only the 
collagen sheets for loading and exclude the fibrin filaments. While fibrin filaments may 
potentially be able to improve nerve regeneration by providing rapidly degradable 
topographical cues, which would open up porosity for axonal growth cone infiltration to 
chase Schwann cells, the high labor cost of generating the discrete fibrin filaments and 
increased complexity of nerve guide preparation are not worth the effort. It is also 
important to consider that while topographical alignment cues from nanofibers have 
improved nerve regeneration, such nanofibers are able to present thousands of aligned 
pathways for directing cells, which is significantly higher than the filament loading level 
that can reasonably be achieved with fibrin filaments. A better potential method for 
incorporating 3D fiber guidance cues for Schwann cells may lie back in the beginning with 
the use of alginate fibers that have cell adhesive cues such as RGD conjugated to the 
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polymer backbone since the alginate fibers form discrete micron-scale fibers when 
hydrated. Ultimately, the best near term strategy for using electrospun hydrogel fibers in 
nerve regeneration would be expected to be usage of only collagen fiber sheets with more 
controlled methods of gradient formation with a protective outer nerve guide such as the 
PGS coated PGA braids, which proved to be valuable in both nerve guide studies for 








Figure 5-1: SYSU in vivo rat sciatic nerve defect animal study groups. Nerve guide 
conduit configurations are assembled to investigate the effect gradient steepness on 
regenerative outcome (G1 vs G2) and as compared to (G3) to characterize any impact the 
“candy store” effect might have on regeneration and if it can be avoided using gradient 
presentation of GDNF. Group 4 serves as an unloaded control to assess fiber addition alone. 
Group 5 serves as an empty nerve guide control and for comparison with the nerve guide 
studies of Chapter 4 and the autograft serves as an additional control. Group 7 tests the 
effect that addition of fibrin filaments might have on regeneration compared to collagen 












Figure 5-2: Loading of PGS coated braids with hydrogel fibers. Aligned collagen fiber 
sheet fills lumen of PGS coated braid and maintains open space interior to the sheets (a). 
Fibrin fibers provide longitudinal topographical guidance cues (b). Cellular outgrowth 
from DRG explant after 7 days culture shows migration of cells along rehydrated fiber 








Figure 5-3: Fill density of lumen cross section as a function of fibrin filament loading 
level for 40, 100, and 200 μm hydrated fibrin filaments. Collagen sheets take up 
approximately 70% of internal cross-sectional space within nerve guide, leaving 30% for 
fibrin fiber filaments. As fiber filaments increase in diameter, maximum number of 
filaments possible to load in lumen are decreased (solid lines). Green lines indicate fibrin 
filament diameters used in NGC study, showing a maximum possible filament loading 





Figure 5-4a: Preparation of fibrin-collagen hydrogel fiber nerve guide. Nerve guide 
preparation. Fibrin fibers are spun for 1 min at 3.25 ml/hr flow rate and collected on 3 cm 
 1.5 cm plastic frame, keeping 6-10 fibers separated from each other during wrapping and 
drying (a). Two suture guidelines (black) are taped down perpendicular to direction of 
fibrin filaments. Fibrin filament ends are pressed down from frame onto dual sided 
adhesive tape and detached from frame, repeat until 60 fibers have been laid down (b). 
Fibrin fiber bundle ends are tied together using sutures (c). Two (or three) secondary plain 
gut sutures are placed underneath bundles approximately 1/3 (and 1/2) the distance interior 
to the two suture ends (d). Air-dried collagen hydrogel fiber sheet (unloaded or GDNF 






Figure 5-4b: Preparation of fibrin-collagen hydrogel fiber nerve guide. Nerve guide 
preparation. One end of collagen fiber sheet is carefully tied with plain gut suture, ensuring 
that fibrin filaments on that end are captured within the collagen wrap (g). Opposite end of 
collagen fiber sheet is tied (h). Excess suture is threaded through eye of sewing needle (i) 
and needle is drawn through PGS coated PGA braided tube (j). Sheet is carefully positioned 
into lumen of coated braid, ethanol can be used as a lubricant if needed, (k) and drawn 






Figure 5-5: Diffusible gradient generation in collagen sheets utilizing modified Krick 
method. Diffusible gradients are prepared by placing dried collagen fiber sheets on Teflon 
surface (a). PDMS mold with triple set of 3 mm punch channels (yields ~2 mm diameter 
hole) is placed over top of collagen sheet frame (b) and sheets are rehydrated by pipetting 
10 μl of DI water into each well (c). Cover placed over high concentration source wells 
and 10 μl of low concentration factor is pipetted into each of the three sink wells (d). Sink 
wells are covered and 10 μl of high concentration solution is added to each source well (e). 
Both source and sink wells are covered and samples are placed in 4°C for six hours to 
establish gradient (f, Fig. 5-6). PDMS covers and mold are removed and sheets are air dried 





Figure 5-6: Testing of diffusible gradient generation in collagen fiber sheets using 
FITC-lysozyme and Krick method. Previous design from thesis of Dr. Kellin Krick was 
based on a 4 mm x 10 mm channel with single pair of source and sink drains for forming 
diffusible gradients (a1). Modification of this concept to incorporate the 1 cm x 1 cm 
collagen sheets was done by introducing two additional source and sink drains on either 
side of the PDMS mold used for gradient (a2). Through addition of 10 μl of 100 μg/ml 
FITC-lysozyme in each source drain and 10 μl of 0 or 25 μg/ml FITC-lysozyme to each 
sink drain, gradient parameters could be controlled to generate different gradient steepness 
visualized with fluorescence microscope images (b) and plotted as intensity versus position 






Figure 5-7: Gross histological examination of fibrin filament containing groups after 
8 and 12 weeks. All fibrin filament containing groups showed extensive signs of either 
graft versus host response or contamination as indicated by the high prevalence of yellow 
infected tissue (c1). The elevated inflammatory response caused a significant increase in 
PGS braid degradation rate (a1, a2) when compared with initially implanted PGS braid (e). 
Samples at the 12-week time point looked slightly better (a2, b2, c2), possibly indicating 
that 8-week fibrin filaments were contaminated while 12-week were not. Distal end on 






Figure 5-8: Gross histological examination of PGS coating only and unloaded collagen 
sheet only groups after 8 weeks. Unlike fibrin filament containing groups, the NGCs 
containing no filler or having only unloaded collagen fiber sheets did not show signs of 












Figure 5-9: Sciatic functional index (SFI) results after 8 weeks NGC implantation. SFI 












Figure 5-10: Longitudinal sections of steep GDNF and no GDNF groups stained with 
Masson’s Trichrome after 8 weeks. Both of these fibrin filament groups show a highly 
collagenous clumping of material that is likely part of the massive inflammation or 
infection seen in these groups in the 8-week time point. The steep GDNF group (top) shows 






Figure 5-11: Toludine blue stained whole cross sections of PGS coating only and 
collagen fiber sheet only groups mid-graft after 8 weeks. PGS coating only group (left) 
shows some shrinkage compared to the collagen fiber sheet group. This shrinkage was not 
seen in the previous Secant study so it is possible that the batch of PGS used in this study 
more rapidly degraded, allowing the PGA braid to compress. Collagen fiber sheet only 
group shows no discrete regions lacking cellular infiltration, demonstrating that cells are 








Figure 5-12: High magnification images of myelinated axons in PGS coating only, 
autograft, and collagen fiber sheet only groups after 8 weeks. Myelination quality looks 
similar between the two nerve guide groups (bottom) and there is a good distribution of 
myelinated axons throughout the ROI. The autograft shows thicker myelin formation than 






Figure 5-13: Myelinated axon density and myelin sheath thickness for unfilled PGS 
coated PGA braid, autograft, and collagen fiber sheet only groups after 8 weeks. 
Autograft highest density of myelinated axons per unit area from histological analysis of 
mid-graft cross sections stained with toluidine blue (a) while collagen fiber sheet 
containing groups show a small increase in myelinated axon density compared to the empty 
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